<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29354029</article-id>
<article-id pub-id-type="pmc">5758507</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2017.00421</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Microglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tay</surname>
<given-names>Tuan Leng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/502442/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Béchade</surname>
<given-names>Catherine</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/501886/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>D’Andrea</surname>
<given-names>Ivana</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/501577/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>St-Pierre</surname>
<given-names>Marie-Kim</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/501600/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Henry</surname>
<given-names>Mathilde S.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/496036/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roumier</surname>
<given-names>Anne</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/447138/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tremblay</surname>
<given-names>Marie-Eve</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/51155/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institute of Neuropathology, University of Freiburg</institution>, <addr-line>Freiburg</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Faculty of Biology, University of Freiburg</institution>, <addr-line>Freiburg</addr-line>, <country>Germany</country></aff>
<aff id="aff3"><sup>3</sup><institution>INSERM UMR-S 839</institution>, <addr-line>Paris</addr-line>, <country>France</country></aff>
<aff id="aff4"><sup>4</sup><institution>Sorbonne Universités, Université Pierre et Marie Curie (UPMC)</institution>, <addr-line>Paris</addr-line>, <country>France</country></aff>
<aff id="aff5"><sup>5</sup><institution>Institut du Fer à Moulin</institution>, <addr-line>Paris</addr-line>, <country>France</country></aff>
<aff id="aff6"><sup>6</sup><institution>Axe Neurosciences, CRCHU de Québec—Université Laval</institution>, <addr-line>Québec, QC</addr-line>, <country>Canada</country></aff>
<aff id="aff7"><sup>7</sup><institution>Département de Médecine Moléculaire, Université Laval</institution>, <addr-line>Québec, QC</addr-line>, <country>Canada</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Alexej Verkhratsky, University of Manchester, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Cinzia Volonté, Consiglio Nazionale delle Ricerche (CNR), Italy; Björn Spittau, Universitätsmedizin Rostock, Germany</p>
</fn>
<corresp id="fn001">*Correspondence: Tuan Leng Tay <email xlink:type="simple">tuan.leng.tay@uniklinik-freiburg.de</email> Anne Roumier <email xlink:type="simple">anne.roumier@inserm.fr</email> Marie-Eve Tremblay <email xlink:type="simple">tremblay.marie-eve@crchudequebec.ulaval.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>421</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Tay, Béchade, D’Andrea, St-Pierre, Henry, Roumier and Tremblay.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Tay, Béchade, D’Andrea, St-Pierre, Henry, Roumier and Tremblay</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Microglia are the predominant immune response cells and professional phagocytes of the central nervous system (CNS) that have been shown to be important for brain development and homeostasis. These cells present a broad spectrum of phenotypes across stages of the lifespan and especially in CNS diseases. Their prevalence in all neurological pathologies makes it pertinent to reexamine their distinct roles during steady-state and disease conditions. A major question in the field is determining whether the clustering and phenotypical transformation of microglial cells are leading causes of pathogenesis, or potentially neuroprotective responses to the onset of disease. The recent explosive growth in our understanding of the origin and homeostasis of microglia, uncovering their roles in shaping of the neural circuitry and synaptic plasticity, allows us to discuss their emerging functions in the contexts of cognitive control and psychiatric disorders. The distinct mesodermal origin and genetic signature of microglia in contrast to other neuroglial cells also make them an interesting target for the development of therapeutics. Here, we review the physiological roles of microglia, their contribution to the effects of environmental risk factors (e.g., maternal infection, early-life stress, dietary imbalance), and their impact on psychiatric disorders initiated during development (e.g., Nasu-Hakola disease (NHD), hereditary diffuse leukoencephaly with spheroids, Rett syndrome, autism spectrum disorders (ASDs), and obsessive-compulsive disorder (OCD)) or adulthood (e.g., alcohol and drug abuse, major depressive disorder (MDD), bipolar disorder (BD), schizophrenia, eating disorders and sleep disorders). Furthermore, we discuss the changes in microglial functions in the context of cognitive aging, and review their implication in neurodegenerative diseases of the aged adult (e.g., Alzheimer’s and Parkinson’s). Taking into account the recent identification of microglia-specific markers, and the availability of compounds that target these cells selectively <italic>in vivo</italic>, we consider the prospect of disease intervention via the microglial route.</p>
</abstract>
<kwd-group>
<kwd>microglia</kwd>
<kwd>early-life stress</kwd>
<kwd>microgliopathies</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>major depressive disorder</kwd>
<kwd>schizophrenia</kwd>
<kwd>aging</kwd>
<kwd>neurodegenerative disease</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Canadian Institutes of Health Research<named-content content-type="fundref-id">10.13039/501100000024</named-content></funding-source>
<award-id rid="cn001">RN283856 - 353750</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content></funding-source>
<award-id rid="cn002">DFG, TA1029/1-1</award-id>
</award-group>
<award-group>
<funding-source id="cn003">Fondation pour la Recherche Médicale<named-content content-type="fundref-id">10.13039/501100002915</named-content></funding-source>
<award-id rid="cn003">DEQ2014039529</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="356"></ref-count>
<page-count count="26"></page-count>
<word-count count="23699"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>The modulation of higher order cognitive functions and the dysregulation thereof that leads to neuropsychiatric diseases may commonly be attributed to brain wiring and neural connectivity. Nevertheless, mounting evidence that non-neural microglia play critical and specific roles during brain development, homeostasis and plasticity, with consequences on neurodevelopmental and neuropsychiatric disorders, should be strongly considered in this context (reviewed in Prinz and Priller, <xref ref-type="bibr" rid="B237">2014</xref>; Tay et al., <xref ref-type="bibr" rid="B300">2017b</xref>). Microglia are tissue resident macrophages of the central nervous system (CNS) parenchyma that share the same yolk sac origin as other long-living tissue macrophages (Gomez Perdiguero et al., <xref ref-type="bibr" rid="B77">2015</xref>). Thus the myeloid identity of microglia makes this population unique within the CNS, as they could be strong candidates for therapeutic interventions, without direct impact on cell types of the neuroectodermal lineage within the brain. Previously we examined in detail the growing literature on the varied roles exerted by microglial cells in the healthy brain, across the lifespan, during which they are constant surveillants, and not simply orchestrators of immune responses (reviewed in Tremblay, <xref ref-type="bibr" rid="B308">2011</xref>; Tremblay et al., <xref ref-type="bibr" rid="B310">2011</xref>; Tay et al., <xref ref-type="bibr" rid="B300">2017b</xref>). Here we expand the discussion and focus on the impact of defective microglial physiological roles, from prenatal to aged CNS, on the emergence of various neurodevelopmental, neuropsychiatric and neurodegenerative disorders, and discuss the potential for treatment by specifically targeting microglial cells.</p>
</sec>
<sec id="s2">
<title>Establishment and Maintenance of CNS Microglia</title>
<p>Even when considering the microglia distinct from other CNS cell types, it is important to recognize their unifying characteristics as much as their inherent differences. The mesodermal microglial network begins to establish itself at 9.0 days post conception in the murine CNS, prior to the appearance of the neuroectodermal lineage (reviewed in Tay et al., <xref ref-type="bibr" rid="B298">2016</xref>, <xref ref-type="bibr" rid="B300">2017b</xref>). Several studies support the notion that yolk sac-derived endogenous microglia of the brain parenchyma are a self-maintaining population that persists and functions throughout the animal’s lifespan (Alliot et al., <xref ref-type="bibr" rid="B3">1999</xref>; Ajami et al., <xref ref-type="bibr" rid="B1">2007</xref>; Ginhoux et al., <xref ref-type="bibr" rid="B74">2010</xref>; Hashimoto et al., <xref ref-type="bibr" rid="B97">2013</xref>; Hoeffel et al., <xref ref-type="bibr" rid="B110">2015</xref>). Yet, recent lineage tracing studies that were conducted in mouse or in human, using genetic approaches, integration of thymidine analogs (Askew et al., <xref ref-type="bibr" rid="B8">2017</xref>; Tay et al., <xref ref-type="bibr" rid="B299">2017a</xref>) or carbon dating (Réu et al., <xref ref-type="bibr" rid="B244">2017</xref>), have provided further evidence that microglial lifespan varies across brain compartments (Lawson et al., <xref ref-type="bibr" rid="B155">1992</xref>). The significance of the varied turnover kinetics of microglia on their brain microenvironment is currently unclear. While this myeloid population purportedly originates from a single erythromyeloid progenitor (Ginhoux et al., <xref ref-type="bibr" rid="B74">2010</xref>; Gomez Perdiguero et al., <xref ref-type="bibr" rid="B77">2015</xref>), microglial heterogeneity is reflected in their varied distribution and morphology within the CNS (Lawson et al., <xref ref-type="bibr" rid="B156">1990</xref>; De Biase et al., <xref ref-type="bibr" rid="B46">2017</xref>), alongside brain region-dependent differences in gene expression (Doorn et al., <xref ref-type="bibr" rid="B54">2015</xref>), bioenergetics, and immunophenotype (Grabert et al., <xref ref-type="bibr" rid="B83">2016</xref>). Variations in microglial density between male and female parietal cortex, amygdala, hippocampus, and preoptic area (Schwarz et al., <xref ref-type="bibr" rid="B264">2012</xref>; Lenz et al., <xref ref-type="bibr" rid="B159">2013</xref>), and sex differences in microglial response to neuropathic pain (Sorge et al., <xref ref-type="bibr" rid="B282">2015</xref>), have been reported in mice. Groundbreaking studies also proposed that the microenvironment in which microglia evolve influences their tissue-specific identities due to a selection pressure for exclusive gene enhancers (Gosselin et al., <xref ref-type="bibr" rid="B81">2014</xref>, <xref ref-type="bibr" rid="B82">2017</xref>; Lavin et al., <xref ref-type="bibr" rid="B154">2014</xref>). Nonetheless, we are still in a conundrum as microglia have, until now, mostly been investigated as a single entity as compared to other cells of myeloid origin (Hickman et al., <xref ref-type="bibr" rid="B104">2008</xref>; Butovsky et al., <xref ref-type="bibr" rid="B27">2012</xref>, <xref ref-type="bibr" rid="B26">2014</xref>; Gautier et al., <xref ref-type="bibr" rid="B72">2012</xref>; Chiu et al., <xref ref-type="bibr" rid="B35">2013</xref>).</p>
<p>What are the factors required for the establishment and maintenance of microglia? We reviewed this in detail previously (Tay et al., <xref ref-type="bibr" rid="B300">2017b</xref>). Here we discuss the new players reported during this past year and briefly highlight the key transcription factors and signaling pathways that are particularly significant to the associated pathologies covered below. Signaling via the microglial colony-stimulating factor 1 receptor (CSF1R; Ginhoux et al., <xref ref-type="bibr" rid="B74">2010</xref>; Erblich et al., <xref ref-type="bibr" rid="B60">2011</xref>; Elmore et al., <xref ref-type="bibr" rid="B59">2014</xref>) in particular via the alternative CSF1R ligand interleukin (IL)-34, was reported to be necessary for the survival and proliferation of microglia throughout early to adult stages (Greter et al., <xref ref-type="bibr" rid="B84">2012</xref>; Wang et al., <xref ref-type="bibr" rid="B329">2012</xref>). In various contexts, the purinergic ionotropic receptor P2X7 (Rigato et al., <xref ref-type="bibr" rid="B246">2012</xref>), and cytokine transforming growth factor β (TGFβ; Butovsky et al., <xref ref-type="bibr" rid="B26">2014</xref>) were described to regulate microglial cell density and maturation. The recruitment of microglia into CNS compartments where they provide essential support during development requires fractalkine (CX3CL1/CX3CR1) signaling (Maggi et al., <xref ref-type="bibr" rid="B174">2011</xref>; Paolicelli et al., <xref ref-type="bibr" rid="B219">2011</xref>; Rogers et al., <xref ref-type="bibr" rid="B249">2011</xref>; Hoshiko et al., <xref ref-type="bibr" rid="B116">2012</xref>; Ueno et al., <xref ref-type="bibr" rid="B312">2013</xref>; Zhan et al., <xref ref-type="bibr" rid="B348">2014</xref>; Pagani et al., <xref ref-type="bibr" rid="B214">2015</xref>; Hellwig et al., <xref ref-type="bibr" rid="B102">2016</xref>; Milior et al., <xref ref-type="bibr" rid="B187">2016</xref>) and neurogenesis-dependent CXCL12/CXCR4 signaling (Arnò et al., <xref ref-type="bibr" rid="B6">2014</xref>). More recent studies also unveiled the importance of transcription factors such as MAFB (Matcovitch-Natan et al., <xref ref-type="bibr" rid="B179">2016</xref>) and Sal-like 1 (SALL1; Buttgereit et al., <xref ref-type="bibr" rid="B28">2016</xref>; Koso et al., <xref ref-type="bibr" rid="B144">2016</xref>) for maintenance of adult microglial homeostasis and function. Besides the transmembrane protein 119 (TMEM119), a microglia-specific cell surface protein of unknown function expressed from early postnatal development until adulthood (Bennett et al., <xref ref-type="bibr" rid="B12">2016</xref>), <italic>Sall1</italic> was proposed to constitute a microglial signature gene considering its lack of expression in other mononuclear phagocytes and CNS cell types (Buttgereit et al., <xref ref-type="bibr" rid="B28">2016</xref>). Regulating the phagocytic functions of adult microglia, the TAM receptor tyrosine kinases MER and AXL were described to be necessary for the removal of apoptotic cells resulting from adult neurogenesis (Fourgeaud et al., <xref ref-type="bibr" rid="B69">2016</xref>). Microglia lacking TAM were shown to be less motile <italic>in vivo</italic> with delayed response to brain damage, thus underscoring the importance of MER and AXL in modulating microglial physiology (Fourgeaud et al., <xref ref-type="bibr" rid="B69">2016</xref>). From a systematic analysis of the transcriptional regulation and epigenetic signature of microglia from yolk sac to adult stages, three distinct temporal stages of microglial development, namely the early-microglia, pre-microglia and adult microglia, were unveiled. The authors further demonstrated that the microglial developmental program is sensitive to environmental perturbations such as prenatal immune activation and microbiome alteration (Matcovitch-Natan et al., <xref ref-type="bibr" rid="B179">2016</xref>). Indeed, it was shown earlier that reconstitution of the gut of mice raised in a germ-free facility with short-chain fatty acid by-products of bacterial fermentation was sufficient to recover a normal ramified microglial phenotype (Erny et al., <xref ref-type="bibr" rid="B61">2015</xref>).</p>
</sec>
<sec id="s3">
<title>Physiological Functions of Microglia in the Brain</title>
<p>Microglia fulfill their roles during development, homeostasis and plasticity mainly through their sensing and scavenging activities, and secretion of trophic factors, cytokines and chemokines. The physiological functions of microglia at steady-state, previously discussed at length (Tay et al., <xref ref-type="bibr" rid="B300">2017b</xref>), are summarized below to provide a context for our main discussions on the impact of defective microglia on psychiatric disorders.</p>
<p>In CNS development, microglia regulate the turnover of neural precursors and neurons by phagocytosis of apoptotic cells and excess newborn neurons (Marín-Teva et al., <xref ref-type="bibr" rid="B176">2004</xref>; Peri and Nüsslein-Volhard, <xref ref-type="bibr" rid="B226">2008</xref>; Swinnen et al., <xref ref-type="bibr" rid="B296">2013</xref>). Furthermore, microglia support neurogenesis, neuronal survival, and the maintenance and maturation of oligodendrocyte progenitor cells through their release of trophic cytokines, also in the adult brain (Sierra et al., <xref ref-type="bibr" rid="B277">2010</xref>; Arnò et al., <xref ref-type="bibr" rid="B6">2014</xref>; Hagemeyer et al., <xref ref-type="bibr" rid="B91">2017</xref>; Wlodarczyk et al., <xref ref-type="bibr" rid="B400">2017</xref>). The positioning of microglial cells along axonal tracts suggests a role in neuronal wiring during embryonic and postnatal stages (Cho et al., <xref ref-type="bibr" rid="B36">2013</xref>; Squarzoni et al., <xref ref-type="bibr" rid="B285">2014</xref>). From early postnatal development until normal aging, a main contribution of microglia in the healthy brain is their activity-based regulation of neuronal activity and synaptic plasticity, which is notably exerted through the refinement of synaptic connections (Wake et al., <xref ref-type="bibr" rid="B324">2009</xref>; Tremblay et al., <xref ref-type="bibr" rid="B309">2010</xref>; Bialas and Stevens, <xref ref-type="bibr" rid="B15">2013</xref>). Real-time two-photon <italic>in vivo</italic> imaging has provided convincing evidence that microglia are extremely dynamic cells. Surveillant microglia continuously extend and retract highly motile processes to interact with their microenvironment, including synapses, at all stages of life (Davalos et al., <xref ref-type="bibr" rid="B45">2005</xref>; Nimmerjahn et al., <xref ref-type="bibr" rid="B204">2005</xref>; Wake et al., <xref ref-type="bibr" rid="B324">2009</xref>; Tremblay et al., <xref ref-type="bibr" rid="B309">2010</xref>; Li et al., <xref ref-type="bibr" rid="B164">2012</xref>). Microglia-synapse interactions regulate the formation and elimination of synapses. As professional phagocytes of the CNS, microglia engulf axon fragments and terminals, as well as dendritic spines, thereby contributing to a crucial pruning function that is regulated by neuronal activity, learning and memory, and the ongoing experience (Watts et al., <xref ref-type="bibr" rid="B330">2004</xref>; Tremblay et al., <xref ref-type="bibr" rid="B309">2010</xref>; Paolicelli et al., <xref ref-type="bibr" rid="B219">2011</xref>; Schafer et al., <xref ref-type="bibr" rid="B258">2012</xref>; Bialas and Stevens, <xref ref-type="bibr" rid="B15">2013</xref>; Squarzoni et al., <xref ref-type="bibr" rid="B285">2014</xref>). Activity- or learning-based dendritic spine formation (Parkhurst et al., <xref ref-type="bibr" rid="B221">2013</xref>; Miyamoto et al., <xref ref-type="bibr" rid="B189">2016</xref>) is mediated through microglial release of brain-derived neurotrophic factor (BDNF; Parkhurst et al., <xref ref-type="bibr" rid="B221">2013</xref>), and their elimination of axon terminals by a TGFβ-dependent cascade that involves the complement proteins C1q and C3 tagging synapses for microglial complement receptor 3 (CR3)-mediated removal (Schafer et al., <xref ref-type="bibr" rid="B258">2012</xref>; Bialas and Stevens, <xref ref-type="bibr" rid="B15">2013</xref>). Fractalkine signaling is also required for hippocampal-associated learning and memory, and the adaptation to a stressful or enriched environment (Maggi et al., <xref ref-type="bibr" rid="B174">2011</xref>; Rogers et al., <xref ref-type="bibr" rid="B249">2011</xref>; Milior et al., <xref ref-type="bibr" rid="B187">2016</xref>). Taken together, functional microglia are essential for synaptic formation, maintenance and plasticity, as well as remodeling of neural networks in response to learning and environmental challenges.</p>
</sec>
<sec id="s4">
<title>Contribution of Microglia to the Environmental Risk Factors for Psychiatric Diseases</title>
<p>Enduring fevers or maternal infections during pregnancy, and physiological injuries at birth (e.g., infection, hypoxia-ischemia and trauma) increase the risk for autism, attention deficit and hyperactivity disorder, and schizophrenia (Patterson, <xref ref-type="bibr" rid="B223">2009</xref>; Brown and Derkits, <xref ref-type="bibr" rid="B22">2010</xref>; Knuesel et al., <xref ref-type="bibr" rid="B142">2014</xref>; Hagberg et al., <xref ref-type="bibr" rid="B90">2015</xref>; Hornig et al., <xref ref-type="bibr" rid="B115">2017</xref>; Instanes et al., <xref ref-type="bibr" rid="B126">2017</xref>). Childhood maltreatment that comprises physical or emotional neglect and sexual abuse, is considered a major risk factor for adult psychiatric conditions that include eating disorders, alcohol and drug abuse, as well as depression (Kessler et al., <xref ref-type="bibr" rid="B141">2010</xref>; Scott et al., <xref ref-type="bibr" rid="B265">2012</xref>). Maternal immune activation is considered a “neurodevelopmental disease primer” that combines with genetics and other environmental cues to induce mental disorders (reviewed in Knuesel et al., <xref ref-type="bibr" rid="B142">2014</xref>; Meyer, <xref ref-type="bibr" rid="B185">2014</xref>) Similarly, stressful events during adulthood, or chronic post-traumatic disorder, increase the risk for depression (Kessler, <xref ref-type="bibr" rid="B140">1997</xref>), accelerate aging, and may favor neurodegenerative disorders, including the sporadic, late onset, forms of Alzheimer’s disease (AD) and Parkinson’s disease (PD; Fidler et al., <xref ref-type="bibr" rid="B65">2011</xref>; Miller and Sadeh, <xref ref-type="bibr" rid="B188">2014</xref>). Such challenges could increase the vulnerability to psychiatric disorders by disrupting microglial functions. Microglial “priming” or increased sensitivity to subsequent insults is one of the proposed mechanisms. Primed microglia differ from reactive cells (frequently referred to as “activated microglia” in literature), by displaying increased expression of genes related to phagocytosis, proliferation, and vesicular release (Orre et al., <xref ref-type="bibr" rid="B211">2014</xref>; Holtman et al., <xref ref-type="bibr" rid="B113">2015</xref>). The response to inflammatory challenges is exacerbated in primed microglia, which release increasing amounts of cytokines (Norden et al., <xref ref-type="bibr" rid="B206">2015</xref>). Priming could also prevent microglia from exerting their normal physiological functions, directly impairing neurogenesis, synaptogenesis, and the wiring of brain circuits, with severe impacts on learning, memory and other cognitive processes (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Models of non-physiological microglia and their impacts on the onset of disease. <bold>(A)</bold> Normal microglia-neuron interactions in the central nervous system (CNS). <bold>(B)</bold> An early microglial dysfunction due to genetic or environmental (e.g., maternal or perinatal stress, inflammation, dietary deficiency) risk factors can lead to impaired neuronal functions and an early emergence of neurodevelopmental disorders. Aberrant release of cytokines, impaired pruning and phagocytic activities can affect neuronal densities, maturation and wiring, thus translating into permanent defects of the neural network. These include an imbalance of excitability to inhibition, or altered connectivity between brain regions, which are sufficient to induce the onset of psychiatric disorders during childhood (e.g., Nasu-Hakola disease (NHD), hereditary diffuse leukoencephaly with spheroids (HDLS), Rett syndrome (RTT), autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD)), or render an individual vulnerable to subsequent insults. <bold>(C)</bold> An early environmental challenge can prime microglia by altering their maturation and inflammatory states with limited immediate impacts on the neuronal network, thus resulting in asymptomatic changes. However, primed microglia are rendered more susceptible to subsequent challenges such as stress or chronic infections, and may adopt abnormal patterns of cytokine secretion or synaptic pruning later in life. These changes may progressively damage the neural system during puberty and adulthood, leading to the emergence of psychiatric disorders (e.g., alcohol and drug abuse, major depressive disorder (MDD), schizophrenia, bipolar disorder (BD), eating disorders and sleep disorders). <bold>(D)</bold> Changes to microglial phenotypes occurring during adulthood may be accelerated by genetic or environmental factors. Non-physiological microglia may have reduced capability to restore CNS homeostasis, or contribute to neurodegeneration and altered wiring, which result in the onset of cognitive disorders in adult [as in <bold>(C)</bold>] and aged patients (e.g., Alzheimer’s disease (AD), dementia and Parkinson’s disease (PD)).</p>
</caption>
<graphic xlink:href="fnmol-10-00421-g0001"></graphic>
</fig>
<p>As sentinels, microglia are likely the first CNS cell type to sense psychological stress and peripheral inflammation, and mediate the effects of perinatal challenges on the developing brain. Offspring exposed to lipopolysaccharide (LPS; from gram-negative bacteria) during embryonic development show mispositioned cortical interneurons at postnatal stages (Squarzoni et al., <xref ref-type="bibr" rid="B285">2014</xref>) and altered glutamatergic transmission as well as long-term potentiation (LTP) in adolescence (Roumier et al., <xref ref-type="bibr" rid="B251">2008</xref>). Animals challenged by inflammation during pre- or post-natal development, or maternal separation, exhibit long-lasting microglial alterations, including an increased prevalence of ameboid morphologies (reviewed in Boksa, <xref ref-type="bibr" rid="B21">2010</xref>; Johnson and Kaffman, <xref ref-type="bibr" rid="B129">2017</xref>). Early-life stress and prenatal inflammation also induce changes in microglial molecular signature (<italic>C1q</italic> and <italic>Cx3cr1</italic>) and phagocytic activity <italic>ex vivo</italic> (Delpech et al., <xref ref-type="bibr" rid="B50">2016</xref>; Mattei et al., <xref ref-type="bibr" rid="B181">2017</xref>), but their effects on phagocytosis are opposite, with prenatal inflammation being inhibitory (Mattei et al., <xref ref-type="bibr" rid="B181">2017</xref>). Prenatal inflammation accelerates the transcriptomic maturation profile of early postnatal microglia towards an adult signature (Matcovitch-Natan et al., <xref ref-type="bibr" rid="B179">2016</xref>). This shift may restrict microglial physiological functions at crucial stages of development, leading to connectivity alterations or excitatory/inhibitory synapses imbalance, and associated behavioral deficits. Maternal or perinatal stress or immune challenge in rodents, induced by cytokines or surrogates of bacteria (LPS) or viruses (viral RNA mimic polyinosinic-polycytidylic acid; Poly I:C), result in behavioral defects at adolescence or adulthood. These comprise anxiety, impairment of memory, sociability and sensorimotor gating, increased repetitive behavior and enhanced psychostimulants sensitivity (reviewed in Weinstock, <xref ref-type="bibr" rid="B331">2001</xref>; Meyer and Feldon, <xref ref-type="bibr" rid="B186">2009</xref>; Boksa, <xref ref-type="bibr" rid="B21">2010</xref>; Careaga et al., <xref ref-type="bibr" rid="B31">2017</xref>). In the offspring exposed to maternal immune challenge, abnormalities in dopaminergic and GABAergic systems, including increased dopaminergic afferences in the nucleus accumbens (NAc) and decreased inhibition of parvalbumin-positive interneurons on cortical pyramidal neurons were also reported (reviewed in Meyer and Feldon, <xref ref-type="bibr" rid="B186">2009</xref>; Estes and McAllister, <xref ref-type="bibr" rid="B62">2016</xref>).</p>
<p>In addition to stress and infections, epidemiological studies on n-3 poly-unsaturated fatty acids (PUFA), contained mainly in seafood and fishes, but not produced by humans, support the belief that a well-balanced diet is essential. An n-3 PUFA-rich maternal diet was shown to improve the intelligence quotient of children (Helland et al., <xref ref-type="bibr" rid="B101">2008</xref>), whereas the absence of dietary n-3 PUFA negatively impacted on the intellectual performances (Hibbeln et al., <xref ref-type="bibr" rid="B103">2007</xref>; reviewed in Luchtman et al., <xref ref-type="bibr" rid="B168">2013</xref>). In mice, an n-3 PUFA-deficient diet during gestation induced the deregulation of hippocampal <italic>Egr1</italic>, <italic>c-Jun, Bdnf</italic> associated with neuronal plasticity in the adolescent offspring. These deleterious effects correlated with impaired microglial motility (in <italic>Cx3cr1-GFP</italic> reporter mice) and decreased expression of inflammation-associated genes <italic>ex vivo</italic>, without alteration in IBA1-positive microglial number (Madore et al., <xref ref-type="bibr" rid="B172">2014</xref>). Further investigation is warranted to determine whether these effects resulted from the anti-inflammatory properties of n3-PUFA acting on microglia, or indirectly from changes in the gut microbiota (Madore et al., <xref ref-type="bibr" rid="B171">2016</xref>). Microglia are affected by other nutritional factors. For instance, a high-fat and high-sucrose maternal diet that induces gestational diabetes in rats, a condition that is associated with decreased cognitive performance and psychiatric disorders in humans, increased the protein levels of pro-inflammatory cytokines and the prevalence of ameboid IBA1-positive microglia in rat neonates (Vuong et al., <xref ref-type="bibr" rid="B321">2017</xref>). Such diet also impaired object memory and induced a shift of hippocampal microglia toward less ramified morphologies in the adult offspring (Vuong et al., <xref ref-type="bibr" rid="B321">2017</xref>). At adulthood, high-fat diet reduces spine density in the dentate gyrus and prefrontal cortex, in addition to impairing novel object memory (Bocarsly et al., <xref ref-type="bibr" rid="B20">2015</xref>; Hao et al., <xref ref-type="bibr" rid="B96">2016</xref>). This diet enhanced the length of IBA1-positive microglial processes (Bocarsly et al., <xref ref-type="bibr" rid="B20">2015</xref>) and the phagocytic activity of isolated microglia toward synaptosomes (Hao et al., <xref ref-type="bibr" rid="B96">2016</xref>), which could mediate the induced changes in connectivity. The saturated fatty acids, which are overrepresented in high-fat, Western-type diet, and which accumulate in the hypothalamus, exert direct pro-inflammatory effects on microglia (identified by IBA1, CD11b or CD68 staining), both in culture and <italic>in vivo</italic> (Valdearcos et al., <xref ref-type="bibr" rid="B314">2014</xref>).</p>
</sec>
<sec id="s5">
<title>Roles of Microglia in Neurodevelopmental Disorders</title>
<p>Abnormal wiring of brain circuits during development is proposed to underlie mood instability, abnormal behavior, and cognitive defects that may arise and develop later in life. Here we review the evidence that certain psychiatric diseases with a neurodevelopmental origin are linked to an early microglial dysfunction (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Genetic and environmental implications for the role of microglia in the progression of psychiatric diseases across the lifespan. Pathologies caused by, or linked to, genetic risk factors are marked with an orange star. Disease-associated priming of microglia due to environmental risk factors, such as perinatal inflammation, maternal and early life stress, dietary imbalance and chronic stress during adulthood, is indicated with a gray star.</p>
</caption>
<graphic xlink:href="fnmol-10-00421-g0002"></graphic>
</fig>
<p>Nasu-Hakola disease (NHD) and <italic>hereditary diffuse leukoencephaly with spheroids</italic> (HDLS) are human diseases associated with behavioral and cognitive alterations resulting from mutations in genes expressed by microglia. These diseases, termed “microgliopathies” (Rademakers et al., <xref ref-type="bibr" rid="B240">2011</xref>), can be considered neurodevelopmental as the microglial mutations affect brain development from prenatal stages, even though disease onset occurs around the fourth decade of life.</p>
<p>NHD is a rare autosomal microgliopathy with a psychiatric outcome, characterized by presenile dementia and bone cysts resulting in premature death (Hakola, <xref ref-type="bibr" rid="B93">1972</xref>; Nasu et al., <xref ref-type="bibr" rid="B202">1973</xref>). The most characteristic abnormalities observed in the postmortem brain of NHD patients comprise a marked loss of myelin, the presence of axon spheroids, astrogliosis, and CD68-positive cells with a large soma and few processes, named “activated microglia”, in the white matter of frontal and temporal lobes (Paloneva et al., <xref ref-type="bibr" rid="B215">2001</xref>). NHD is caused by recessive gene mutations of <italic>DAP12</italic> (<italic>TYRO Protein Tyrosine Kinase Binding Protein</italic>) or <italic>TREM2</italic> (<italic>Triggering Receptor Expressed On Myeloid Cells 2</italic>, Paloneva et al., <xref ref-type="bibr" rid="B216">2000</xref>, <xref ref-type="bibr" rid="B217">2002</xref>; Bianchin et al., <xref ref-type="bibr" rid="B16">2004</xref>). DAP12 is a transmembrane protein that transduces signals from several lymphoid and myeloid receptors including TREM2. In mice, <italic>Trem2</italic> and <italic>Tyrobp</italic> (the gene encoding DAP12) are expressed by a variety of innate immune cells (Lanier and Bakker, <xref ref-type="bibr" rid="B152">2000</xref>), such as microglia in the CNS (Roumier et al., <xref ref-type="bibr" rid="B250">2004</xref>; Wakselman et al., <xref ref-type="bibr" rid="B325">2008</xref>; Hsieh et al., <xref ref-type="bibr" rid="B118">2009</xref>; Hickman et al., <xref ref-type="bibr" rid="B105">2013</xref>). The molecular mechanisms linking the TREM2-DAP12 pathway to NHD remain elusive. However, analysis of DAP12-deficient mice revealed several neuronal alterations at adulthood, notably enhanced hippocampal LTP (Roumier et al., <xref ref-type="bibr" rid="B250">2004</xref>) and impaired sensorimotor gating (Kaifu et al., <xref ref-type="bibr" rid="B133">2003</xref>), which could account for the cognitive and behavioral symptoms of NHD patients. Transcriptional profiling of DAP12-deficient microglia at embryonic day 17.5 revealed a down-regulation of genes involved in neurite formation accompanied by defasciculation of corpus callosum axons (Pont-Lezica et al., <xref ref-type="bibr" rid="B236">2014</xref>), while the lack of DAP12 impaired the outgrowth of dopaminergic axons and altered the positioning of neocortical interneurons in prenatal mice (Squarzoni et al., <xref ref-type="bibr" rid="B285">2014</xref>). A role for TREM2-DAP12 pathway in clearing apoptotic neurons was also demonstrated in microglial culture (Takahashi et al., <xref ref-type="bibr" rid="B297">2005</xref>; Wakselman et al., <xref ref-type="bibr" rid="B325">2008</xref>) and during developmental cell death <italic>in vivo</italic> in mice (Takahashi et al., <xref ref-type="bibr" rid="B297">2005</xref>; Wakselman et al., <xref ref-type="bibr" rid="B325">2008</xref>). These data show that prenatal dysfunction of microglia due to compromised TREM2-DAP12 signaling can affect synaptic function as well as axonal outgrowth and guidance, which may trigger psychiatric defects in humans.</p>
<p>Another microgliopathy is HDLS, a rare autosomal dominant disease defined by progressive motor, behavioral, and cognitive alterations leading to severe dementia (Axelsson et al., <xref ref-type="bibr" rid="B9">1984</xref>). Studies have shown that HDLS patients present degenerative alterations reminiscent of NHD (Axelsson et al., <xref ref-type="bibr" rid="B9">1984</xref>; Rademakers et al., <xref ref-type="bibr" rid="B240">2011</xref>; Sundal et al., <xref ref-type="bibr" rid="B294">2012</xref>; Konno et al., <xref ref-type="bibr" rid="B143">2014</xref>). HDLS is caused by mutations in the tyrosine kinase domain of <italic>CSF1R</italic> (Rademakers et al., <xref ref-type="bibr" rid="B240">2011</xref>). In mouse brain, <italic>Csf1r</italic> is expressed by microglia (Geissmann et al., <xref ref-type="bibr" rid="B73">2010</xref>) and, as mentioned above, is essential to their development and maintenance. The mechanisms linking CSF1R dysfunction to HDLS remain unknown. However, DAP12 regulates the ability of CSF1R to control the survival and proliferation of bone marrow-derived macrophages <italic>in vitro</italic> (Otero et al., <xref ref-type="bibr" rid="B212">2009</xref>). This suggests that NHD and HDLS may involve a deficit of the same signaling pathway, induced through their respective mutations of <italic>TYROBP</italic>, <italic>TREM2</italic> or <italic>CSF1R</italic> genes.</p>
<p><italic>Rett syndrome</italic> (RTT) is a X-linked mental disorder affecting mostly girls, with an onset in the first 2 years of life, in which multiple neurologic, motor, digestive and respiratory symptoms combine with an intellectual disability (Chahrour and Zoghbi, <xref ref-type="bibr" rid="B33">2007</xref>). The disease is caused by mutations in the (<italic>MECP2</italic>) gene encoding the transcription repressor methyl-CpG-binding protein 2 (Amir et al., <xref ref-type="bibr" rid="B4">1999</xref>). As RTT patients and genetic mouse models exhibit dendritic abnormalities such as decreased spine density (reviewed in Xu et al., <xref ref-type="bibr" rid="B342">2014</xref>), the disease was originally attributed to <italic>MECP2</italic> deficiency in the neurons. However, studies of RTT mouse models have shown that all types of glial cells including microglia ubiquitously express this gene. In mice, the loss of <italic>Mecp2</italic> in microglia leads to the release of high levels of glutamate, resulting in neurotoxicity and dendritic damage <italic>in vitro</italic> (Maezawa and Jin, <xref ref-type="bibr" rid="B173">2010</xref>). Recently, microglia (in <italic>Cx3cr1-GFP</italic> reporter mice) were implicated in RTT through their excessive removal of axon terminals at disease end-stages in <italic>Mecp2</italic> null mice (Schafer et al., <xref ref-type="bibr" rid="B257">2016</xref>). However, this process was independent from microglial loss of <italic>Mecp2</italic> expression, suggesting their contribution to the pathological “de-wiring” through the engulfment of synaptic elements rendered vulnerable by the loss of <italic>Mecp2</italic> in neurons or other glial cells (Schafer et al., <xref ref-type="bibr" rid="B257">2016</xref>).</p>
<p><italic>Autism spectrum disorders (ASDs)</italic> are characterized by impaired social communication as well as restrictive and repetitive patterns of interest and behaviors. ASDs are diagnosed at 2–3 years of age, often with clinical signs visible earlier. A common anatomical endophenotype is the transient brain overgrowth measured between 2 and 6 years of age that normalizes during adolescence or adulthood (reviewed in Courchesne et al., <xref ref-type="bibr" rid="B41">2007</xref>, <xref ref-type="bibr" rid="B40">2011</xref>). The cause is unknown, but may reflect abnormal axonal sprouting, cell proliferation, or deficient removal of neurons, synapses or glial cells. Impairment in the processing and integration of multiple sensory and emotional inputs, characteristic of ASD, was proposed to result from connectivity defects, notably related to dysregulated neurogenesis and neuronal migration (Packer, <xref ref-type="bibr" rid="B213">2016</xref>). The connectivity hypothesis is consistent with the local variations of spine density, e.g., increased among cortical layers (Hutsler and Zhang, <xref ref-type="bibr" rid="B124">2010</xref>), and altered excitation/inhibition ratio observed in sensory, social or emotional brain regions of ASD patients (Rubenstein and Merzenich, <xref ref-type="bibr" rid="B253">2003</xref>). Moreover, among the hundreds of genes associated with ASD by genome-wide association studies and whole genome sequencing (Betancur, <xref ref-type="bibr" rid="B14">2011</xref>; Pinto et al., <xref ref-type="bibr" rid="B231">2014</xref>; Yuen et al., <xref ref-type="bibr" rid="B347">2017</xref>), several were found to be involved in synapse assembly and maintenance (Peca and Feng, <xref ref-type="bibr" rid="B224">2012</xref>; Pinto et al., <xref ref-type="bibr" rid="B231">2014</xref>; Yuen et al., <xref ref-type="bibr" rid="B347">2017</xref>). Postmortem transcriptional analyses of ASD brain samples additionally showed a down-regulation of expression modules enriched with genes related to synaptic transmission (Voineagu et al., <xref ref-type="bibr" rid="B319">2011</xref>; Gupta et al., <xref ref-type="bibr" rid="B87">2014</xref>).</p>
<p>Considering the physiological role of microglia in neurogenesis control, circuit wiring, as well as synapse stabilization and pruning, their function in ASD has been investigated (reviewed in Koyama and Ikegaya, <xref ref-type="bibr" rid="B145">2015</xref>; Edmonson et al., <xref ref-type="bibr" rid="B58">2016</xref>). One of the first postmortem studies of ASD patients reported an increased immunoreactivity for MHC class II (HLA-DR) within the cerebellum and cerebral cortical regions (Vargas et al., <xref ref-type="bibr" rid="B318">2005</xref>). Since then, other postmortem studies confirmed that microglial alterations, mainly related to cellular density, soma volume and complexity of ramifications, were more frequent in ASD patients than age-matched controls (Morgan et al., <xref ref-type="bibr" rid="B193">2010</xref>; Lee et al., <xref ref-type="bibr" rid="B158">2017</xref>). However, not all ASD cases exhibited microglial abnormalities (Morgan et al., <xref ref-type="bibr" rid="B193">2010</xref>), which may reflect a diversity of etiologies. Increased binding for translocator protein (TSPO), notably expressed by microglia and induced in response to inflammatory stimuli (Rupprecht et al., <xref ref-type="bibr" rid="B254">2010</xref>; Karlstetter et al., <xref ref-type="bibr" rid="B136">2014</xref>; Sandiego et al., <xref ref-type="bibr" rid="B256">2015</xref>), was also measured by positron emission tomography (PET) imaging in several brain regions of ASD patients (Fatemi et al., <xref ref-type="bibr" rid="B63">2012</xref>; Suzuki et al., <xref ref-type="bibr" rid="B295">2013</xref>). Dysregulation of microglia in ASD is supported by postmortem transcriptional analyses showing an upregulation of gene expression modules enriched with microglial markers (Voineagu et al., <xref ref-type="bibr" rid="B319">2011</xref>), and genes associated with an anti-inflammatory state and the anti-viral type-I interferon pathway (Gupta et al., <xref ref-type="bibr" rid="B87">2014</xref>). Rare genetic variants of <italic>CX3CR1</italic> were also associated with an increased risk of ASD (Ishizuka et al., <xref ref-type="bibr" rid="B127">2017</xref>). <italic>Cx3cr1</italic> knockout mice displayed phenotypes reminiscent of autism such as repetitive behavior and social interaction defects that could be caused by abnormal connectivity (Paolicelli et al., <xref ref-type="bibr" rid="B219">2011</xref>; Zhan et al., <xref ref-type="bibr" rid="B348">2014</xref>). In these mice, the survival of cortical neurons was impaired (Ueno et al., <xref ref-type="bibr" rid="B312">2013</xref>), hippocampal excitatory synapses showed morphological and physiological features of immaturity (Paolicelli et al., <xref ref-type="bibr" rid="B219">2011</xref>; Rogers et al., <xref ref-type="bibr" rid="B249">2011</xref>; Zhan et al., <xref ref-type="bibr" rid="B348">2014</xref>), the maturation of glutamatergic thalamocortical synapses was delayed during postnatal development (Hoshiko et al., <xref ref-type="bibr" rid="B116">2012</xref>), while the positioning of neocortical interneurons was altered prenatally (Squarzoni et al., <xref ref-type="bibr" rid="B285">2014</xref>). These defects could result from a delayed microglial colonization of specific brain regions including the hippocampus and cerebral cortex during development (Paolicelli et al., <xref ref-type="bibr" rid="B219">2011</xref>; Hoshiko et al., <xref ref-type="bibr" rid="B116">2012</xref>; reviewed in Paolicelli et al., <xref ref-type="bibr" rid="B218">2014</xref>). Overall, these findings indicate that environmental risk factors, particularly perinatal infection, could impair the crucial synaptic pruning function of microglia (Knuesel et al., <xref ref-type="bibr" rid="B142">2014</xref>; Delpech et al., <xref ref-type="bibr" rid="B50">2016</xref>; Mattei et al., <xref ref-type="bibr" rid="B181">2017</xref>). The prevalence of microglia with a primed morphology that was observed in a subset of young (6-year-old) ASD patients (Morgan et al., <xref ref-type="bibr" rid="B193">2010</xref>) support this hypothesis of an active, causative role of microglia, but direct evidence is lacking. Microglial priming might alternatively reflect a secondary reaction to neuronal apoptosis and circuit rewiring that occurred to compensate for an early brain overgrowth or increase in spine density.</p>
<p><italic>Obsessive-compulsive disorder</italic> (OCD) is characterized by recurrent and uncontrollable thoughts (obsessions) and actions (compulsions) leading to socially-invalidating behaviors such as stereotypy, trichotillomania and excessive cleaning. It is considered a heterogeneous disorder with distinct subtypes having different etiologies (Hirschtritt et al., <xref ref-type="bibr" rid="B109">2017</xref>). Based on a knockout mouse model for the homeobox gene <italic>Hoxb8</italic>, expressed in the myeloid lineage, which showed compulsive grooming (Chen et al., <xref ref-type="bibr" rid="B34">2010</xref>), microglial genetic deficiency was proposed to induce OCD. It was also reported that patients with frontotemporal dementia that carried mutations of the gene encoding progranulin (<italic>GRN</italic>), as well as mice deficient for this gene, displayed OCD and self-grooming behavior, respectively (Lui et al., <xref ref-type="bibr" rid="B169">2016</xref>; Krabbe et al., <xref ref-type="bibr" rid="B147">2017</xref>). While <italic>Grn</italic> function and expression pattern remain poorly-defined, microglia from <italic>Grn</italic> knockout mice, when co-cultured with neurons, more actively internalized synaptophysin-positive puncta that co-labeled with C1qa, correlating with a selective loss of inhibitory synapses in the ventral thalamus (Lui et al., <xref ref-type="bibr" rid="B169">2016</xref>; Krabbe et al., <xref ref-type="bibr" rid="B147">2017</xref>). This loss could contribute to the thalamic hyperexcitability measured in these mice (Lui et al., <xref ref-type="bibr" rid="B169">2016</xref>; Krabbe et al., <xref ref-type="bibr" rid="B147">2017</xref>), which is reminiscent of the dysfunctional striato-thalamo-cortical circuits described in OCD patients (Burguière et al., <xref ref-type="bibr" rid="B23">2015</xref>). Crossing the <italic>Grn</italic> knockout mice with <italic>C1qa</italic> knockout mice prevented the excessive synaptic pruning and rescued the OCD phenotype (Lui et al., <xref ref-type="bibr" rid="B169">2016</xref>). Microglia-specific <italic>Grn</italic> knockouts similarly displayed an excessive grooming phenotype at adulthood (Krabbe et al., <xref ref-type="bibr" rid="B147">2017</xref>), further implicating microglia in this disorder.</p>
</sec>
<sec id="s6">
<title>Roles of Microglia in Adult Neuropsychiatric Diseases</title>
<p>Genome-wide studies revealed an association of immune, neuronal and synaptic pathways with several adult neuropsychiatric diseases (The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium, <xref ref-type="bibr" rid="B302">2015</xref>), suggesting that the inflammatory CNS milieu and microglia are implicated in these disorders, either in pathogenesis or progression. In this section, we review the pre- and clinical evidence that altered microglial physiological functions may contribute to psychiatric disorders with an onset in late adolescence or adulthood (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>).</p>
<p><italic>Alcohol and drug abuse</italic> result in cognitive impairment and neurodegeneration. The proposed mechanisms, mainly derived from animal studies, include signaling through microglial Toll-like receptors (TLR), which form a subfamily of pattern recognition receptors (PRRs) allowing innate immune cells to detect changes in homeostasis through the recognition of an array of pathogen-associated molecular patterns (PAMPs; linked to microbial pathogens and cellular stress) and danger-associated molecular patterns (DAMPs; released by cellular damage). The recruitment of TLRs contributes to amplifying microglial release of pro-inflammatory mediators (Stridh et al., <xref ref-type="bibr" rid="B292">2013</xref>; Yao et al., <xref ref-type="bibr" rid="B343">2013</xref>).</p>
<p>A first binge of ethanol in rats induced microglial priming leading to increased immunoreactivity for CR3 and IBA1, and enhanced hippocampal levels of TNFα (tumor necrosis factor alpha), upon a subsequent intake (Marshall et al., <xref ref-type="bibr" rid="B177">2016</xref>). Alcohol exposure in mice similarly potentiated the effects of LPS on brain levels of IL-1β and TNFα, impaired hippocampal neurogenesis, and increased immunoreactivity against IBA1 (Qin et al., <xref ref-type="bibr" rid="B239">2008</xref>). After an acute binge of alcohol in mice, microglial depletion by treatment with a CSF1R inhibitor (PLX5622) increased the brain levels of anti-inflammatory genes, while reducing pro-inflammatory ones (e.g., <italic>Tnfa</italic>, <italic>Ccl2</italic>, Walter and Crews, <xref ref-type="bibr" rid="B326">2017</xref>). Supporting TLRs involvement in microglial pro-inflammatory state upon alcohol exposure, administration of the TLR3 agonist Poly I:C before alcohol enhanced brain levels of TNFα, IL-1β, IL-6 and MCP-1 (monocyte chemoattractant protein-1) mRNA and protein, immunoreactivity against IBA1 and NOXgp91phox (a subunit of NADPH oxidase that generates superoxide and is expressed mainly by microglia), as well as neurodegeneration in the cerebral cortex and hippocampus of mice (Qin and Crews, <xref ref-type="bibr" rid="B238">2012</xref>). These effects were blocked by treatment with minocycline, a tetracycline antibiotic with neuroprotective and anti-inflammatory properties, or the opioid receptor antagonist naltrexone, which also exerts anti-inflammatory effects notably via binding to TLRs (Qin and Crews, <xref ref-type="bibr" rid="B238">2012</xref>). Knockdown of TLR4, which is triggered by LPS and recognizes DAMPs released by injured tissue, prevented alcohol-induced increase of IBA1-immunoreactivity and protected against neuronal apoptosis in cerebral cortex of mice (Alfonso-Loeches et al., <xref ref-type="bibr" rid="B2">2010</xref>). Alcohol-preferring rats had high levels of TLR4 protein and MCP-1 in the central amygdala (CeA) and ventral tegmental area (VTA), while inhibition of both proteins in these areas decreased the excessive alcohol intake, suggesting that TLR4/MCP1 signaling might regulate alcohol self-administration (June et al., <xref ref-type="bibr" rid="B131">2015</xref>). In human, the levels of microglia-associated MCP-1 were increased in postmortem VTA, CeA, substantia nigra, and hippocampus of alcoholics compared to healthy controls (He and Crews, <xref ref-type="bibr" rid="B98">2008</xref>). An increased mRNA expression of <italic>TLR7</italic>, which is activated by single-stranded RNA, and <italic>ITGAM</italic> (encoding CD11b), was also measured in postmortem hippocampus of alcoholics (Coleman et al., <xref ref-type="bibr" rid="B38">2017</xref>). These overall findings present microglial TLRs as promising therapeutic targets for alcoholism.</p>
<p>Similarly, TLRs have a critical contribution to opioids dependence, which is associated with cognitive deficits during both abuse and withdrawal periods, affecting attention, working and episodic memory, as well as executive functions (Dhingra et al., <xref ref-type="bibr" rid="B51">2015</xref>). Chronic exposure to morphine induced apoptosis of primary fetal human microglia, which could be reversed by the opioid receptor antagonist naloxone, suggesting a prominent role of opioid receptor signaling in this process (Hu et al., <xref ref-type="bibr" rid="B120">2002</xref>). Morphine also led to increased mRNA expression of <italic>Tlr9</italic>, a detector of unmethylated CpG dinucleotides found in bacterial and viral DNA, resulting in the apoptosis of primary mouse microglia (He et al., <xref ref-type="bibr" rid="B99">2011</xref>). Morphine tolerance was postponed by blocking release of pro-inflammatory mediators. Systemic treatment with the phosphodiesterase inhibitor Ibudilast (suppressor of microglial pro-inflammatory response through TLR4 signaling) or minocycline both reduced opioids withdrawal in addition to promoting analgesia (Hutchinson et al., <xref ref-type="bibr" rid="B123">2009</xref>). Microglial pannexin-1 was additionally identified as a potential clinical target for opioids withdrawal. Genetic deletion of microglial <italic>pannexin-1</italic> in mice dampened ATP release from spinal cord dorsal horn microglia, and blunted morphine-induced long-term facilitation, thus reducing the severity of withdrawal without affecting analgesia (Burma et al., <xref ref-type="bibr" rid="B24">2017</xref>).</p>
<p>Methamphetamine causes neuropathology through mechanisms that comprise neurotoxicity to serotonin and dopamine neurons, as well as release of pro-inflammatory mediators, eventually resulting in cognitive impairment (Gonçalves et al., <xref ref-type="bibr" rid="B78">2010</xref>; Xu et al., <xref ref-type="bibr" rid="B341">2017</xref>). Microglial response to inflammatory stimuli measured by PET with TSPO ligands was most pronounced in the midbrain, striatum, thalamus, and orbitofrontal, and insular cortices of human abusers (Sekine et al., <xref ref-type="bibr" rid="B267">2008</xref>). Similarly, the density of IBA1-positive microglia increased in striatum of methamphetamine-exposed mice (Thomas et al., <xref ref-type="bibr" rid="B303">2004</xref>; Lloyd et al., <xref ref-type="bibr" rid="B167">2017</xref>). Acute methamphetamine enhanced mRNA levels of <italic>Tnfa</italic>, <italic>Il6</italic> and <italic>Il1b</italic>, in striatum and hippocampus of mice (Gonçalves et al., <xref ref-type="bibr" rid="B79">2008</xref>). Co-localization of IBA1-positive microglia with the purinergic receptor P2X7R was additionally shown to increase in striatum of exposed mice, while pharmacological blockade or silencing of P2X7R in embryonic stem cell-derived microglia prevented their increased migration, reduced phagocytosis, and enhanced pro-inflammatory release induced by methamphetamine (Fernandes et al., <xref ref-type="bibr" rid="B64">2016</xref>). These findings suggest that modulating microglial phenotype might help to prevent the neurological effects of chronic methamphetamine. Pharmacological treatment with minocycline indeed prevented the reduction of serotonin and dopamine levels, and the behavioral impairment of mice receiving methamphetamine (Zhang et al., <xref ref-type="bibr" rid="B349">2006</xref>). In healthy humans, minocycline similarly decreased the subjective rewarding effects of dextroamphetamine (enantiomer of methamphetamine; Sofuoglu et al., <xref ref-type="bibr" rid="B281">2011</xref>). Likewise, in methamphetamine abusers, Ibudilast reduced the rewarding effects of methamphetamine (Worley et al., <xref ref-type="bibr" rid="B339">2016</xref>).</p>
<p>As with opioids and methamphetamine, the rewarding properties of cocaine are related to an increased release of dopamine in the NAc (Pontieri et al., <xref ref-type="bibr" rid="B235">1995</xref>). Cocaine was shown to interact with microglial TLR4, increase <italic>Il1b</italic> mRNA levels in VTA, extracellular dopamine in NAc, as well as increase conditioned place preference and self-administration (Northcutt et al., <xref ref-type="bibr" rid="B207">2015</xref>). These effects were all suppressed by treatment with TLR4 antagonists in mice, indicating a crucial role of TLR4 in cocaine reward and reinforcement (Northcutt et al., <xref ref-type="bibr" rid="B207">2015</xref>). Increase in IL-1β mRNA and protein levels after acute cocaine administration was also measured in the cerebral cortex and NAc of rats (Cearley et al., <xref ref-type="bibr" rid="B32">2011</xref>). Repeated intake of cocaine was shown to increase TNFα mRNA and protein levels in the NAc, resulting in synaptic depression and suppressed cocaine-induced behavioral sensitization in mice (Lewitus et al., <xref ref-type="bibr" rid="B162">2016</xref>). In this study, microglia displayed increased IBA1-immunoreactivity, enlarged soma, and reduced process arborization in the NAc, and were identified as the cell type responsible for the release of TNFα using microglia-specific knockouts. Dopamine was additionally shown to increase microglial release of TNFα <italic>ex vivo</italic>, through the recruitment of D2 dopamine receptors (Lewitus et al., <xref ref-type="bibr" rid="B162">2016</xref>). The weak TLR4 agonist monophosphoryl lipid A (MPLA; variant of LPS) also resulted in the suppression of behavioral sensitization, a process that required microglial TNFα (Lewitus et al., <xref ref-type="bibr" rid="B162">2016</xref>), further supporting the idea that TLRs could be promising therapeutic targets.</p>
<p><italic>Major depressive disorder</italic> (MDD) is characterized by anhedonia (sense of worthlessness) and cognitive impairment (Krishnan and Nestler, <xref ref-type="bibr" rid="B150">2008</xref>). It affects 10%–15% of the general population worldwide. Functional magnetic resonance imaging (fMRI) and morphometric analysis indicate a consistent reduction in activity and size of the prefrontal cortex in MDD patients (Drevets et al., <xref ref-type="bibr" rid="B57">1997</xref>; Rajkowska et al., <xref ref-type="bibr" rid="B242">1999</xref>). Correlative fMRI analysis revealed an altered connectivity, within and between numerous brain regions relevant to resting mode, cognitive functions, and emotions (reviewed in Mulders et al., <xref ref-type="bibr" rid="B197">2015</xref>). The hypothesis of a decreased connectivity in the prefrontal cortex is supported by reduced spine density and down-regulation of genes related to synaptic function (Kang et al., <xref ref-type="bibr" rid="B135">2012</xref>). Despite the large number of MDD patients, we still have very limited understanding of the pathogenic mechanisms, which are obviously heterogeneous. For instance, a comprehensive comparison of transcription profiles in MDD patients and a mouse model of chronic unpredictable stress identified connectivity modules that were differentially enriched in microglia from each sex (Labonté et al., <xref ref-type="bibr" rid="B151">2017</xref>).</p>
<p>An immunological hypothesis was proposed from the evidence that several core symptoms of MDD resemble sickness behavior (i.e., a set of adaptive behavioral changes comprising lethargy, depressed mood, reduced social exploration and loss of appetite) resulting from infectious or inflammatory conditions (Dantzer et al., <xref ref-type="bibr" rid="B44">2008</xref>). According to this model, the chronicity of inflammation would induce a long-lasting depressive phenotype in subjects that are genetically predisposed or exposed to an adverse environment (Dantzer et al., <xref ref-type="bibr" rid="B44">2008</xref>). This hypothesis is supported by the observation that subsets of MDD patients have elevated levels of circulating cytokines (mainly TNFα and IL-6; Dowlati et al., <xref ref-type="bibr" rid="B56">2010</xref>), and increased expression of innate immunity-related genes in blood (Leday et al., <xref ref-type="bibr" rid="B157">2018</xref>). In the brain, PET studies have reported increased TSPO binding in prefrontal cortex, insula and anterior cingulate cortex of MDD patients that positively correlated with their depression severity (Setiawan et al., <xref ref-type="bibr" rid="B270">2015</xref>). This association of elevated inflammatory status in the CNS with depression severity was particularly significant in patients with suicidal thoughts (Holmes et al., <xref ref-type="bibr" rid="B112">2018</xref>). Consistently, an increased density and enlargement of primed IBA1-positive microglia, associated with the upregulation of the genes encoding IBA1 and MCP-1, was observed in postmortem white matter of dorsal prefrontal and anterior cingulate cortex of depressed patients that had committed suicide (Steiner et al., <xref ref-type="bibr" rid="B286">2008</xref>; Torres-Platas et al., <xref ref-type="bibr" rid="B307">2014</xref>). Preliminary studies using minocycline as an add-on treatment (to selective serotonin reuptake inhibitors) for MDD also brought encouraging results (Dean et al., <xref ref-type="bibr" rid="B48">2017</xref>; Husain et al., <xref ref-type="bibr" rid="B122">2017</xref>) but require replication and further analysis regarding the inflammatory status of the patients.</p>
<p>Rodent models of chronic stress-induced depression revealed that connectivity (assessed by spine density or dendritic arborization) was overall decreased in prefrontal cortex, like in depressed patients, while an opposite effect was observed in NAc and amygdala (reviewed in Christoffel et al., <xref ref-type="bibr" rid="B37">2011</xref>). Chronic stress also inhibited neurogenesis (reviewed in Kang et al., <xref ref-type="bibr" rid="B134">2016</xref>), and affected microglial density, morphology, and gene expression, with modalities that depended on the nature and duration of the stress paradigm and examined brain region(s) (reviewed in Yirmiya et al., <xref ref-type="bibr" rid="B345">2015</xref>; Calcia et al., <xref ref-type="bibr" rid="B29">2016</xref>; Tian et al., <xref ref-type="bibr" rid="B304">2017</xref>). Microglial hyper-ramification was reported in rat and mouse after forced swim or restraint stress (Hinwood et al., <xref ref-type="bibr" rid="B107">2012</xref>, <xref ref-type="bibr" rid="B108">2013</xref>; Hellwig et al., <xref ref-type="bibr" rid="B102">2016</xref>), whereas repeated social defeat or chronic unpredictable stress de-ramified microglia (Kreisel et al., <xref ref-type="bibr" rid="B149">2014</xref>; Wohleb et al., <xref ref-type="bibr" rid="B336">2015</xref>; Milior et al., <xref ref-type="bibr" rid="B187">2016</xref>; reviewed in Tian et al., <xref ref-type="bibr" rid="B304">2017</xref>). These alterations could mediate vulnerability or resilience to depression. First, a number of microglial genes regulated by stress encode proteins modulating synaptic plasticity and adaptive behaviors (IL-1β, TNFα; reviewed in Delpech et al., <xref ref-type="bibr" rid="B49">2015</xref>). Second, phagocytosis of neuronal and synaptic material by microglia (in <italic>Cx3cr1</italic>-GFP reporter mice) increased in response to chronic stress (Milior et al., <xref ref-type="bibr" rid="B187">2016</xref>; Wohleb et al., <xref ref-type="bibr" rid="B337">2018</xref>). Repeated social defeat or chronic unpredictable stress in mice also induced a strong increase in the density of microglia exhibiting signs of oxidative stress thus appearing “dark” in electron microscopy (Bisht et al., <xref ref-type="bibr" rid="B17">2016</xref>; Figure <xref ref-type="fig" rid="F3">3</xref>). As dark microglia were shown to interact more extensively with synapses than typical microglia, it is possible that their increased prevalence upon chronic psychological stress is related to a pathological rewiring of the brain.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Typical vs. dark microglia. <bold>(A)</bold> Typical microglia (m) that displays a light cytoplasm (ct) and nucleoplasm (np) with a clearly defined heterochromatin (hc) pattern, as well as intact organelles in the hypothalamus of a healthy adult mouse. Mitochondrion = mt; ma = myelinated axon. <bold>(B)</bold> Dark microglia (dm) in the hippocampus of a chronically-stressed <italic>Cx3cr1</italic> knockout mouse showing various signs of oxidative stress, including the darkening/condensation of its cytoplasm and nucleoplasm, making it appear as dark as mitochondria, and dilation of its endoplasmic reticulum (er) bv, blood vessel. <bold>(C)</bold> Processes from typical microglia are generally bulky and make focal contacts with synaptic elements. Several phagocytic inclusions (in) are shown in an IBA1-stained process, in addition to a synapse between an axon terminal (t) and a dendritic spine (s; colored in purple), within the hippocampus of a healthy adult mouse. <bold>(D)</bold> By contrast, dark microglia’s processes extensively encircle synaptic elements (colored in purple), including shrunken terminals undergoing digestion, which are surrounded by extended extracellular space (asterisk), and entire excitatory synapses, as shown in the hippocampus of a chronically-stressed <italic>Cx3cr1</italic> knockout mouse. Microglial contacts with synaptic clefts are indicated by arrowheads in <bold>(C,D)</bold>. Blood vessels, cells and cellular elements are labeled by the large bold font. Organelles and subcellular compartments are labeled by the smaller font.</p>
</caption>
<graphic xlink:href="fnmol-10-00421-g0003"></graphic>
</fig>
<p>Signaling between the neuronal fractalkine and its receptor CX3CR1 seems particularly relevant to the stress response (Wolf et al., <xref ref-type="bibr" rid="B338">2013</xref>; Paolicelli et al., <xref ref-type="bibr" rid="B218">2014</xref>; Sheridan et al., <xref ref-type="bibr" rid="B274">2014</xref>). Four studies reported that <italic>Cx3cr1</italic>-deficient mice were resistant to chronic stress exposure (i.e., chronic unpredictable stress, forced swim, or a two-hit model combining maternal separation and chronic unpredictable stress at adulthood (Hellwig et al., <xref ref-type="bibr" rid="B102">2016</xref>; Milior et al., <xref ref-type="bibr" rid="B187">2016</xref>; Rimmerman et al., <xref ref-type="bibr" rid="B247">2017</xref>; Winkler et al., <xref ref-type="bibr" rid="B334">2017</xref>)). Altogether these murine studies suggest that the resistance of microglia to stress-induced changes in density and morphology (Hellwig et al., <xref ref-type="bibr" rid="B102">2016</xref>; Milior et al., <xref ref-type="bibr" rid="B187">2016</xref>) could prevent the detrimental behavioral outcomes of stress. Nevertheless, at the molecular level, microglia from <italic>Cx3cr1</italic> knockout mice responded to stress, albeit differently than microglia from wild-type mice. For instance, chronic stress downregulated <italic>Ptgds</italic> (prostaglandin D2 synthase) and <italic>Gpr88</italic> (a G protein coupled receptor) in microglia from wild-type mice, but upregulated these genes in <italic>Cx3cr1</italic> knockout mice. As treatments modulating microglial functions (e.g., minocycline, GM-CSF and M-CSF, LPS, overexpression of <italic>Il1ra</italic>) were shown to rescue microglial alterations, neurogenesis, and behavioral dysfunctions in stressed animals (reviewed in Hinwood et al., <xref ref-type="bibr" rid="B108">2013</xref>; Kreisel et al., <xref ref-type="bibr" rid="B149">2014</xref>), some of the stress-induced microglial changes might be related to resilience, instead of conferring vulnerability to depression (reviewed in Kreisel et al., <xref ref-type="bibr" rid="B149">2014</xref>; Yirmiya et al., <xref ref-type="bibr" rid="B345">2015</xref>).</p>
<p><italic>Schizophrenia</italic> is a heterogeneous mental disorder associated with positive (e.g., hallucinations) and negative (e.g., abnormal social behavior, confused thinking) symptoms. It affects 0.3%–3% of the general population worldwide, depending on the inclusion criteria, and emerges in late adolescence or early adulthood (van Os and Kapur, <xref ref-type="bibr" rid="B316">2009</xref>). Schizophrenic patients present an impaired hippocampal neurogenesis (reviewed in Kang et al., <xref ref-type="bibr" rid="B134">2016</xref>) and altered neuronal connectivity, illustrated by a reproducibly low spine density in several regions of the cerebral cortex and hippocampus, which altogether contribute to gray matter loss, reduced hippocampal size, and functional hypoactivity (reviewed in Penzes et al., <xref ref-type="bibr" rid="B225">2011</xref>). Moreover, a decrease of inhibitory markers (GAD67, the GABA synthetizing enzyme and parvalbumin), both at mRNA and protein levels, support the hypothesis of an excitation/inhibition imbalance (reviewed in Gonzalez-Burgos et al., <xref ref-type="bibr" rid="B80">2015</xref>; Canitano and Pallagrosi, <xref ref-type="bibr" rid="B30">2017</xref>).</p>
<p>Indirect evidence that microglia could be implicated in schizophrenia came from clinical studies reporting a significant decrease of positive and negative symptoms when minocycline was added to the antipsychotic treatment (Miyaoka et al., <xref ref-type="bibr" rid="B191">2008</xref>, <xref ref-type="bibr" rid="B190">2012</xref>; Levkovitz et al., <xref ref-type="bibr" rid="B161">2010</xref>). Large-scale studies unraveled the risk association of schizophrenia with genetic markers across the MHC locus, particularly genes encoding complement C4, proposing an immune vulnerability that could involve microglia (Sekar et al., <xref ref-type="bibr" rid="B266">2016</xref>). C4 expression was detected in subsets of neurons and astrocytes from human postmortem hippocampus and prefrontal cortex, while <italic>C4</italic> knockout mice displayed impaired synaptic refinement (Sekar et al., <xref ref-type="bibr" rid="B266">2016</xref>). Moreover, addition of C4 increased the phagocytosis of synaptosomes by human iPSC-derived microglia <italic>in vitro</italic> (Sellgren et al., <xref ref-type="bibr" rid="B268">2017</xref>). Whether the reduced spine density reported in postmortem schizophrenia brains resulted from an impaired synaptogenesis or an exacerbated microglial phagocytosis is still undetermined due to the lack of relevant human data. In addition, PET revealed an increased binding of TSPO ligands in the hippocampus (Doorduin et al., <xref ref-type="bibr" rid="B53">2009</xref>), total gray matter (van Berckel et al., <xref ref-type="bibr" rid="B315">2008</xref>), and gray matter of frontal and temporal lobes of schizophrenic patients compared to healthy controls (Bloomfield et al., <xref ref-type="bibr" rid="B19">2016</xref>). However, further investigations using more selective TSPO ligands are necessary for conclusive findings (Coughlin et al., <xref ref-type="bibr" rid="B39">2016</xref>; Notter et al., <xref ref-type="bibr" rid="B208">2017</xref>). In postmortem prefrontal cortex, genes of a specific inflammatory module comprising <italic>IL6</italic>, <italic>IL8</italic>, and <italic>SERPIN3</italic> were shown to be overexpressed, while the density of MHC class II-positive microglia was increased (Fillman et al., <xref ref-type="bibr" rid="B66">2013</xref>). In these samples, dystrophy of MHC class II-positive microglia, revealed by the thinning, shortening and fragmentation of their processes, was additionally observed (Radewicz et al., <xref ref-type="bibr" rid="B241">2000</xref>; Wierzba-Bobrowicz et al., <xref ref-type="bibr" rid="B332">2004</xref>, <xref ref-type="bibr" rid="B333">2005</xref>; Busse et al., <xref ref-type="bibr" rid="B25">2012</xref>). Overall, an alteration of the genetic inflammatory profile in prefrontal cortex was fourfold more frequent in schizophrenic vs. control patients (Fillman et al., <xref ref-type="bibr" rid="B66">2013</xref>). Nevertheless, changes of microglia in schizophrenia may depend on the different etiologies, disease progression, as well as history of treatment and substance abuse.</p>
<p><italic>Bipolar disorder</italic> (BD) is characterized by recurrent episodes of mania followed by depression, generally beginning in adolescence or early adulthood. Few studies have investigated the roles of CNS immune regulation in BD specifically. A potential role of the immune system was suggested by the increased plasmatic levels of pro-inflammatory cytokines measured in patients during acute episodes of mania or depression, compared to recovery phases (Muneer, <xref ref-type="bibr" rid="B198">2016a</xref>). Postmortem analyses reported increased mRNA and proteins levels of IL-1β, iNOS and CD11b in frontal cortex of BD patients (Rao et al., <xref ref-type="bibr" rid="B243">2010</xref>). Exacerbated inflammatory response was also indicated by PET imaging showing a significant increase of TSPO binding in the right hippocampus of BD patients (Haarman et al., <xref ref-type="bibr" rid="B88">2014</xref>). Although BD has a high heritability, its genetic determinants are unknown, and there is no animal model that may reliably distinguish BD from unipolar depression or schizophrenia. Nevertheless, one specific trait of BD seems to be the decrease in BDNF serum levels during manic or depressive phases. This decrease in BDNF correlated with the clinical severity, normalizing at recovery phases or in medication-induced remissions (Lin, <xref ref-type="bibr" rid="B166">2009</xref>; reviewed in Muneer, <xref ref-type="bibr" rid="B199">2016b</xref>). Whether microglial-derived BDNF linked to dendritic spine formation in mouse (Parkhurst et al., <xref ref-type="bibr" rid="B221">2013</xref>) could underlie different synaptic plasticity levels between acute and remission episodes remains unclear. Although highly speculative, this mechanism could possibly account for the maladaptive behavior of BD patients.</p>
<sec id="s6-1">
<title>Eating Disorders</title>
<p>Very little data exist on the pathogenesis of eating disorders, such as anorexia nervosa and bulimia nervosa, with relation to microglia. One study showed that stimulation of TLR2 by intracerebroventricular injection of the synthetic ligand Pam3CSK4 induced anorexia and increased IBA1-positive microglial density and structural contacts with proopiomelanocortin (POMC) neurons in the hypothalamic arcuate nucleus of mice (Jin et al., <xref ref-type="bibr" rid="B128">2016</xref>). However, further experiments are required to determine whether this anorexia mediated by TLR2, which is likely a transient symptom of sickness behavior, shares pathogenic mechanisms with anorexia nervosa, which develops over months to years in humans. Microglia were also proposed to mediate the excessive dietary intake, by acting on the hypothalamic control of energy balance (Valdearcos et al., <xref ref-type="bibr" rid="B314">2014</xref>, <xref ref-type="bibr" rid="B313">2017</xref>). In particular, silencing microglial inflammatory signaling via NF-kB pathway (using microglia-specific knockouts for <italic>Ikkβ</italic>) or depleting microglia (with the CSF1R inhibitor PLX5622) protected high fat diet-fed mice against hyperphagia (Valdearcos et al., <xref ref-type="bibr" rid="B314">2014</xref>, <xref ref-type="bibr" rid="B313">2017</xref>). In contrast, microglia-specific knockouts of A20, a primary negative regulator of NF-kB activity, showed exaggerated pro-inflammatory microglial activities <italic>ex vivo</italic>, changes in hypothalamic densities of microglia and infiltrating myeloid cells, as well as metabolic dysfunction and obesity, independently from the diet (Valdearcos et al., <xref ref-type="bibr" rid="B313">2017</xref>). These findings open the possibility to exploit microglial inhibitors in the context of human metabolic pathologies.</p>
</sec>
<sec id="s6-2">
<title>Sleep Disorders</title>
<p>Sleep is vital to maintaining health. It allows to restore synaptic homeostasis, clear the brain from toxins, and consolidate memory (Diekelmann and Born, <xref ref-type="bibr" rid="B52">2010</xref>; Xie et al., <xref ref-type="bibr" rid="B340">2013</xref>; Tononi and Cirelli, <xref ref-type="bibr" rid="B305">2014</xref>). Sleep comprises a non-rapid-eye-movement state identified by slow EEG waves and a rapid-eye-movement sleep (REM) state associated with brain activation, as well as inhibition of muscle tone and saccadic eye movements. A PET longitudinal follow-up study showed that patients affected by idiopathic REM sleep behavior disorder were more vulnerable to subsequently developing PD and other synucleinopathies, i.e., neurodegenerative diseases characterized by an abnormal accumulation of α-synuclein in neurons and glial cells. These patients displayed increased TSPO binding in the substantia nigra, associated with a decreased dopaminergic activity in the putamen (Stokholm et al., <xref ref-type="bibr" rid="B289">2017</xref>), suggesting that immune cell activation could represent a biomarker and/or therapeutic target for both idiopathic REM sleep behavior disorder and synucleinopathies. Microglia are linked to several sleep disorders, including sleep deprivation discussed below (reviewed in Nadjar et al., <xref ref-type="bibr" rid="B201">2017</xref>).</p>
<p>Sleep deprivation induces tiredness, sleepiness, irritability and concentration difficulties, as well as more serious outcomes like cognitive impairment, anxiety and neurodegeneration when it becomes chronic (Musiek and Holtzman, <xref ref-type="bibr" rid="B200">2016</xref>; Pires et al., <xref ref-type="bibr" rid="B232">2016</xref>). Studies in rodent models of chronic sleep deprivation reported an increased expression of CR3 protein and hypertrophy of CR3-positive microglia in rat hippocampus (Hsu et al., <xref ref-type="bibr" rid="B119">2003</xref>) and enhanced mRNA levels of pro-inflammatory cytokines in mouse brain (Wisor et al., <xref ref-type="bibr" rid="B335">2011</xref>). Sleep deprived mice also presented an increase in EEG slow waves that could be reversed by the administration of minocycline (Wisor et al., <xref ref-type="bibr" rid="B335">2011</xref>). An increase in IBA1-positive microglial co-localization with VGLUT1-positive glutamatergic terminals, associated with less ramified morphologies, was reported in mouse prefrontal cortex upon chronic sleep deprivation (Bellesi et al., <xref ref-type="bibr" rid="B11">2017</xref>). Since the brain levels of C3 protein were concomitantly enhanced (Bellesi et al., <xref ref-type="bibr" rid="B11">2017</xref>), the authors proposed that complement-mediated synaptic pruning might be exacerbated by chronic sleep deprivation. The expression of MER, regulating microglial process motility and phagocytosis, was also increased by chronic sleep deprivation (Bellesi et al., <xref ref-type="bibr" rid="B11">2017</xref>). Whether microglia help to restore the disrupted homeostasis during chronic sleep deprivation, or contribute to its detrimental consequences on synaptic loss and cognitive dysfunction remains to be investigated.</p>
</sec>
</sec>
<sec id="s7">
<title>Defective Microglial Wiring of the CNS in Old Age</title>
<p>Microglia are not exempted from the natural transformation experienced by the body over time (Tay et al., <xref ref-type="bibr" rid="B300">2017b</xref>). Here we discuss the impact of age-related microglial alterations and their consequences on cognitive functions (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>).</p>
<sec id="s7-1">
<title>Physiological Aging</title>
<p>One of the first noticeable changes with aging was the increased prevalence of dystrophic microglia primarily identified by their cytoplasmic fragmentation and appearance of short, twisted processes (Streit et al., <xref ref-type="bibr" rid="B291">2004</xref>; Ritzel et al., <xref ref-type="bibr" rid="B248">2015</xref>). Although seen in young age (Streit et al., <xref ref-type="bibr" rid="B291">2004</xref>), their increase could imply a reduced area surveyed for harmful debris. Additionally, ameboid microglia, also encountered in early CNS development (Kaur and Ling, <xref ref-type="bibr" rid="B137">1991</xref>; Leong and Ling, <xref ref-type="bibr" rid="B160">1992</xref>), became more prevalent with aging (Rozovsky et al., <xref ref-type="bibr" rid="B252">1998</xref>; Jyothi et al., <xref ref-type="bibr" rid="B132">2015</xref>). Aged microglia, in general, showed increased oxidative stress, corroborated <italic>ex vivo</italic> by their increased production of reactive oxygen species (ROS; Ritzel et al., <xref ref-type="bibr" rid="B248">2015</xref>) and reduced antioxidant glutathione activity (Njie et al., <xref ref-type="bibr" rid="B205">2012</xref>). Dark microglia displaying various signs of oxidative stress and encircling synaptic elements with their highly-ramified processes showing strong immunoreactivity for CD11b (Bisht et al., <xref ref-type="bibr" rid="B17">2016</xref>), a component of CR3 that is involved in synaptic pruning, also become numerous with aging. This suggests that dark microglia could mediate synaptic loss and ultimately lead to cognitive dysfunction (Figure <xref ref-type="fig" rid="F3">3</xref>).</p>
<p>In aging, there is also an increased presence of reactive microglia showing increased MHC class II-immunoreactivity, enlarged cell bodies, and reduced number of short and thick processes (Perry et al., <xref ref-type="bibr" rid="B228">1993</xref>; Rozovsky et al., <xref ref-type="bibr" rid="B252">1998</xref>; Hefendehl et al., <xref ref-type="bibr" rid="B100">2014</xref>). As for the dystrophic cells described above, shorter microglial processes could be detrimental to their ability to survey the parenchyma. A reduced area surveyed by individual microglia was indeed measured in aging, but found to be compensated by a 14% increase in microglial cells in the somatosensory cortex of <italic>Cx3cr1</italic>-GFP reporter mice <italic>in vivo</italic> (Hefendehl et al., <xref ref-type="bibr" rid="B100">2014</xref>). An increased microglial density is supported by previous murine studies in the retina (<italic>Cx3cr1</italic>-GFP mice; Damani et al., <xref ref-type="bibr" rid="B43">2011</xref>), dentate gyrus and hippocampus CA1 (CR3-immnostaining; Mouton et al., <xref ref-type="bibr" rid="B196">2002</xref>), as well as auditory and visual cortices (IBA1-immunostaining; Tremblay et al., <xref ref-type="bibr" rid="B311">2012</xref>). Remarkably, the disparity where females had greater numbers of CR3-microglia in the dentate gyrus and CA1 than males became more pronounced with aging (Mouton et al., <xref ref-type="bibr" rid="B196">2002</xref>). Another striking change in old rodents is the abundance of microglial clusters, seen in white matter (CR3-staining; Perry et al., <xref ref-type="bibr" rid="B228">1993</xref>) and cerebral cortex (IBA1-staining, <italic>Cx3cr1</italic>-GFP mice; Tremblay et al., <xref ref-type="bibr" rid="B311">2012</xref>; Hefendehl et al., <xref ref-type="bibr" rid="B100">2014</xref>). The clumping of microglia could arise from their proliferation, or an increased egress from their designated territory (Hefendehl et al., <xref ref-type="bibr" rid="B100">2014</xref>), resulting in parenchymal areas devoid of surveillance, which could make the brain more vulnerable to the harmful accumulation of debris. In addition, a decrease in microglial process motility during aging was detected in mouse cerebral cortex <italic>in vivo</italic> (Hefendehl et al., <xref ref-type="bibr" rid="B100">2014</xref>) and retina <italic>ex vivo</italic> (Damani et al., <xref ref-type="bibr" rid="B43">2011</xref>). Genes related to process motility like <italic>Pf4</italic>, <italic>Itga4</italic> and <italic>Cxcr4</italic> were indeed measured at lower levels in aged vs. young mouse cerebral cortex (Orre et al., <xref ref-type="bibr" rid="B211">2014</xref>). These aged-related alterations of microglial density, distribution, morphology and dynamics altogether suggest a decline in their capacity to properly survey and preserve the brain milieu against threats.</p>
<p>Microglial release of pro- and anti-inflammatory cytokines becomes disturbed as well with age. Increased brain levels of TNFα and IL-1β mRNA or proteins were measured in aged rodents in steady-state conditions or upon immune challenge (Sierra et al., <xref ref-type="bibr" rid="B278">2007</xref>; Stichel and Luebbert, <xref ref-type="bibr" rid="B288">2007</xref>; Njie et al., <xref ref-type="bibr" rid="B205">2012</xref>). Previous <italic>in vitro</italic> studies have shown that TNFα mediates neuronal loss (De Lella Ezcurra et al., <xref ref-type="bibr" rid="B47">2010</xref>; Kaur et al., <xref ref-type="bibr" rid="B138">2014</xref>), notably through microglial “phagoptosis” of viable neurons (Neniskyte et al., <xref ref-type="bibr" rid="B203">2014</xref>). IL-1β has the capacity to alter microglial morphology from ramified to ameboid in rat hippocampal slice culture (Hailer et al., <xref ref-type="bibr" rid="B92">2005</xref>). IL-1β by itself did not affect neuronal viability but its inhibition using IL-1ra, a receptor antagonist of IL-1, reduced neuronal damage after an excitotoxicity insult in rat hippocampal slice culture (Hailer et al., <xref ref-type="bibr" rid="B92">2005</xref>). Pro-inflammatory IL-6 mRNA and proteins were also increased in the brain (Sierra et al., <xref ref-type="bibr" rid="B278">2007</xref>) and isolated microglia (Ye and Johnson, <xref ref-type="bibr" rid="B344">1999</xref>) from aged mice. Even though IL-6 is expressed by astrocytes, neurons and microglia, only the latter displayed an age-dependent increase in IL-6 production in mice (Ye and Johnson, <xref ref-type="bibr" rid="B344">1999</xref>). In addition, anti-inflammatory cytokines, such as IL-10 and TGFβ1, were detected in larger quantities in the aged brain of mice (Sierra et al., <xref ref-type="bibr" rid="B278">2007</xref>), leading to the hypothesis that anti-inflammatory cytokines increase during aging to dampen the detrimental effects of pro-inflammatory cytokines and prevent inflammation from impairing further microglial functions (Sierra et al., <xref ref-type="bibr" rid="B278">2007</xref>).</p>
<p>Synapses in vulnerable regions are affected over time, as indicated by the age-related decrease in the expression of genes associated with synaptic vesicle trafficking or neuromodulation that was measured in the superior frontal gyrus and postcentral gyrus, and to a lesser degree in the hippocampus and entorhinal cortex, of human postmortem samples (Berchtold et al., <xref ref-type="bibr" rid="B13">2013</xref>). Synaptic loss has been observed in multiple brain regions with aging, for instance the temporal lobe of postmortem human samples (Anderson and Rutledge, <xref ref-type="bibr" rid="B5">1996</xref>), prefrontal cortex of rhesus monkeys (Peters et al., <xref ref-type="bibr" rid="B229">2008</xref>) and olfactory bulb of mice (Richard et al., <xref ref-type="bibr" rid="B245">2010</xref>; extensively reviewed in Petralia et al., <xref ref-type="bibr" rid="B230">2014</xref>). However, in other brain regions, such as the somatosensory cortex of mice, reduced size and long-term stability of spines was instead observed <italic>in vivo</italic> (Mostany et al., <xref ref-type="bibr" rid="B194">2013</xref>). In addition, increased brain levels of C1q, and several other components of the complement pathway, were measured in aged mice and human (Cribbs et al., <xref ref-type="bibr" rid="B42">2012</xref>; Stephan et al., <xref ref-type="bibr" rid="B287">2013</xref>). Mice deficient for C3 were additionally found to be protected from synaptic loss and neuronal death during aging, in the hippocampus CA3, suggesting that microglia are implicated in synaptic loss or remodeling during normal aging by means of the complement pathway (Shi et al., <xref ref-type="bibr" rid="B276">2015</xref>).</p>
</sec>
<sec id="s7-2">
<title>Age-Related Neurodegeneration</title>
<p>Age is the main risk factor for neurodegenerative diseases. The most prevalent, AD and PD, are associated to elevated CNS inflammatory milieu, synaptic dysfunction and loss, cognitive decline and dementia (Šišková and Tremblay, <xref ref-type="bibr" rid="B280">2013</xref>).</p>
<p>AD is characterized by the appearance of neurofibrillary tangles and accumulation of amyloid β (reviewed in Perl, <xref ref-type="bibr" rid="B227">2010</xref>). Seen in multiple brain regions, including frontal cortex (Scheff et al., <xref ref-type="bibr" rid="B260">1990</xref>) and temporal lobes (Scheff and Price, <xref ref-type="bibr" rid="B259">1993</xref>), synaptic loss is an early event in AD (Scheff et al., <xref ref-type="bibr" rid="B261">2006</xref>) that correlates with the severity of cognitive dysfunction (Terry et al., <xref ref-type="bibr" rid="B301">1991</xref>; Spires-Jones and Hyman, <xref ref-type="bibr" rid="B284">2014</xref>). Early onset AD which typically begins around 40 years of age (Seltzer and Sherwin, <xref ref-type="bibr" rid="B269">1983</xref>) has been associated with mutations in <italic>APP</italic>, <italic>PSEN1</italic> and <italic>PSEN2</italic> (Bekris et al., <xref ref-type="bibr" rid="B10">2010</xref>), and also with polymorphisms in several microglial genes including <italic>CD33</italic> (Griciuc et al., <xref ref-type="bibr" rid="B85">2013</xref>; Malik et al., <xref ref-type="bibr" rid="B175">2013</xref>), <italic>ABI3</italic> (Sims et al., <xref ref-type="bibr" rid="B279">2017</xref>), <italic>PLCG2</italic> (Sims et al., <xref ref-type="bibr" rid="B279">2017</xref>), and <italic>TREM2</italic> (Guerreiro et al., <xref ref-type="bibr" rid="B86">2013</xref>; Jonsson et al., <xref ref-type="bibr" rid="B130">2013</xref>; Suárez-Calvet et al., <xref ref-type="bibr" rid="B293">2016</xref>; Sims et al., <xref ref-type="bibr" rid="B279">2017</xref>). Late onset AD is a sporadic form of the disease that affects a majority of patients (up to 95%) and usually develops after 65 years of age (Seltzer and Sherwin, <xref ref-type="bibr" rid="B269">1983</xref>). Chronic psychological stress across the lifespan is considered a main risk factor for this late onset form of AD (Miller and Sadeh, <xref ref-type="bibr" rid="B188">2014</xref>). In mice, exposure to early-life stress was shown to alter the inflammatory response to amyloid β pathology during adulthood (Hoeijmakers et al., <xref ref-type="bibr" rid="B111">2017</xref>). APP/PS1 mice housed with limited bedding and nesting materials in their first postnatal week displayed reduced amyloid β deposition that was notably accompanied by increased CD68- and IBA1-immunoreactivity in the dentate gyrus at 4 months of age (Hoeijmakers et al., <xref ref-type="bibr" rid="B111">2017</xref>).</p>
<p>While the number of microglia is similar between healthy subjects and AD patients (Griciuc et al., <xref ref-type="bibr" rid="B85">2013</xref>), an increased prevalence of reactive microglia positive for MHC class II was described in the cerebral cortex of patients with senile dementia of the AD type (McGeer et al., <xref ref-type="bibr" rid="B183">1987</xref>), both in gray and white matter, particularly in association with the amyloid β plaques (Mattiace et al., <xref ref-type="bibr" rid="B182">1990</xref>). However, an absence of reactive IBA1-positive microglia was also reported in the cortical gray matter of postmortem AD samples (Streit et al., <xref ref-type="bibr" rid="B290">2009</xref>). The authors thus suggested that microglial “activation” could be related to peripheral infections which affect the CNS over the course of AD pathology, rather than the disease itself. Additionally, as in normal aging, an increased prevalence of dystrophic microglia was discerned both in the frontal (Flanary et al., <xref ref-type="bibr" rid="B67">2007</xref>) and temporal (Streit et al., <xref ref-type="bibr" rid="B290">2009</xref>) lobes of postmortem AD brains, even appearing in temporal lobes before Tau pathology (Streit et al., <xref ref-type="bibr" rid="B290">2009</xref>).</p>
<p>Upregulated in plaque-associated microglia (Frank et al., <xref ref-type="bibr" rid="B70">2008</xref>; Melchior et al., <xref ref-type="bibr" rid="B184">2010</xref>; Guerreiro et al., <xref ref-type="bibr" rid="B86">2013</xref>), TREM2 is expressed by dark microglia (Bisht et al., <xref ref-type="bibr" rid="B17">2016</xref>), disease-associated microglia (DAM; Keren-Shaul et al., <xref ref-type="bibr" rid="B139">2017</xref>), and microglia dependent on the TREM2-APOE pathway (Krasemann et al., <xref ref-type="bibr" rid="B148">2017</xref>), three subtypes that were described in AD mouse models. Deletion or dominant negative mutations of <italic>Trem2</italic> were shown to worsen AD progression in the 5xFAD and APP/PS1 mouse models of AD (Jay et al., <xref ref-type="bibr" rid="B501">2015</xref>, <xref ref-type="bibr" rid="B505">2017</xref>; Yuan et al., <xref ref-type="bibr" rid="B502">2016</xref>; Ulland et al., <xref ref-type="bibr" rid="B503">2017</xref>), but <italic>Trem2</italic> deletion also reduced amyloid β burden, increased neuronal loss, prevented microglial association with the plaques, and resulted in their apoptosis in the 5xFAD model (Wang Y. et al., <xref ref-type="bibr" rid="B328">2015</xref>). Genetic deletion of <italic>Trem2</italic> in a mouse model of Tau pathology (PS19) resulted in an attenuated atrophy of the entorhinal and piriform cortices, together with increased protein levels of PSD95 in hippocampus (Leyns et al., <xref ref-type="bibr" rid="B163">2017</xref>). IBA1-positive microglial density and morphology normalized in the piriform cortex and hippocampus, while the levels of genes coding for pro-inflammatory or phagocytic markers (IL-1α, IL-1β, TNFα and C1q) decreased in the piriform cortex (Leyns et al., <xref ref-type="bibr" rid="B163">2017</xref>). IBA1-positive microglia expressing APOE also became less prevalent, within the piriform cortex, indicating a phenotypic shift. By contrast, Tau phosphorylation or solubility were unaltered in the piriform cortex and hippocampus (Leyns et al., <xref ref-type="bibr" rid="B163">2017</xref>). These findings suggest that TREM2 could mitigate microglial response to Tau pathology, thus protecting against neurodegeneration.</p>
<p>Microglial capacity to phagocytose amyloid β efficiently is affected by aging and AD. As a matter of fact, microglia demonstrate an age-dependent ability to phagocytose since microglial cells isolated from 6 to 8 months old wild-type mice could not clear amyloid β fibrils with the same efficiency as microglia isolated at postnatal day 0 (Floden and Combs, <xref ref-type="bibr" rid="B68">2011</xref>). Using acute hippocampal slices from 7 to 9-week old APP/PS1 mice, the phagocytic ability of microglia was also shown to be compromised in amyloid β plaque-burdened areas specifically (Krabbe et al., <xref ref-type="bibr" rid="B146">2013</xref>). Similarly, an age-related decrease in mRNA expression of genes coding for amyloid β receptors (e.g., SRA, CD36, RAGE) or degrading enzymes (e.g., insulysin, neprilysin, MMP9) was detected <italic>ex vivo</italic> in microglia from APP/PS1 mice (Hickman et al., <xref ref-type="bibr" rid="B104">2008</xref>). While amyloid β triggers synaptic loss in rat hippocampal slices (Shankar et al., <xref ref-type="bibr" rid="B271">2007</xref>, <xref ref-type="bibr" rid="B272">2008</xref>), microglial phagocytosis of both amyloid β and dendritic spines was shown to be mediated by microglial TDP-43, a DNA-RNA binding protein encoded by <italic>Tardbp</italic> gene. Microglia-specific knockouts of <italic>Tardbp</italic>, crossed with an APP model, displayed reduced amyloid β load, but also an exacerbated synaptic loss (Paolicelli et al., <xref ref-type="bibr" rid="B220">2017</xref>). For instance, spine density was reduced, while IBA1-microglial co-localization with PSD95 puncta and expression of CD68 were increased in somatosensory and motor cortices (Paolicelli et al., <xref ref-type="bibr" rid="B220">2017</xref>). This finding supports the importance of orienting microglial phagocytosis toward specific cargos in future therapies for AD and other neurodegenerative diseases.</p>
<p>The synaptic impairment caused by amyloid β was also associated with the complement cascade (Hong et al., <xref ref-type="bibr" rid="B114">2016</xref>). Microglia-mediated synaptic pruning was shown to be abnormally activated early in AD pathology, directly affecting synaptic viability (Hong et al., <xref ref-type="bibr" rid="B114">2016</xref>). In particular, an increase of C1q-immunoreactivity was observed in regions vulnerable to synaptic alterations, defined by the loss of synapsin-PSD95 puncta, such as the hippocampus of J20 and APP/PS1 mice. Intraventricular injection of oligomeric amyloid β increased the co-localization of C1q with PSD95, and decreased microglial expression of CD68 in hippocampus. Gene deletion or pharmacological antagonism of C1q in the AD models further halted their loss of synapsin-PSD95 puncta, while rescuing LTP in acute hippocampal slices (Hong et al., <xref ref-type="bibr" rid="B114">2016</xref>). This suggests that oligomeric amyloid β could drive synaptic pruning via the complement cascade or weaken synapses thus leading to their elimination. Additionally, <italic>C3</italic> deficient APP/PS1 mice displayed increased numbers of Vglut2-GluR1 puncta and protein levels of various synaptic markers during aging in the hippocampus, where IBA1-positive microglia recovered surveillant morphologies near plaques (Shi et al., <xref ref-type="bibr" rid="B275">2017</xref>). Brain levels of pro-inflammatory TNFα, IFNγ and IL-12 proteins were also found to be reduced, and those of anti-inflammatory IL-10 to be increased (Shi et al., <xref ref-type="bibr" rid="B275">2017</xref>).</p>
<p>The neuropathology of PD is characterized by a loss of dopaminergic neurons in the midbrain, accompanied by the presence of Lewy Bodies, which are aggregates positive for α-synuclein, and chronic elevation of brain inflammatory responses (reviewed in Wang Q. et al., <xref ref-type="bibr" rid="B327">2015</xref>). Genetic and sporadic forms of the disease were both described (reviewed in Schneider and Obeso, <xref ref-type="bibr" rid="B262">2015</xref>; Poewe et al., <xref ref-type="bibr" rid="B234">2017</xref>). Early onset PD, which primarily affects individuals younger than 40 years of age, is caused by mutations of <italic>SNCA</italic>, <italic>PINK1</italic>, <italic>DJ-1</italic> and <italic>Parkin</italic>, or exposure to neurotoxins (reviewed in Schrag and Schott, <xref ref-type="bibr" rid="B263">2006</xref>). Late onset PD that emerges between 55 and 65 years of age is instead categorized as sporadic, and associated with mutations and variants of <italic>LRRK2</italic> (reviewed in Volta et al., <xref ref-type="bibr" rid="B320">2015</xref>) that is notably, among other cell types, expressed by microglia (reviewed in Russo et al., <xref ref-type="bibr" rid="B255">2014</xref>). Polymorphisms in genes encoding pro-inflammatory cytokines such as TNF-α and IL-1β, and MHC class II were associated with a higher risk of developing PD (Wahner et al., <xref ref-type="bibr" rid="B323">2007</xref>; Hamza et al., <xref ref-type="bibr" rid="B94">2010</xref>). Chronic psychological stress was proposed to confer an increased susceptibility risk to late onset PD (reviewed in Hou et al., <xref ref-type="bibr" rid="B117">2014</xref>; Vyas et al., <xref ref-type="bibr" rid="B322">2016</xref>). In mice, chronic restraint stress that occurs before administration of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), causing the death of midbrain dopaminergic neurons, was shown to exacerbate the motor deficits, learning impairment, further reduce the dopaminergic levels, and increase the loss of dopaminergic neurons in the substantia nigra (Lauretti et al., <xref ref-type="bibr" rid="B153">2016</xref>). In wild-type mice, chronic restraint stress similarly induced a loss of dopaminergic neurons, increased the aggregation of α-synuclein, reduced proteins levels of CX3CR1 and IBA1, as well as IBA1-positive microglial density in the substantia nigra (Ong et al., <xref ref-type="bibr" rid="B210">2017</xref>).</p>
<p>In postmortem PD brain, reactive microglia immunopositive for MHC class II, ICAM-1 (CD54), LFA-1 (CD11a), CD68, TLR2, and displaying ameboid morphologies, were encountered among several regions comprising the substantia nigra, striatum and hippocampus of postmortem PD brains (Imamura et al., <xref ref-type="bibr" rid="B125">2003</xref>; Doorn et al., <xref ref-type="bibr" rid="B55">2014</xref>). Microglial alterations were similarly reported in animal models of PD induced by neurotoxins. For instance, rotenone increased the density of CR3-positive microglia and altered their morphology toward enlarged cells with short, stubby processes, in the striatum and substantia nigra of rats (Sherer et al., <xref ref-type="bibr" rid="B273">2003</xref>). MPTP also increased the density of MHC class II-positive microglia and their heterogeneity, especially in the substantia nigra and globus pallidus, resulting in the concomitant presence of ramified, ameboid, and multinucleated morphologies in monkeys (Hurley et al., <xref ref-type="bibr" rid="B121">2003</xref>). Administration of MPTP in <italic>Ifng</italic> knockout mice reduced the loss of dopaminergic neurons and terminals, as well as decreased CD11b-positive microglial density in the substantia nigra (Mount et al., <xref ref-type="bibr" rid="B195">2007</xref>). <italic>In vitro</italic>, exogenous application of aggregated α-synuclein was sufficient to transform microglia into ameboid cells, increase their phagocytosis of α-synuclein, as well as exacerbate oxidative stress (production of ROS) and the death of dopaminergic neurons in mesencephalic neuron-microglia culture (Zhang et al., <xref ref-type="bibr" rid="B350">2005</xref>). The phagocytosis of α-synuclein is an age-dependent ability, with isolated microglia from older mice showing a reduced capacity to clear α-synuclein <italic>ex vivo</italic> (Bliederhaeuser et al., <xref ref-type="bibr" rid="B18">2016</xref>). In a mouse model of PD that expresses a mutant form of human α-synuclein, IBA1-immunoreactivity was found to be dramatically increased in the spinal cord, where increased mRNA and proteins levels of AXL were also detected, in exclusive association with IBA1-positive cells (Fourgeaud et al., <xref ref-type="bibr" rid="B69">2016</xref>). By contrast, upregulation of AXL was found to be minimal in the brain (Fourgeaud et al., <xref ref-type="bibr" rid="B69">2016</xref>). The authors speculated that wild-type microglia might execute TAM-dependent phagoptosis of the distressed motor neurons, thus prolonging survival, considering that <italic>Thy1-Syn</italic><sup>hA53Ttg</sup> mice also knockout for <italic>Mer</italic> and <italic>Axl</italic> displayed a modest life extension (Fourgeaud et al., <xref ref-type="bibr" rid="B69">2016</xref>). However, the roles of microglia in PD pathogenesis remain largely unknown.</p>
</sec>
</sec>
<sec id="s8">
<title>Perspectives</title>
<p>In recent years, clinical and preclinical studies have advanced our understanding of the roles of microglia in modulating cognitive functions, and their implications in neurodevelopmental, neuropsychiatric, and neurodegenerative disorders. The evidence that CNS inflammatory response is exacerbated in several psychiatric diseases mainly came from gene expression and immunohistochemical postmortem studies, and are now supplemented by PET neuroimaging with TSPO ligands (reviewed in Mondelli et al., <xref ref-type="bibr" rid="B192">2017</xref>). However, current tracers have limitations in specificity and sensitivity. Thus, the development of microglia-specific ligands is a high priority. A selective antagonist of CX<sub>3</sub>CR1, 2-[<sup>18</sup>F]FBTTP, was radiosynthetized and shown to cross the blood-brain barrier using PET imaging in mice. Its application in models of “neuroinflammation” is currently investigated (Mease et al., <xref ref-type="bibr" rid="B504">2015</xref>). In parallel, clinical trials have started to assess the therapeutic potential of the tetracycline derivative, minocycline (Figure <xref ref-type="fig" rid="F4">4</xref>). Although its mechanisms of action remain elusive, minocycline has neuroprotective properties and is efficient at dampening pro-inflammatory responses and normalizing microglial phagocytosis (Plane et al., <xref ref-type="bibr" rid="B233">2010</xref>; Garrido-Mesa et al., <xref ref-type="bibr" rid="B71">2013</xref>; Mattei et al., <xref ref-type="bibr" rid="B180">2014</xref>). Due to its excellent safety profile, it has been used alone or as an add-on treatment in numerous clinical trials for neurodegenerative diseases, and more recently, in psychiatric disorders, as we have discussed. Current clinical trials now couple the determination of brain inflammatory status (by PET imaging, combined with CSF or blood analysis), to minocycline response (e.g., clinical trial NCT02362529), in order to determine how levels of pro-inflammatory markers before the treatment could predict the clinical response. If the therapeutic effects of minocycline depend on its anti-inflammatory action, one would expect patients with an exacerbated inflammatory profile to be most responsive. Of note, even if minocycline does not target microglia specifically, it could indirectly modulate their physiological functions via astrocytes and vascular endothelial cells. Studies have demonstrated that astrocytes act under the control of reactive microglia in the context of inflammation (Pascual et al., <xref ref-type="bibr" rid="B222">2012</xref>; Habbas et al., <xref ref-type="bibr" rid="B89">2015</xref>; Liddelow et al., <xref ref-type="bibr" rid="B165">2017</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Effects of microglial targeting in animal models and human patients discussed in this review. <bold>(A)</bold> Temporal effects of transient microglial depletion in rodents and nonhuman primates across the lifespan. <bold>(B)</bold> Potential clinical effects of minocycline on modulating the roles of microglia in adult psychiatric diseases.</p>
</caption>
<graphic xlink:href="fnmol-10-00421-g0004"></graphic>
</fig>
<p>Animal models, especially microglia-specific gene knockout strategies, have been particularly informative, considering that the readout of microglial pathophysiological alterations is not easily achieved in human subjects. For instance, several groups have taken advantage of the fractalkine receptor to specifically target microglia by crossing the conditional <italic>Cx3cr1<sup>creER</sup></italic> mouse lines (Goldmann et al., <xref ref-type="bibr" rid="B76">2013</xref>; Parkhurst et al., <xref ref-type="bibr" rid="B221">2013</xref>; Yona et al., <xref ref-type="bibr" rid="B346">2013</xref>) with transgenics carrying genes of interest flanked by <italic>loxP</italic> sites in different disease paradigms (Figure <xref ref-type="fig" rid="F4">4</xref>). While the <italic>Cx3cr1</italic><sup>creER</sup> lines are exceptional tools for dissecting the specific roles of microglia in the brain, long-lived yolk sac-derived non-parenchymal brain macrophages may be partially targeted as collaterals, thus confounding the observations (Goldmann et al., <xref ref-type="bibr" rid="B75">2016</xref>). To date a bona fide microglia-specific marker that labels all microglia, from the post-erythromyeloid progenitor stage up to old age, is still unavailable. Notably, a somatic mutation in the erythromyeloid progenitor of microglia was shown to cause neurodegenerative disease in mouse and human (Mass et al., <xref ref-type="bibr" rid="B178">2017</xref>). However, as mentioned above, <italic>Tmem119</italic> and <italic>Sall1</italic> were shown to be selectively expressed by microglia across different contexts of health and disease (Bennett et al., <xref ref-type="bibr" rid="B12">2016</xref>; Buttgereit et al., <xref ref-type="bibr" rid="B28">2016</xref>). The impact of pharmacologically depleting microglia (Elmore et al., <xref ref-type="bibr" rid="B59">2014</xref>; Torres et al., <xref ref-type="bibr" rid="B306">2016</xref>; VanRyzin et al., <xref ref-type="bibr" rid="B317">2016</xref>) was additionally explored in multiple preclinical animal studies (reviewed in Han et al., <xref ref-type="bibr" rid="B95">2017</xref>; Lund et al., <xref ref-type="bibr" rid="B170">2017</xref>; Figure <xref ref-type="fig" rid="F4">4</xref>). The current evidence suggest that a transient depletion during early postnatal and juvenile stages has a prolonged impact on cognition and social behavior (Parkhurst et al., <xref ref-type="bibr" rid="B221">2013</xref>; VanRyzin et al., <xref ref-type="bibr" rid="B317">2016</xref>), in contrast to the reversible alterations induced by adult treatment with the selective CSF1R inhibitor PLX3397 (Elmore et al., <xref ref-type="bibr" rid="B59">2014</xref>; Torres et al., <xref ref-type="bibr" rid="B306">2016</xref>). Two independent investigations in AD mouse models, APP/PS1 (Olmos-Alonso et al., <xref ref-type="bibr" rid="B209">2016</xref>) and 5xFAD (Spangenberg et al., <xref ref-type="bibr" rid="B283">2016</xref>), further inhibited microglial proliferation or depletion using the CSF1R inhibitors GW2580 and PLX3397, respectively. Both studies concluded that the progression of AD pathology was delayed with an overall reduction of pro-inflammatory responses although amyloid β load remained unchanged. In contrast, a study that analyzed in mice the propagation of Tau protein revealed a suppression of Tau pathology when microglia were depleted using PLX3397 or intracerebroventricular infusion of clodronate liposomes, in a viral-driven neuron-specific expression of mutant human <italic>Tau</italic> transgene (Asai et al., <xref ref-type="bibr" rid="B7">2015</xref>). Recently PLX3397 was also administered to two Rhesus macaques, in what is possibly the first attempt to deplete microglia in nonhuman primates, in order to understand the dynamics of their depletion in relation to CNS immune cell activation by PET imaging (Hillmer et al., <xref ref-type="bibr" rid="B106">2017</xref>). TSPO binding suggested differential recovery of microglia after depletion in healthy vs. LPS-challenged macaques (Hillmer et al., <xref ref-type="bibr" rid="B106">2017</xref>). Since these pharmacological compounds also target non-parenchymal CNS macrophages and other myeloid cells in the periphery, further characterizations of their effects based on brain compartments, gray vs. white matter, nature and stage of pathologies, and sex-dependency (VanRyzin et al., <xref ref-type="bibr" rid="B317">2016</xref>; Labonté et al., <xref ref-type="bibr" rid="B151">2017</xref>) are required.</p>
</sec>
<sec id="s9" sec-type="conclusion">
<title>Conclusion</title>
<p>Overall, the findings presented in this review indicate that microglia are increasingly implicated in the pathophysiology of various developmental and neurodegenerative psychiatric disorders, even though the exact mechanisms underlying this association are still undetermined. Critical physiological roles of microglia, including their secretion of cytokines and neurotrophins, phagocytosis, and interactions with synapses, regulate normal brain development, function and plasticity. Animal studies have revealed that abnormal neuronal and synaptic densities, impaired circuit wiring, and imbalance of excitation/inhibition, can result from altered neurogenesis or neuronal survival, impaired synaptic pruning, or altered levels of pro- and anti-inflammatory cytokines. These deficits and alterations were commonly reported in psychiatric disorders. In particular, environmental insults such as perinatal infection, early postnatal and chronic stress, were shown to compromise physiological microglial functions and induce permanent changes in the brain with direct consequences on mood and cognition. Furthermore, microglia could be primed by an early immunological challenge, rendering them more susceptible to a subsequent insult and favoring the emergence of psychiatric conditions later in life. Considering the brain region-dependent slow turnover of microglia, the accumulation of repetitive priming events such as infections and stress across a lifetime may further precipitate the age-dependent deterioration of their physiological functions, resulting in the onset of cognitive aging and neurodegenerative disorders. Due to their unique mesodermal origin, microglia are promising therapeutic targets to gain access to the CNS without directly modifying non-myeloid cell types of the CNS. To precisely characterize the microglial phenotypes implicated in different psychiatric disorders, improvement in selectivity of radiotracers for patient examinations is required. Finally, better characterization of the existing pharmacological compounds able to modulate microglial phenotypes may accelerate the implementation of effective therapies for psychiatric disorders.</p>
</sec>
<sec id="s10">
<title>Author Contributions</title>
<p>TLT, AR and MET designed the review outline, recruited CB, ID, MKS and MSH, and supervised the overall project. All the authors contributed to the literature search and to the manuscript writing.</p>
</sec>
<sec id="s11">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We are grateful to Drs. Luc Maroteaux and Patricia Gaspar, as well as Prof. Laura Civiero for their insightful revision of our manuscript. TLT was supported by the German Research Foundation (DFG, TA1029/1-1) and the Ministry of Science, Research and the Arts of Baden-Wuerttemberg (Research Seed Capital). MKS was supported by excellence scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC), Fonds de recherche du Québec—Nature et technologies (FRQNT), and Faculty of Medicine of Université Laval. MET was funded by the Canadian Institutes of Health Research (CIHR, award no. RN283856 - 353750) and is a Canada Research Chair (Tier 2) in <italic>Neuroimmune plasticity in health and therapy</italic>. AR is supported by UPMC and funded by BIO-PSY Labex and Agence Nationale de la Recherche (ANR). ID is supported by Fondation pour la Recherche Médicale (DEQ2014039529) and BIO-PSY Labex and CB by INSERM. We dedicate this work to all women in Science, and to one of our strongest advocates and pioneer of glial research, Prof. Ben A. Barres.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajami</surname><given-names>B.</given-names></name><name><surname>Bennett</surname><given-names>J. L.</given-names></name><name><surname>Krieger</surname><given-names>C.</given-names></name><name><surname>Tetzlaff</surname><given-names>W.</given-names></name><name><surname>Rossi</surname><given-names>F. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Local self-renewal can sustain CNS microglia maintenance and function throughout adult life</article-title>. <source/>Nat. Neurosci.
<volume>10</volume>, <fpage>1538</fpage>–<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1038/nn2014</pub-id><pub-id pub-id-type="pmid">18026097</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonso-Loeches</surname><given-names>S.</given-names></name><name><surname>Pascual-Lucas</surname><given-names>M.</given-names></name><name><surname>Blanco</surname><given-names>A. M.</given-names></name><name><surname>Sanchez-Vera</surname><given-names>I.</given-names></name><name><surname>Guerri</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>8285</fpage>–<lpage>8295</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0976-10.2010</pub-id><pub-id pub-id-type="pmid">20554880</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alliot</surname><given-names>F.</given-names></name><name><surname>Godin</surname><given-names>I.</given-names></name><name><surname>Pessac</surname><given-names>B.</given-names></name></person-group> (<year>1999</year>). <article-title>Microglia derive from progenitors, originating from the yolk sac and which proliferate in the brain</article-title>. <source/>Dev. Brain Res.
<volume>117</volume>, <fpage>145</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-3806(99)00113-3</pub-id><pub-id pub-id-type="pmid">10567732</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R. E.</given-names></name><name><surname>Van Den Veyver</surname><given-names>I. B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C. Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>. <source/>Nat. Genet.
<volume>23</volume>, <fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id><pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>B.</given-names></name><name><surname>Rutledge</surname><given-names>V.</given-names></name></person-group> (<year>1996</year>). <article-title>Age and hemisphere effects on dendritic structure</article-title>. <source/>Brain
<volume>119</volume>, <fpage>1983</fpage>–<lpage>1990</lpage>. <pub-id pub-id-type="doi">10.1093/brain/119.6.1983</pub-id><pub-id pub-id-type="pmid">9010002</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnò</surname><given-names>B.</given-names></name><name><surname>Grassivaro</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>C.</given-names></name><name><surname>Bergamaschi</surname><given-names>A.</given-names></name><name><surname>Castiglioni</surname><given-names>V.</given-names></name><name><surname>Furlan</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>5611</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms6611</pub-id><pub-id pub-id-type="pmid">25425146</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asai</surname><given-names>H.</given-names></name><name><surname>Ikezu</surname><given-names>S.</given-names></name><name><surname>Tsunoda</surname><given-names>S.</given-names></name><name><surname>Medalla</surname><given-names>M.</given-names></name><name><surname>Luebke</surname><given-names>J.</given-names></name><name><surname>Haydar</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Depletion of microglia and inhibition of exosome synthesis halt tau propagation</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>1584</fpage>–<lpage>1593</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4132</pub-id><pub-id pub-id-type="pmid">26436904</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Askew</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Olmos-Alonso</surname><given-names>A.</given-names></name><name><surname>Garcia-Moreno</surname><given-names>F.</given-names></name><name><surname>Liang</surname><given-names>Y.</given-names></name><name><surname>Richardson</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain</article-title>. <source/>Cell Rep.
<volume>18</volume>, <fpage>391</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.12.041</pub-id><pub-id pub-id-type="pmid">28076784</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelsson</surname><given-names>R.</given-names></name><name><surname>Röyttä</surname><given-names>M.</given-names></name><name><surname>Sourander</surname><given-names>P.</given-names></name><name><surname>Akesson</surname><given-names>H. O.</given-names></name><name><surname>Andersen</surname><given-names>O.</given-names></name></person-group> (<year>1984</year>). <article-title>Hereditary diffuse leucoencephalopathy with spheroids</article-title>. <source/>Acta Psychiatr. Scand. Suppl.
<volume>314</volume>, <fpage>1</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="pmid">6595937</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekris</surname><given-names>L. M.</given-names></name><name><surname>Yu</surname><given-names>C. E.</given-names></name><name><surname>Bird</surname><given-names>T. D.</given-names></name><name><surname>Tsuang</surname><given-names>D. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetics of Alzheimer disease</article-title>. <source/>J. Geriatr. Psychiatry Neurol.
<volume>23</volume>, <fpage>213</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1177/0891988710383571</pub-id><pub-id pub-id-type="pmid">21045163</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellesi</surname><given-names>M.</given-names></name><name><surname>De Vivo</surname><given-names>L.</given-names></name><name><surname>Chini</surname><given-names>M.</given-names></name><name><surname>Gilli</surname><given-names>F.</given-names></name><name><surname>Tononi</surname><given-names>G.</given-names></name><name><surname>Cirelli</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>5263</fpage>–<lpage>5273</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3981-16.2017</pub-id><pub-id pub-id-type="pmid">28539349</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>M. L.</given-names></name><name><surname>Bennett</surname><given-names>F. C.</given-names></name><name><surname>Liddelow</surname><given-names>S. A.</given-names></name><name><surname>Ajami</surname><given-names>B.</given-names></name><name><surname>Zamanian</surname><given-names>J. L.</given-names></name><name><surname>Fernhoff</surname><given-names>N. B.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>New tools for studying microglia in the mouse and human CNS</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>113</volume>, <fpage>E1738</fpage>–<lpage>E1746</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1525528113</pub-id><pub-id pub-id-type="pmid">26884166</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berchtold</surname><given-names>N. C.</given-names></name><name><surname>Coleman</surname><given-names>P. D.</given-names></name><name><surname>Cribbs</surname><given-names>D. H.</given-names></name><name><surname>Rogers</surname><given-names>J.</given-names></name><name><surname>Gillen</surname><given-names>D. L.</given-names></name><name><surname>Cotman</surname><given-names>C. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer’s disease</article-title>. <source/>Neurobiol. Aging
<volume>34</volume>, <fpage>1653</fpage>–<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.11.024</pub-id><pub-id pub-id-type="pmid">23273601</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betancur</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting</article-title>. <source/>Brain Res.
<volume>1380</volume>, <fpage>42</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.11.078</pub-id><pub-id pub-id-type="pmid">21129364</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bialas</surname><given-names>A. R.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>1773</fpage>–<lpage>1782</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3560</pub-id><pub-id pub-id-type="pmid">24162655</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchin</surname><given-names>M. M.</given-names></name><name><surname>Capella</surname><given-names>H. M.</given-names></name><name><surname>Chaves</surname><given-names>D. L.</given-names></name><name><surname>Steindel</surname><given-names>M.</given-names></name><name><surname>Grisard</surname><given-names>E. C.</given-names></name><name><surname>Ganev</surname><given-names>G. G.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy—PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects</article-title>. <source/>Cell. Mol. Neurobiol.
<volume>24</volume>, <fpage>1</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1023/b:cemn.0000012721.08168.ee</pub-id><pub-id pub-id-type="pmid">15049507</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Sharma</surname><given-names>K. P.</given-names></name><name><surname>Lecours</surname><given-names>C.</given-names></name><name><surname>Sánchez</surname><given-names>M. G.</given-names></name><name><surname>El Hajj</surname><given-names>H.</given-names></name><name><surname>Milior</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Dark microglia: a new phenotype predominantly associated with pathological states</article-title>. <source/>Glia
<volume>64</volume>, <fpage>826</fpage>–<lpage>839</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22966</pub-id><pub-id pub-id-type="pmid">26847266</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bliederhaeuser</surname><given-names>C.</given-names></name><name><surname>Grozdanov</surname><given-names>V.</given-names></name><name><surname>Speidel</surname><given-names>A.</given-names></name><name><surname>Zondler</surname><given-names>L.</given-names></name><name><surname>Ruf</surname><given-names>W. P.</given-names></name><name><surname>Bayer</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Age-dependent defects of α-synuclein oligomer uptake in microglia and monocytes</article-title>. <source/>Acta Neuropathol.
<volume>131</volume>, <fpage>379</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-015-1504-2</pub-id><pub-id pub-id-type="pmid">26576561</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloomfield</surname><given-names>P. S.</given-names></name><name><surname>Selvaraj</surname><given-names>S.</given-names></name><name><surname>Veronese</surname><given-names>M.</given-names></name><name><surname>Rizzo</surname><given-names>G.</given-names></name><name><surname>Bertoldo</surname><given-names>A.</given-names></name><name><surname>Owen</surname><given-names>D. R.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [<sup>11</sup>C]PBR28 PET brain imaging study</article-title>. <source/>Am. J. Psychiatry
<volume>173</volume>, <fpage>44</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2015.14101358</pub-id><pub-id pub-id-type="pmid">26472628</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bocarsly</surname><given-names>M. E.</given-names></name><name><surname>Fasolino</surname><given-names>M.</given-names></name><name><surname>Kane</surname><given-names>G. A.</given-names></name><name><surname>Lamarca</surname><given-names>E. A.</given-names></name><name><surname>Kirschen</surname><given-names>G. W.</given-names></name><name><surname>Karatsoreos</surname><given-names>I. N.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Obesity diminishes synaptic markers, alters microglial morphology and impairs cognitive function</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>112</volume>, <fpage>15731</fpage>–<lpage>15736</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1511593112</pub-id><pub-id pub-id-type="pmid">26644559</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boksa</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of prenatal infection on brain development and behavior: a review of findings from animal models</article-title>. <source/>Brain Behav. Immun.
<volume>24</volume>, <fpage>881</fpage>–<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2010.03.005</pub-id><pub-id pub-id-type="pmid">20230889</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A. S.</given-names></name><name><surname>Derkits</surname><given-names>E. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Prenatal infection and schizophrenia: a review of epidemiologic and translational studies</article-title>. <source/>Am. J. Psychiatry
<volume>167</volume>, <fpage>261</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2009.09030361</pub-id><pub-id pub-id-type="pmid">20123911</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burguière</surname><given-names>E.</given-names></name><name><surname>Monteiro</surname><given-names>P.</given-names></name><name><surname>Mallet</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name><name><surname>Graybiel</surname><given-names>A. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Striatal circuits, habits and implications for obsessive-compulsive disorder</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>30</volume>, <fpage>59</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2014.08.008</pub-id><pub-id pub-id-type="pmid">25241072</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burma</surname><given-names>N. E.</given-names></name><name><surname>Bonin</surname><given-names>R. P.</given-names></name><name><surname>Leduc-Pessah</surname><given-names>H.</given-names></name><name><surname>Baimel</surname><given-names>C.</given-names></name><name><surname>Cairncross</surname><given-names>Z. F.</given-names></name><name><surname>Mousseau</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents</article-title>. <source/>Nat. Med.
<volume>23</volume>, <fpage>355</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4281</pub-id><pub-id pub-id-type="pmid">28134928</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busse</surname><given-names>S.</given-names></name><name><surname>Busse</surname><given-names>M.</given-names></name><name><surname>Schiltz</surname><given-names>K.</given-names></name><name><surname>Bielau</surname><given-names>H.</given-names></name><name><surname>Gos</surname><given-names>T.</given-names></name><name><surname>Brisch</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?</article-title>
<source/>Brain Behav. Immun.
<volume>26</volume>, <fpage>1273</fpage>–<lpage>1279</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2012.08.005</pub-id><pub-id pub-id-type="pmid">22917959</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butovsky</surname><given-names>O.</given-names></name><name><surname>Jedrychowski</surname><given-names>M. P.</given-names></name><name><surname>Moore</surname><given-names>C. S.</given-names></name><name><surname>Cialic</surname><given-names>R.</given-names></name><name><surname>Lanser</surname><given-names>A. J.</given-names></name><name><surname>Gabriely</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Identification of a unique TGF-β-dependent molecular and functional signature in microglia</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>131</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3599</pub-id><pub-id pub-id-type="pmid">24316888</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butovsky</surname><given-names>O.</given-names></name><name><surname>Siddiqui</surname><given-names>S.</given-names></name><name><surname>Gabriely</surname><given-names>G.</given-names></name><name><surname>Lanser</surname><given-names>A. J.</given-names></name><name><surname>Dake</surname><given-names>B.</given-names></name><name><surname>Murugaiyan</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS</article-title>. <source/>J. Clin. Invest.
<volume>122</volume>, <fpage>3063</fpage>–<lpage>3087</lpage>. <pub-id pub-id-type="doi">10.1172/jci62636</pub-id><pub-id pub-id-type="pmid">22863620</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buttgereit</surname><given-names>A.</given-names></name><name><surname>Lelios</surname><given-names>I.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Vrohlings</surname><given-names>M.</given-names></name><name><surname>Krakoski</surname><given-names>N. R.</given-names></name><name><surname>Gautier</surname><given-names>E. L.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Sall1 is a transcriptional regulator defining microglia identity and function</article-title>. <source/>Nat. Immunol.
<volume>17</volume>, <fpage>1397</fpage>–<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3585</pub-id><pub-id pub-id-type="pmid">27776109</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calcia</surname><given-names>M. A.</given-names></name><name><surname>Bonsall</surname><given-names>D. R.</given-names></name><name><surname>Bloomfield</surname><given-names>P. S.</given-names></name><name><surname>Selvaraj</surname><given-names>S.</given-names></name><name><surname>Barichello</surname><given-names>T.</given-names></name><name><surname>Howes</surname><given-names>O. D.</given-names></name></person-group> (<year>2016</year>). <article-title>Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness</article-title>. <source/>Psychopharmacology
<volume>233</volume>, <fpage>1637</fpage>–<lpage>1650</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-016-4218-9</pub-id><pub-id pub-id-type="pmid">26847047</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canitano</surname><given-names>R.</given-names></name><name><surname>Pallagrosi</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Autism spectrum disorders and schizophrenia spectrum disorders: excitation/inhibition imbalance and developmental trajectories</article-title>. <source/>Front. Psychiatry
<volume>8</volume>:<fpage>69</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2017.00069</pub-id><pub-id pub-id-type="pmid">28507523</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Careaga</surname><given-names>M.</given-names></name><name><surname>Murai</surname><given-names>T.</given-names></name><name><surname>Bauman</surname><given-names>M. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates</article-title>. <source/>Biol. Psychiatry
<volume>81</volume>, <fpage>391</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2016.10.020</pub-id><pub-id pub-id-type="pmid">28137374</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cearley</surname><given-names>C. N.</given-names></name><name><surname>Blindheim</surname><given-names>K.</given-names></name><name><surname>Sorg</surname><given-names>B. A.</given-names></name><name><surname>Krueger</surname><given-names>J. M.</given-names></name><name><surname>Churchill</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Acute cocaine increases interleukin-1β mRNA and immunoreactive cells in the cortex and nucleus accumbens</article-title>. <source/>Neurochem. Res.
<volume>36</volume>, <fpage>686</fpage>–<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-011-0410-9</pub-id><pub-id pub-id-type="pmid">21399909</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>2007</year>). <article-title>The story of Rett syndrome: from clinic to neurobiology</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>422</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.001</pub-id><pub-id pub-id-type="pmid">17988628</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.-K.</given-names></name><name><surname>Tvrdik</surname><given-names>P.</given-names></name><name><surname>Peden</surname><given-names>E.</given-names></name><name><surname>Cho</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Spangrude</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Hematopoietic origin of pathological grooming in Hoxb8 mutant mice</article-title>. <source/>Cell
<volume>141</volume>, <fpage>775</fpage>–<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.03.055</pub-id><pub-id pub-id-type="pmid">20510925</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>I. M.</given-names></name><name><surname>Morimoto</surname><given-names>E. T.</given-names></name><name><surname>Goodarzi</surname><given-names>H.</given-names></name><name><surname>Liao</surname><given-names>J. T.</given-names></name><name><surname>O’keeffe</surname><given-names>S.</given-names></name><name><surname>Phatnani</surname><given-names>H. P.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model</article-title>. <source/>Cell Rep.
<volume>4</volume>, <fpage>385</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.018</pub-id><pub-id pub-id-type="pmid">23850290</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>K. H.</given-names></name><name><surname>Cheong</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Abe</surname><given-names>H.</given-names></name><name><surname>Murakami</surname><given-names>G.</given-names></name><name><surname>Cho</surname><given-names>B. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Site-specific distribution of CD68-positive microglial cells in the brains of human midterm fetuses: a topographical relationship with growing axons</article-title>. <source/>Biomed Res. Int.
<volume>2013</volume>:<fpage>762303</fpage>. <pub-id pub-id-type="doi">10.1155/2013/762303</pub-id><pub-id pub-id-type="pmid">24459672</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christoffel</surname><given-names>D. J.</given-names></name><name><surname>Golden</surname><given-names>S. A.</given-names></name><name><surname>Russo</surname><given-names>S. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Structural and synaptic plasticity in stress-related disorders</article-title>. <source/>Rev. Neurosci.
<volume>22</volume>, <fpage>535</fpage>–<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1515/rns.2011.044</pub-id><pub-id pub-id-type="pmid">21967517</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>L. G.</given-names><suffix>Jr.</suffix></name><name><surname>Zou</surname><given-names>J.</given-names></name><name><surname>Crews</surname><given-names>F. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7</article-title>. <source/>J. Neuroinflammation
<volume>14</volume>:<fpage>22</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-017-0799-4</pub-id><pub-id pub-id-type="pmid">28118842</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coughlin</surname><given-names>J. M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Ambinder</surname><given-names>E. B.</given-names></name><name><surname>Ward</surname><given-names>R. E.</given-names></name><name><surname>Minn</surname><given-names>I.</given-names></name><name><surname>Vranesic</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title><italic>In vivo</italic> markers of inflammatory response in recent-onset schizophrenia: a combined study using [<sup>11</sup>C]DPA-713 PET and analysis of CSF and plasma</article-title>. <source/>Transl. Psychiatry
<volume>6</volume>:<fpage>e777</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2016.40</pub-id><pub-id pub-id-type="pmid">27070405</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courchesne</surname><given-names>E.</given-names></name><name><surname>Campbell</surname><given-names>K.</given-names></name><name><surname>Solso</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Brain growth across the life span in autism: age-specific changes in anatomical pathology</article-title>. <source/>Brain Res.
<volume>1380</volume>, <fpage>138</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.101</pub-id><pub-id pub-id-type="pmid">20920490</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courchesne</surname><given-names>E.</given-names></name><name><surname>Pierce</surname><given-names>K.</given-names></name><name><surname>Schumann</surname><given-names>C. M.</given-names></name><name><surname>Redcay</surname><given-names>E.</given-names></name><name><surname>Buckwalter</surname><given-names>J. A.</given-names></name><name><surname>Kennedy</surname><given-names>D. P.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Mapping early brain development in autism</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>399</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.016</pub-id><pub-id pub-id-type="pmid">17964254</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cribbs</surname><given-names>D. H.</given-names></name><name><surname>Berchtold</surname><given-names>N. C.</given-names></name><name><surname>Perreau</surname><given-names>V.</given-names></name><name><surname>Coleman</surname><given-names>P. D.</given-names></name><name><surname>Rogers</surname><given-names>J.</given-names></name><name><surname>Tenner</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study</article-title>. <source/>J. Neuroinflammation
<volume>9</volume>:<fpage>179</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-179</pub-id><pub-id pub-id-type="pmid">22824372</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damani</surname><given-names>M. R.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Fontainhas</surname><given-names>A. M.</given-names></name><name><surname>Amaral</surname><given-names>J.</given-names></name><name><surname>Fariss</surname><given-names>R. N.</given-names></name><name><surname>Wong</surname><given-names>W. T.</given-names></name></person-group> (<year>2011</year>). <article-title>Age-related alterations in the dynamic behavior of microglia</article-title>. <source/>Aging Cell
<volume>10</volume>, <fpage>263</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00660.x</pub-id><pub-id pub-id-type="pmid">21108733</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantzer</surname><given-names>R.</given-names></name><name><surname>O’connor</surname><given-names>J. C.</given-names></name><name><surname>Freund</surname><given-names>G. G.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name></person-group> (<year>2008</year>). <article-title>From inflammation to sickness and depression: when the immune system subjugates the brain</article-title>. <source/>Nat. Rev. Neurosci.
<volume>9</volume>, <fpage>46</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2297</pub-id><pub-id pub-id-type="pmid">18073775</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davalos</surname><given-names>D.</given-names></name><name><surname>Grutzendler</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>J. V.</given-names></name><name><surname>Zuo</surname><given-names>Y.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>ATP mediates rapid microglial response to local brain injury <italic>in vivo</italic></article-title>. <source/>Nat. Neurosci.
<volume>8</volume>, <fpage>752</fpage>–<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1038/nn1472</pub-id><pub-id pub-id-type="pmid">15895084</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>O. M.</given-names></name><name><surname>Kanchanatawan</surname><given-names>B.</given-names></name><name><surname>Ashton</surname><given-names>M.</given-names></name><name><surname>Mohebbi</surname><given-names>M.</given-names></name><name><surname>Ng</surname><given-names>C. H.</given-names></name><name><surname>Maes</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial</article-title>. <source/>Aust. N Z J. Psychiatry
<volume>51</volume>, <fpage>829</fpage>–<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1177/0004867417709357</pub-id><pub-id pub-id-type="pmid">28578592</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Biase</surname><given-names>L. M.</given-names></name><name><surname>Schuebel</surname><given-names>K. E.</given-names></name><name><surname>Fusfeld</surname><given-names>Z. H.</given-names></name><name><surname>Jair</surname><given-names>K.</given-names></name><name><surname>Hawes</surname><given-names>I. A.</given-names></name><name><surname>Cimbro</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Local cues establish and maintain region-specific phenotypes of basal ganglia microglia</article-title>. <source/>Neuron
<volume>95</volume>, <fpage>341.e6</fpage>–<lpage>356.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.020</pub-id><pub-id pub-id-type="pmid">28689984</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Lella Ezcurra</surname><given-names>A. L.</given-names></name><name><surname>Chertoff</surname><given-names>M.</given-names></name><name><surname>Ferrari</surname><given-names>C.</given-names></name><name><surname>Graciarena</surname><given-names>M.</given-names></name><name><surname>Pitossi</surname><given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>Chronic expression of low levels of tumor necrosis factor-α in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation</article-title>. <source/>Neurobiol. Dis.
<volume>37</volume>, <fpage>630</fpage>–<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.11.018</pub-id><pub-id pub-id-type="pmid">19969084</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delpech</surname><given-names>J. C.</given-names></name><name><surname>Saucisse</surname><given-names>N.</given-names></name><name><surname>Parkes</surname><given-names>S. L.</given-names></name><name><surname>Lacabanne</surname><given-names>C.</given-names></name><name><surname>Aubert</surname><given-names>A.</given-names></name><name><surname>Casenave</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Microglial activation enhances associative taste memory through purinergic modulation of glutamatergic neurotransmission</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>3022</fpage>–<lpage>3033</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3028-14.2015</pub-id><pub-id pub-id-type="pmid">25698740</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delpech</surname><given-names>J. C.</given-names></name><name><surname>Wei</surname><given-names>L.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Madore</surname><given-names>C.</given-names></name><name><surname>Butovsky</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Early life stress perturbs the maturation of microglia in the developing hippocampus</article-title>. <source/>Brain Behav. Immun.
<volume>57</volume>, <fpage>79</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.06.006</pub-id><pub-id pub-id-type="pmid">27301858</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhingra</surname><given-names>L.</given-names></name><name><surname>Ahmed</surname><given-names>E.</given-names></name><name><surname>Shin</surname><given-names>J.</given-names></name><name><surname>Scharaga</surname><given-names>E.</given-names></name><name><surname>Magun</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Cognitive effects and sedation</article-title>. <source/>Pain Med.
<volume>16</volume>, <fpage>S37</fpage>–<lpage>S43</lpage>. <pub-id pub-id-type="doi">10.1111/pme.12912</pub-id><pub-id pub-id-type="pmid">26461075</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diekelmann</surname><given-names>S.</given-names></name><name><surname>Born</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>The memory function of sleep</article-title>. <source/>Nat. Rev. Neurosci.
<volume>11</volume>, <fpage>114</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2762</pub-id><pub-id pub-id-type="pmid">20046194</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doorduin</surname><given-names>J.</given-names></name><name><surname>de Vries</surname><given-names>E. F.</given-names></name><name><surname>Willemsen</surname><given-names>A. T.</given-names></name><name><surname>de Groot</surname><given-names>J. C.</given-names></name><name><surname>Dierckx</surname><given-names>R. A.</given-names></name><name><surname>Klein</surname><given-names>H. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Neuroinflammation in schizophrenia-related psychosis: a PET study</article-title>. <source/>J. Nucl. Med.
<volume>50</volume>, <fpage>1801</fpage>–<lpage>1807</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.109.066647</pub-id><pub-id pub-id-type="pmid">19837763</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doorn</surname><given-names>K. J.</given-names></name><name><surname>Brevé</surname><given-names>J. J.</given-names></name><name><surname>Drukarch</surname><given-names>B.</given-names></name><name><surname>Boddeke</surname><given-names>H. W.</given-names></name><name><surname>Huitinga</surname><given-names>I.</given-names></name><name><surname>Lucassen</surname><given-names>P. J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Brain region-specific gene expression profiles in freshly isolated rat microglia</article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>:<fpage>84</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00084</pub-id><pub-id pub-id-type="pmid">25814934</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doorn</surname><given-names>K. J.</given-names></name><name><surname>Moors</surname><given-names>T.</given-names></name><name><surname>Drukarch</surname><given-names>B.</given-names></name><name><surname>van de Berg</surname><given-names>W.</given-names></name><name><surname>Lucassen</surname><given-names>P. J.</given-names></name><name><surname>van Dam</surname><given-names>A. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients</article-title>. <source/>Acta Neuropathol. Commun.
<volume>2</volume>:<fpage>90</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-014-0090-1</pub-id><pub-id pub-id-type="pmid">25099483</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowlati</surname><given-names>Y.</given-names></name><name><surname>Herrmann</surname><given-names>N.</given-names></name><name><surname>Swardfager</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Sham</surname><given-names>L.</given-names></name><name><surname>Reim</surname><given-names>E. K.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A meta-analysis of cytokines in major depression</article-title>. <source/>Biol. Psychiatry
<volume>67</volume>, <fpage>446</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.09.033</pub-id><pub-id pub-id-type="pmid">20015486</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drevets</surname><given-names>W. C.</given-names></name><name><surname>Price</surname><given-names>J. L.</given-names></name><name><surname>Simpson</surname><given-names>J. R.</given-names><suffix>Jr.</suffix></name><name><surname>Todd</surname><given-names>R. D.</given-names></name><name><surname>Reich</surname><given-names>T.</given-names></name><name><surname>Vannier</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Subgenual prefrontal cortex abnormalities in mood disorders</article-title>. <source/>Nature
<volume>386</volume>, <fpage>824</fpage>–<lpage>827</lpage>. <pub-id pub-id-type="doi">10.1038/386824a0</pub-id><pub-id pub-id-type="pmid">9126739</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edmonson</surname><given-names>C. A.</given-names></name><name><surname>Ziats</surname><given-names>M. N.</given-names></name><name><surname>Rennert</surname><given-names>O. M.</given-names></name></person-group> (<year>2016</year>). <article-title>A non-inflammatory role for microglia in autism spectrum disorders</article-title>. <source/>Front. Neurol.
<volume>7</volume>:<fpage>9</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2016.00009</pub-id><pub-id pub-id-type="pmid">26869989</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmore</surname><given-names>M. R.</given-names></name><name><surname>Najafi</surname><given-names>A. R.</given-names></name><name><surname>Koike</surname><given-names>M. A.</given-names></name><name><surname>Dagher</surname><given-names>N. N.</given-names></name><name><surname>Spangenberg</surname><given-names>E. E.</given-names></name><name><surname>Rice</surname><given-names>R. A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain</article-title>. <source/>Neuron
<volume>82</volume>, <fpage>380</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.02.040</pub-id><pub-id pub-id-type="pmid">24742461</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erblich</surname><given-names>B.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Etgen</surname><given-names>A. M.</given-names></name><name><surname>Dobrenis</surname><given-names>K.</given-names></name><name><surname>Pollard</surname><given-names>J. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits</article-title>. <source/>PLoS One
<volume>6</volume>:<fpage>e26317</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0026317</pub-id><pub-id pub-id-type="pmid">22046273</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erny</surname><given-names>D.</given-names></name><name><surname>Hrabě de Angelis</surname><given-names>A. L.</given-names></name><name><surname>Jaitin</surname><given-names>D.</given-names></name><name><surname>Wieghofer</surname><given-names>P.</given-names></name><name><surname>Staszewski</surname><given-names>O.</given-names></name><name><surname>David</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>965</fpage>–<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4030</pub-id><pub-id pub-id-type="pmid">26030851</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname><given-names>M. L.</given-names></name><name><surname>McAllister</surname><given-names>A. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Maternal immune activation: implications for neuropsychiatric disorders</article-title>. <source/>Science
<volume>353</volume>, <fpage>772</fpage>–<lpage>777</lpage>. <pub-id pub-id-type="doi">10.1126/science.aag3194</pub-id><pub-id pub-id-type="pmid">27540164</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name><name><surname>Aldinger</surname><given-names>K. A.</given-names></name><name><surname>Ashwood</surname><given-names>P.</given-names></name><name><surname>Bauman</surname><given-names>M. L.</given-names></name><name><surname>Blaha</surname><given-names>C. D.</given-names></name><name><surname>Blatt</surname><given-names>G. J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Consensus paper: pathological role of the cerebellum in autism</article-title>. <source/>Cerebellum
<volume>11</volume>, <fpage>777</fpage>–<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1007/s12311-012-0355-9</pub-id><pub-id pub-id-type="pmid">22370873</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>N. C.</given-names></name><name><surname>Sriram</surname><given-names>U.</given-names></name><name><surname>Gofman</surname><given-names>L.</given-names></name><name><surname>Cenna</surname><given-names>J. M.</given-names></name><name><surname>Ramirez</surname><given-names>S. H.</given-names></name><name><surname>Potula</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Methamphetamine alters microglial immune function through P2X7R signaling</article-title>. <source/>J. Neuroinflammation
<volume>13</volume>:<fpage>91</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-016-0553-3</pub-id><pub-id pub-id-type="pmid">27117066</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fidler</surname><given-names>J. A.</given-names></name><name><surname>Treleaven</surname><given-names>C. M.</given-names></name><name><surname>Frakes</surname><given-names>A.</given-names></name><name><surname>Tamsett</surname><given-names>T. J.</given-names></name><name><surname>McCrate</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>S. H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone</article-title>. <source/>FASEB J.
<volume>25</volume>, <fpage>4369</fpage>–<lpage>4377</lpage>. <pub-id pub-id-type="doi">10.1096/fj.11-190819</pub-id><pub-id pub-id-type="pmid">21876068</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fillman</surname><given-names>S. G.</given-names></name><name><surname>Cloonan</surname><given-names>N.</given-names></name><name><surname>Catts</surname><given-names>V. S.</given-names></name><name><surname>Miller</surname><given-names>L. C.</given-names></name><name><surname>Wong</surname><given-names>J.</given-names></name><name><surname>McCrossin</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia</article-title>. <source/>Mol. Psychiatry
<volume>18</volume>, <fpage>206</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.110</pub-id><pub-id pub-id-type="pmid">22869038</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flanary</surname><given-names>B. E.</given-names></name><name><surname>Sammons</surname><given-names>N. W.</given-names></name><name><surname>Nguyen</surname><given-names>C.</given-names></name><name><surname>Walker</surname><given-names>D.</given-names></name><name><surname>Streit</surname><given-names>W. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Evidence that aging and amyloid promote microglial cell senescence</article-title>. <source/>Rejuvenation Res.
<volume>10</volume>, <fpage>61</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2006.9096</pub-id><pub-id pub-id-type="pmid">17378753</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floden</surname><given-names>A. M.</given-names></name><name><surname>Combs</surname><given-names>C. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Microglia demonstrate age-dependent interaction with amyloid-β fibrils</article-title>. <source/>J. Alzheimers Dis.
<volume>25</volume>, <fpage>279</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2011-101014</pub-id><pub-id pub-id-type="pmid">21403390</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourgeaud</surname><given-names>L.</given-names></name><name><surname>Través</surname><given-names>P. G.</given-names></name><name><surname>Tufail</surname><given-names>Y.</given-names></name><name><surname>Leal-Bailey</surname><given-names>H.</given-names></name><name><surname>Lew</surname><given-names>E. D.</given-names></name><name><surname>Burrola</surname><given-names>P. G.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>TAM receptors regulate multiple features of microglial physiology</article-title>. <source/>Nature
<volume>532</volume>, <fpage>240</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1038/nature17630</pub-id><pub-id pub-id-type="pmid">27049947</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>S.</given-names></name><name><surname>Burbach</surname><given-names>G. J.</given-names></name><name><surname>Bonin</surname><given-names>M.</given-names></name><name><surname>Walter</surname><given-names>M.</given-names></name><name><surname>Streit</surname><given-names>W.</given-names></name><name><surname>Bechmann</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice</article-title>. <source/>Glia
<volume>56</volume>, <fpage>1438</fpage>–<lpage>1447</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20710</pub-id><pub-id pub-id-type="pmid">18551625</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrido-Mesa</surname><given-names>N.</given-names></name><name><surname>Zarzuelo</surname><given-names>A.</given-names></name><name><surname>Gálvez</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Minocycline: far beyond an antibiotic</article-title>. <source/>Br. J. Pharmacol.
<volume>169</volume>, <fpage>337</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12139</pub-id><pub-id pub-id-type="pmid">23441623</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname><given-names>E. L.</given-names></name><name><surname>Shay</surname><given-names>T.</given-names></name><name><surname>Miller</surname><given-names>J.</given-names></name><name><surname>Greter</surname><given-names>M.</given-names></name><name><surname>Jakubzick</surname><given-names>C.</given-names></name><name><surname>Ivanov</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages</article-title>. <source/>Nat. Immunol.
<volume>13</volume>, <fpage>1118</fpage>–<lpage>1128</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2419</pub-id><pub-id pub-id-type="pmid">23023392</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geissmann</surname><given-names>F.</given-names></name><name><surname>Manz</surname><given-names>M. G.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><name><surname>Sieweke</surname><given-names>M. H.</given-names></name><name><surname>Merad</surname><given-names>M.</given-names></name><name><surname>Ley</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Development of monocytes, macrophages, and dendritic cells</article-title>. <source/>Science
<volume>327</volume>, <fpage>656</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1126/science.1178331</pub-id><pub-id pub-id-type="pmid">20133564</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F.</given-names></name><name><surname>Greter</surname><given-names>M.</given-names></name><name><surname>Leboeuf</surname><given-names>M.</given-names></name><name><surname>Nandi</surname><given-names>S.</given-names></name><name><surname>See</surname><given-names>P.</given-names></name><name><surname>Gokhan</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Fate mapping analysis reveals that adult microglia derive from primitive macrophages</article-title>. <source/>Science
<volume>330</volume>, <fpage>841</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1126/science.1194637</pub-id><pub-id pub-id-type="pmid">20966214</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldmann</surname><given-names>T.</given-names></name><name><surname>Wieghofer</surname><given-names>P.</given-names></name><name><surname>Jordão</surname><given-names>M. J.</given-names></name><name><surname>Prutek</surname><given-names>F.</given-names></name><name><surname>Hagemeyer</surname><given-names>N.</given-names></name><name><surname>Frenzel</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Origin, fate and dynamics of macrophages at central nervous system interfaces</article-title>. <source/>Nat. Immunol.
<volume>17</volume>, <fpage>797</fpage>–<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3423</pub-id><pub-id pub-id-type="pmid">27135602</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldmann</surname><given-names>T.</given-names></name><name><surname>Wieghofer</surname><given-names>P.</given-names></name><name><surname>Müller</surname><given-names>P. F.</given-names></name><name><surname>Wolf</surname><given-names>Y.</given-names></name><name><surname>Varol</surname><given-names>D.</given-names></name><name><surname>Yona</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>1618</fpage>–<lpage>1626</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3531</pub-id><pub-id pub-id-type="pmid">24077561</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez Perdiguero</surname><given-names>E.</given-names></name><name><surname>Klapproth</surname><given-names>K.</given-names></name><name><surname>Schulz</surname><given-names>C.</given-names></name><name><surname>Busch</surname><given-names>K.</given-names></name><name><surname>Azzoni</surname><given-names>E.</given-names></name><name><surname>Crozet</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors</article-title>. <source/>Nature
<volume>518</volume>, <fpage>547</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/nature13989</pub-id><pub-id pub-id-type="pmid">25470051</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonçalves</surname><given-names>J.</given-names></name><name><surname>Baptista</surname><given-names>S.</given-names></name><name><surname>Martins</surname><given-names>T.</given-names></name><name><surname>Milhazes</surname><given-names>N.</given-names></name><name><surname>Borges</surname><given-names>F.</given-names></name><name><surname>Ribeiro</surname><given-names>C. F.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin</article-title>. <source/>Eur. J. Neurosci.
<volume>31</volume>, <fpage>315</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.07059.x</pub-id><pub-id pub-id-type="pmid">20074221</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonçalves</surname><given-names>J.</given-names></name><name><surname>Martins</surname><given-names>T.</given-names></name><name><surname>Ferreira</surname><given-names>R.</given-names></name><name><surname>Milhazes</surname><given-names>N.</given-names></name><name><surname>Borges</surname><given-names>F.</given-names></name><name><surname>Ribeiro</surname><given-names>C. F.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Methamphetamine-induced early increase of IL-6 and TNF-α mRNA expression in the mouse brain</article-title>. <source/>Ann. N Y Acad. Sci.
<volume>1139</volume>, <fpage>103</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1432.043</pub-id><pub-id pub-id-type="pmid">18991854</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Burgos</surname><given-names>G.</given-names></name><name><surname>Cho</surname><given-names>R. Y.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia</article-title>. <source/>Biol. Psychiatry
<volume>77</volume>, <fpage>1031</fpage>–<lpage>1040</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.03.010</pub-id><pub-id pub-id-type="pmid">25863358</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosselin</surname><given-names>D.</given-names></name><name><surname>Link</surname><given-names>V. M.</given-names></name><name><surname>Romanoski</surname><given-names>C. E.</given-names></name><name><surname>Fonseca</surname><given-names>G. J.</given-names></name><name><surname>Eichenfield</surname><given-names>D. Z.</given-names></name><name><surname>Spann</surname><given-names>N. J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Environment drives selection and function of enhancers controlling tissue-specific macrophage identities</article-title>. <source/>Cell
<volume>159</volume>, <fpage>1327</fpage>–<lpage>1340</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.11.023</pub-id><pub-id pub-id-type="pmid">25480297</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosselin</surname><given-names>D.</given-names></name><name><surname>Skola</surname><given-names>D.</given-names></name><name><surname>Coufal</surname><given-names>N. G.</given-names></name><name><surname>Holtman</surname><given-names>I. R.</given-names></name><name><surname>Schlachetzki</surname><given-names>J. C. M.</given-names></name><name><surname>Sajti</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>An environment-dependent transcriptional network specifies human microglia identity</article-title>. <source/>Science
<volume>356</volume>:<fpage>eaal3222</fpage>. <pub-id pub-id-type="doi">10.1126/science.aal3222</pub-id><pub-id pub-id-type="pmid">28546318</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabert</surname><given-names>K.</given-names></name><name><surname>Michoel</surname><given-names>T.</given-names></name><name><surname>Karavolos</surname><given-names>M. H.</given-names></name><name><surname>Clohisey</surname><given-names>S.</given-names></name><name><surname>Baillie</surname><given-names>J. K.</given-names></name><name><surname>Stevens</surname><given-names>M. P.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Microglial brain region-dependent diversity and selective regional sensitivities to aging</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>504</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4222</pub-id><pub-id pub-id-type="pmid">26780511</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greter</surname><given-names>M.</given-names></name><name><surname>Lelios</surname><given-names>I.</given-names></name><name><surname>Pelczar</surname><given-names>P.</given-names></name><name><surname>Hoeffel</surname><given-names>G.</given-names></name><name><surname>Price</surname><given-names>J.</given-names></name><name><surname>Leboeuf</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia</article-title>. <source/>Immunity
<volume>37</volume>, <fpage>1050</fpage>–<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.11.001</pub-id><pub-id pub-id-type="pmid">23177320</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griciuc</surname><given-names>A.</given-names></name><name><surname>Serrano-Pozo</surname><given-names>A.</given-names></name><name><surname>Parrado</surname><given-names>A. R.</given-names></name><name><surname>Lesinski</surname><given-names>A. N.</given-names></name><name><surname>Asselin</surname><given-names>C. N.</given-names></name><name><surname>Mullin</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid β</article-title>. <source/>Neuron
<volume>78</volume>, <fpage>631</fpage>–<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.04.014</pub-id><pub-id pub-id-type="pmid">23623698</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerreiro</surname><given-names>R.</given-names></name><name><surname>Wojtas</surname><given-names>A.</given-names></name><name><surname>Bras</surname><given-names>J.</given-names></name><name><surname>Carrasquillo</surname><given-names>M.</given-names></name><name><surname>Rogaeva</surname><given-names>E.</given-names></name><name><surname>Majounie</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>TREM2 variants in Alzheimer’s disease</article-title>. <source/>N. Engl. J. Med.
<volume>368</volume>, <fpage>117</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1211851</pub-id><pub-id pub-id-type="pmid">23150934</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Ellis</surname><given-names>S. E.</given-names></name><name><surname>Ashar</surname><given-names>F. N.</given-names></name><name><surname>Moes</surname><given-names>A.</given-names></name><name><surname>Bader</surname><given-names>J. S.</given-names></name><name><surname>Zhan</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>5748</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms6748</pub-id><pub-id pub-id-type="pmid">25494366</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haarman</surname><given-names>B. C.</given-names></name><name><surname>Riemersma-Van der Lek</surname><given-names>R. F.</given-names></name><name><surname>de Groot</surname><given-names>J. C.</given-names></name><name><surname>Ruhé</surname><given-names>H. G.</given-names></name><name><surname>Klein</surname><given-names>H. C.</given-names></name><name><surname>Zandstra</surname><given-names>T. E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Neuroinflammation in bipolar disorder—A [<sup>11</sup>C]-(<italic>R</italic>)-PK11195 positron emission tomography study</article-title>. <source/>Brain Behav. Immun.
<volume>40</volume>, <fpage>219</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.03.016</pub-id><pub-id pub-id-type="pmid">24703991</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habbas</surname><given-names>S.</given-names></name><name><surname>Santello</surname><given-names>M.</given-names></name><name><surname>Becker</surname><given-names>D.</given-names></name><name><surname>Stubbe</surname><given-names>H.</given-names></name><name><surname>Zappia</surname><given-names>G.</given-names></name><name><surname>Liaudet</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Neuroinflammatory TNFα impairs memory via astrocyte signaling</article-title>. <source/>Cell
<volume>163</volume>, <fpage>1730</fpage>–<lpage>1741</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.11.023</pub-id><pub-id pub-id-type="pmid">26686654</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>H.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><name><surname>Vannucci</surname><given-names>S. J.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name><name><surname>Vexler</surname><given-names>Z. S.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The role of inflammation in perinatal brain injury</article-title>. <source/>Nat. Rev. Neurol.
<volume>11</volume>, <fpage>192</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.13</pub-id><pub-id pub-id-type="pmid">25686754</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagemeyer</surname><given-names>N.</given-names></name><name><surname>Hanft</surname><given-names>K. M.</given-names></name><name><surname>Akriditou</surname><given-names>M. A.</given-names></name><name><surname>Unger</surname><given-names>N.</given-names></name><name><surname>Park</surname><given-names>E. S.</given-names></name><name><surname>Stanley</surname><given-names>E. R.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood</article-title>. <source/>Acta Neuropathol.
<volume>134</volume>, <fpage>441</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-017-1747-1</pub-id><pub-id pub-id-type="pmid">28685323</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hailer</surname><given-names>N. P.</given-names></name><name><surname>Vogt</surname><given-names>C.</given-names></name><name><surname>Korf</surname><given-names>H. W.</given-names></name><name><surname>Dehghani</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Interleukin-1β exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures</article-title>. <source/>Eur. J. Neurosci.
<volume>21</volume>, <fpage>2347</fpage>–<lpage>2360</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04067.x</pub-id><pub-id pub-id-type="pmid">15932594</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakola</surname><given-names>H. P.</given-names></name></person-group> (<year>1972</year>). <article-title>Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia</article-title>. <source/>Acta Psychiatr. Scand. Suppl.
<volume>232</volume>, <fpage>1</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="pmid">4509294</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamza</surname><given-names>T. H.</given-names></name><name><surname>Zabetian</surname><given-names>C. P.</given-names></name><name><surname>Tenesa</surname><given-names>A.</given-names></name><name><surname>Laederach</surname><given-names>A.</given-names></name><name><surname>Montimurro</surname><given-names>J.</given-names></name><name><surname>Yearout</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease</article-title>. <source/>Nat. Genet.
<volume>42</volume>, <fpage>781</fpage>–<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1038/ng.642</pub-id><pub-id pub-id-type="pmid">20711177</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Harris</surname><given-names>R. A.</given-names></name><name><surname>Zhang</surname><given-names>X. M.</given-names></name></person-group> (<year>2017</year>). <article-title>An updated assessment of microglia depletion: current concepts and future directions</article-title>. <source/>Mol. Brain
<volume>10</volume>:<fpage>25</fpage>. <pub-id pub-id-type="doi">10.1186/s13041-017-0307-x</pub-id><pub-id pub-id-type="pmid">28629387</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>S.</given-names></name><name><surname>Dey</surname><given-names>A.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Stranahan</surname><given-names>A. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Dietary obesity reversibly induces synaptic stripping by microglia and impairs hippocampal plasticity</article-title>. <source/>Brain Behav. Immun.
<volume>51</volume>, <fpage>230</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.08.023</pub-id><pub-id pub-id-type="pmid">26336035</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>D.</given-names></name><name><surname>Chow</surname><given-names>A.</given-names></name><name><surname>Noizat</surname><given-names>C.</given-names></name><name><surname>Teo</surname><given-names>P.</given-names></name><name><surname>Beasley</surname><given-names>M. B.</given-names></name><name><surname>Leboeuf</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes</article-title>. <source/>Immunity
<volume>38</volume>, <fpage>792</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.004</pub-id><pub-id pub-id-type="pmid">23601688</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Crews</surname><given-names>F. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Increased MCP-1 and microglia in various regions of the human alcoholic brain</article-title>. <source/>Exp. Neurol.
<volume>210</volume>, <fpage>349</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2007.11.017</pub-id><pub-id pub-id-type="pmid">18190912</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Miao</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Toll-like receptor 9 is required for opioid-induced microglia apoptosis</article-title>. <source/>PLoS One
<volume>6</volume>:<fpage>e18190</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0018190</pub-id><pub-id pub-id-type="pmid">21559519</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hefendehl</surname><given-names>J. K.</given-names></name><name><surname>Neher</surname><given-names>J. J.</given-names></name><name><surname>Sühs</surname><given-names>R. B.</given-names></name><name><surname>Kohsaka</surname><given-names>S.</given-names></name><name><surname>Skodras</surname><given-names>A.</given-names></name><name><surname>Jucker</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Homeostatic and injury-induced microglia behavior in the aging brain</article-title>. <source/>Aging Cell
<volume>13</volume>, <fpage>60</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12149</pub-id><pub-id pub-id-type="pmid">23953759</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helland</surname><given-names>I. B.</given-names></name><name><surname>Smith</surname><given-names>L.</given-names></name><name><surname>Blomen</surname><given-names>B.</given-names></name><name><surname>Saarem</surname><given-names>K.</given-names></name><name><surname>Saugstad</surname><given-names>O. D.</given-names></name><name><surname>Drevon</surname><given-names>C. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children’s IQ and body mass index at 7 years of age</article-title>. <source/>Pediatrics
<volume>122</volume>, <fpage>e472</fpage>–<lpage>e479</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2007-2762</pub-id><pub-id pub-id-type="pmid">18676533</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellwig</surname><given-names>S.</given-names></name><name><surname>Brioschi</surname><given-names>S.</given-names></name><name><surname>Dieni</surname><given-names>S.</given-names></name><name><surname>Frings</surname><given-names>L.</given-names></name><name><surname>Masuch</surname><given-names>A.</given-names></name><name><surname>Blank</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice</article-title>. <source/>Brain Behav. Immun.
<volume>55</volume>, <fpage>126</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.11.008</pub-id><pub-id pub-id-type="pmid">26576722</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hibbeln</surname><given-names>J. R.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><name><surname>Steer</surname><given-names>C.</given-names></name><name><surname>Emmett</surname><given-names>P.</given-names></name><name><surname>Rogers</surname><given-names>I.</given-names></name><name><surname>Williams</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study</article-title>. <source/>Lancet
<volume>369</volume>, <fpage>578</fpage>–<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1097/01.aoa.0000288250.85361.6b</pub-id><pub-id pub-id-type="pmid">17307104</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickman</surname><given-names>S. E.</given-names></name><name><surname>Allison</surname><given-names>E. K.</given-names></name><name><surname>El Khoury</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer’s disease mice</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>8354</fpage>–<lpage>8360</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0616-08.2008</pub-id><pub-id pub-id-type="pmid">18701698</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickman</surname><given-names>S. E.</given-names></name><name><surname>Kingery</surname><given-names>N. D.</given-names></name><name><surname>Ohsumi</surname><given-names>T. K.</given-names></name><name><surname>Borowsky</surname><given-names>M. L.</given-names></name><name><surname>Wang</surname><given-names>L.-C.</given-names></name><name><surname>Means</surname><given-names>T. K.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The microglial sensome revealed by direct RNA sequencing</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>1896</fpage>–<lpage>1905</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3554</pub-id><pub-id pub-id-type="pmid">24162652</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillmer</surname><given-names>A. T.</given-names></name><name><surname>Holden</surname><given-names>D.</given-names></name><name><surname>Fowles</surname><given-names>K.</given-names></name><name><surname>Nabulsi</surname><given-names>N.</given-names></name><name><surname>West</surname><given-names>B. L.</given-names></name><name><surname>Carson</surname><given-names>R. E.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Microglial depletion and activation: a [<sup>11</sup>C]PBR28 PET study in nonhuman primates</article-title>. <source/>EJNMMI Res.
<volume>7</volume>:<fpage>59</fpage>. <pub-id pub-id-type="doi">10.1186/s13550-017-0305-0</pub-id><pub-id pub-id-type="pmid">28741281</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinwood</surname><given-names>M.</given-names></name><name><surname>Morandini</surname><given-names>J.</given-names></name><name><surname>Day</surname><given-names>T. A.</given-names></name><name><surname>Walker</surname><given-names>F. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex</article-title>. <source/>Cereb. Cortex
<volume>22</volume>, <fpage>1442</fpage>–<lpage>1454</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhr229</pub-id><pub-id pub-id-type="pmid">21878486</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinwood</surname><given-names>M.</given-names></name><name><surname>Tynan</surname><given-names>R. J.</given-names></name><name><surname>Charnley</surname><given-names>J. L.</given-names></name><name><surname>Beynon</surname><given-names>S. B.</given-names></name><name><surname>Day</surname><given-names>T. A.</given-names></name><name><surname>Walker</surname><given-names>F. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline</article-title>. <source/>Cereb. Cortex
<volume>23</volume>, <fpage>1784</fpage>–<lpage>1797</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhs151</pub-id><pub-id pub-id-type="pmid">22710611</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirschtritt</surname><given-names>M. E.</given-names></name><name><surname>Bloch</surname><given-names>M. H.</given-names></name><name><surname>Mathews</surname><given-names>C. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Obsessive-compulsive disorder: advances in diagnosis and treatment</article-title>. <source/>JAMA
<volume>317</volume>, <fpage>1358</fpage>–<lpage>1367</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2017.2200</pub-id><pub-id pub-id-type="pmid">28384832</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeffel</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Lavin</surname><given-names>Y.</given-names></name><name><surname>Low</surname><given-names>D.</given-names></name><name><surname>Almeida</surname><given-names>F. F.</given-names></name><name><surname>See</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>C-Myb<sup>+</sup> erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages</article-title>. <source/>Immunity
<volume>42</volume>, <fpage>665</fpage>–<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.03.011</pub-id><pub-id pub-id-type="pmid">25902481</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeijmakers</surname><given-names>L.</given-names></name><name><surname>Ruigrok</surname><given-names>S. R.</given-names></name><name><surname>Amelianchik</surname><given-names>A.</given-names></name><name><surname>Ivan</surname><given-names>D.</given-names></name><name><surname>van Dam</surname><given-names>A. M.</given-names></name><name><surname>Lucassen</surname><given-names>P. J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer’s disease mouse model</article-title>. <source/>Brain Behav. Immun.
<volume>63</volume>, <fpage>160</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.12.023</pub-id><pub-id pub-id-type="pmid">28027926</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>S. E.</given-names></name><name><surname>Hinz</surname><given-names>R.</given-names></name><name><surname>Conen</surname><given-names>S.</given-names></name><name><surname>Gregory</surname><given-names>C. J.</given-names></name><name><surname>Matthews</surname><given-names>J. C.</given-names></name><name><surname>Anton-Rodriguez</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study</article-title>. <source/>Biol. Psychiatry
<volume>83</volume>, <fpage>61</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.08.005</pub-id><pub-id pub-id-type="pmid">28939116</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holtman</surname><given-names>I. R.</given-names></name><name><surname>Raj</surname><given-names>D. D.</given-names></name><name><surname>Miller</surname><given-names>J. A.</given-names></name><name><surname>Schaafsma</surname><given-names>W.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Brouwer</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis</article-title>. <source/>Acta Neuropathol. Commun.
<volume>3</volume>:<fpage>31</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-015-0203-5</pub-id><pub-id pub-id-type="pmid">26001565</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Beja-Glasser</surname><given-names>V. F.</given-names></name><name><surname>Nfonoyim</surname><given-names>B. M.</given-names></name><name><surname>Frouin</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Ramakrishnan</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Complement and microglia mediate early synapse loss in Alzheimer mouse models</article-title>. <source/>Science
<volume>352</volume>, <fpage>712</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad8373</pub-id><pub-id pub-id-type="pmid">27033548</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornig</surname><given-names>M.</given-names></name><name><surname>Bresnahan</surname><given-names>M. A.</given-names></name><name><surname>Che</surname><given-names>X.</given-names></name><name><surname>Schultz</surname><given-names>A. F.</given-names></name><name><surname>Ukaigwe</surname><given-names>J. E.</given-names></name><name><surname>Eddy</surname><given-names>M. L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Prenatal fever and autism risk</article-title>. <source/>Mol. Psychiatry [Epub ahead of print]. <pub-id pub-id-type="doi">10.1038/mp.2017.119</pub-id><pub-id pub-id-type="pmid">28607458</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshiko</surname><given-names>M.</given-names></name><name><surname>Arnoux</surname><given-names>I.</given-names></name><name><surname>Avignone</surname><given-names>E.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Audinat</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>15106</fpage>–<lpage>15111</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1167-12.2012</pub-id><pub-id pub-id-type="pmid">23100431</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>G.</given-names></name><name><surname>Tian</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Yuan</surname><given-names>T. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Chronic stress and Parkinson’s disease</article-title>. <source/>CNS Neurosci. Ther.
<volume>20</volume>, <fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12209</pub-id><pub-id pub-id-type="pmid">24341934</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>C. L.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><name><surname>Spusta</surname><given-names>S. C.</given-names></name><name><surname>Niemi</surname><given-names>E. C.</given-names></name><name><surname>Yenari</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>M. C.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia</article-title>. <source/>J. Neurochem.
<volume>109</volume>, <fpage>1144</fpage>–<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06042.x</pub-id><pub-id pub-id-type="pmid">19302484</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>J. C.</given-names></name><name><surname>Lee</surname><given-names>Y. S.</given-names></name><name><surname>Chang</surname><given-names>C. N.</given-names></name><name><surname>Chuang</surname><given-names>H. L.</given-names></name><name><surname>Ling</surname><given-names>E. A.</given-names></name><name><surname>Lan</surname><given-names>C. T.</given-names></name></person-group> (<year>2003</year>). <article-title>Sleep deprivation inhibits expression of NADPH-d and NOS while activating microglia and astroglia in the rat hippocampus</article-title>. <source/>Cells Tissues Organs
<volume>173</volume>, <fpage>242</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1159/000070380</pub-id><pub-id pub-id-type="pmid">12766354</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Sheng</surname><given-names>W. S.</given-names></name><name><surname>Lokensgard</surname><given-names>J. R.</given-names></name><name><surname>Peterson</surname><given-names>P. K.</given-names></name></person-group> (<year>2002</year>). <article-title>Morphine induces apoptosis of human microglia and neurons</article-title>. <source/>Neuropharmacology
<volume>42</volume>, <fpage>829</fpage>–<lpage>836</lpage>. <pub-id pub-id-type="doi">10.1016/s0028-3908(02)00030-8</pub-id><pub-id pub-id-type="pmid">12015209</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>S. D.</given-names></name><name><surname>O’Banion</surname><given-names>M. K.</given-names></name><name><surname>Song</surname><given-names>D. D.</given-names></name><name><surname>Arana</surname><given-names>F. S.</given-names></name><name><surname>Olschowka</surname><given-names>J. A.</given-names></name><name><surname>Haber</surname><given-names>S. N.</given-names></name></person-group> (<year>2003</year>). <article-title>Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys</article-title>. <source/>Exp. Neurol.
<volume>184</volume>, <fpage>659</fpage>–<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-4886(03)00273-5</pub-id><pub-id pub-id-type="pmid">14769357</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husain</surname><given-names>M. I.</given-names></name><name><surname>Chaudhry</surname><given-names>I. B.</given-names></name><name><surname>Husain</surname><given-names>N.</given-names></name><name><surname>Khoso</surname><given-names>A. B.</given-names></name><name><surname>Rahman</surname><given-names>R. R.</given-names></name><name><surname>Hamirani</surname><given-names>M. M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Minocycline as an adjunct for treatment-resistant depressive symptoms: a pilot randomised placebo-controlled trial</article-title>. <source/>J. Psychopharmacol.
<volume>31</volume>, <fpage>1166</fpage>–<lpage>1175</lpage>. <pub-id pub-id-type="doi">10.1177/0269881117724352</pub-id><pub-id pub-id-type="pmid">28857658</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchinson</surname><given-names>M. R.</given-names></name><name><surname>Lewis</surname><given-names>S. S.</given-names></name><name><surname>Coats</surname><given-names>B. D.</given-names></name><name><surname>Skyba</surname><given-names>D. A.</given-names></name><name><surname>Crysdale</surname><given-names>N. Y.</given-names></name><name><surname>Berkelhammer</surname><given-names>D. L.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)</article-title>. <source/>Brain Behav. Immun.
<volume>23</volume>, <fpage>240</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2008.09.012</pub-id><pub-id pub-id-type="pmid">18938237</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutsler</surname><given-names>J. J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders</article-title>. <source/>Brain Res.
<volume>1309</volume>, <fpage>83</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.09.120</pub-id><pub-id pub-id-type="pmid">19896929</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imamura</surname><given-names>K.</given-names></name><name><surname>Hishikawa</surname><given-names>N.</given-names></name><name><surname>Sawada</surname><given-names>M.</given-names></name><name><surname>Nagatsu</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name><name><surname>Hashizume</surname><given-names>Y.</given-names></name></person-group> (<year>2003</year>). <article-title>Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains</article-title>. <source/>Acta Neuropathol.
<volume>106</volume>, <fpage>518</fpage>–<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-003-0766-2</pub-id><pub-id pub-id-type="pmid">14513261</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Instanes</surname><given-names>J. T.</given-names></name><name><surname>Halmøy</surname><given-names>A.</given-names></name><name><surname>Engeland</surname><given-names>A.</given-names></name><name><surname>Haavik</surname><given-names>J.</given-names></name><name><surname>Furu</surname><given-names>K.</given-names></name><name><surname>Klungsøyr</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases</article-title>. <source/>Biol. Psychiatry
<volume>81</volume>, <fpage>452</fpage>–<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.11.024</pub-id><pub-id pub-id-type="pmid">26809250</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishizuka</surname><given-names>K.</given-names></name><name><surname>Fujita</surname><given-names>Y.</given-names></name><name><surname>Kawabata</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>H.</given-names></name><name><surname>Iwayama</surname><given-names>Y.</given-names></name><name><surname>Inada</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders</article-title>. <source/>Transl. Psychiatry
<volume>7</volume>:<fpage>e1184</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2017.173</pub-id><pub-id pub-id-type="pmid">28763059</pub-id></mixed-citation>
</ref>
<ref id="B505">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>T. R.</given-names></name><name><surname>Hirsch</surname><given-names>A. M.</given-names></name><name><surname>Broihier</surname><given-names>M. L.</given-names></name><name><surname>Miller</surname><given-names>C. M.</given-names></name><name><surname>Neilson</surname><given-names>L. E.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer’s disease</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>637</fpage>–<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2110-16.2016</pub-id><pub-id pub-id-type="pmid">28100745</pub-id></mixed-citation>
</ref>
<ref id="B501">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>T. R.</given-names></name><name><surname>Miller</surname><given-names>C. M.</given-names></name><name><surname>Cheng</surname><given-names>P. J.</given-names></name><name><surname>Graham</surname><given-names>L. C.</given-names></name><name><surname>Bemiller</surname><given-names>S.</given-names></name><name><surname>Broihier</surname><given-names>M. L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>TREM2 deficiency eliminates TREM2<sup>+</sup> inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models</article-title>. <source/>J. Exp. Med.
<volume>212</volume>, <fpage>287</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20142322</pub-id><pub-id pub-id-type="pmid">25732305</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J. G.</given-names></name><name><surname>Park</surname><given-names>J. W.</given-names></name><name><surname>Koch</surname><given-names>M.</given-names></name><name><surname>Horvath</surname><given-names>T. L.</given-names></name><name><surname>Lee</surname><given-names>B. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Hypothalamic TLR2 triggers sickness behavior via a microglia-neuronal axis</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>29424</fpage>. <pub-id pub-id-type="doi">10.1038/srep29424</pub-id><pub-id pub-id-type="pmid">27405276</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>F. K.</given-names></name><name><surname>Kaffman</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Early life stress perturbs the function of microglia in the developing rodent brain: new insights and future challenges</article-title>. <source/>Brain Behav. Immun. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1016/j.bbi.2017.06.008</pub-id><pub-id pub-id-type="pmid">28625767</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname><given-names>T.</given-names></name><name><surname>Stefansson</surname><given-names>H.</given-names></name><name><surname>Steinberg</surname><given-names>S.</given-names></name><name><surname>Jonsdottir</surname><given-names>I.</given-names></name><name><surname>Jonsson</surname><given-names>P. V.</given-names></name><name><surname>Snaedal</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Variant of TREM2 associated with the risk of Alzheimer’s disease</article-title>. <source/>N. Engl. J. Med.
<volume>368</volume>, <fpage>107</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1211103</pub-id><pub-id pub-id-type="pmid">23150908</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>June</surname><given-names>H. L.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Warnock</surname><given-names>K. T.</given-names></name><name><surname>Bell</surname><given-names>K. A.</given-names></name><name><surname>Balan</surname><given-names>I.</given-names></name><name><surname>Bollino</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>CRF-amplified neuronal TLR4/MCP-1 signaling regulates alcohol self-administration</article-title>. <source/>Neuropsychopharmacology
<volume>40</volume>, <fpage>1549</fpage>–<lpage>1559</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2015.4</pub-id><pub-id pub-id-type="pmid">25567426</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jyothi</surname><given-names>H. J.</given-names></name><name><surname>Vidyadhara</surname><given-names>D. J.</given-names></name><name><surname>Mahadevan</surname><given-names>A.</given-names></name><name><surname>Philip</surname><given-names>M.</given-names></name><name><surname>Parmar</surname><given-names>S. K.</given-names></name><name><surname>Manohari</surname><given-names>S. G.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta</article-title>. <source/>Neurobiol. Aging
<volume>36</volume>, <fpage>3321</fpage>–<lpage>3333</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.08.024</pub-id><pub-id pub-id-type="pmid">26433682</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaifu</surname><given-names>T.</given-names></name><name><surname>Nakahara</surname><given-names>J.</given-names></name><name><surname>Inui</surname><given-names>M.</given-names></name><name><surname>Mishima</surname><given-names>K.</given-names></name><name><surname>Momiyama</surname><given-names>T.</given-names></name><name><surname>Kaji</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice</article-title>. <source/>J. Clin. Invest.
<volume>111</volume>, <fpage>323</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1172/jci16923</pub-id><pub-id pub-id-type="pmid">12569157</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>H. J.</given-names></name><name><surname>Voleti</surname><given-names>B.</given-names></name><name><surname>Hajszan</surname><given-names>T.</given-names></name><name><surname>Rajkowska</surname><given-names>G.</given-names></name><name><surname>Stockmeier</surname><given-names>C. A.</given-names></name><name><surname>Licznerski</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Decreased expression of synapse-related genes and loss of synapses in major depressive disorder</article-title>. <source/>Nat. Med.
<volume>18</volume>, <fpage>1413</fpage>–<lpage>1417</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2886</pub-id><pub-id pub-id-type="pmid">22885997</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>E.</given-names></name><name><surname>Wen</surname><given-names>Z.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Christian</surname><given-names>K. M.</given-names></name><name><surname>Ming</surname><given-names>G. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Adult neurogenesis and psychiatric disorders</article-title>. <source/>Cold Spring Harb. Perspect. Biol.
<volume>8</volume>:<fpage>a019026</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a019026</pub-id><pub-id pub-id-type="pmid">26801682</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlstetter</surname><given-names>M.</given-names></name><name><surname>Nothdurfter</surname><given-names>C.</given-names></name><name><surname>Aslanidis</surname><given-names>A.</given-names></name><name><surname>Moeller</surname><given-names>K.</given-names></name><name><surname>Horn</surname><given-names>F.</given-names></name><name><surname>Scholz</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis</article-title>. <source/>J. Neuroinflammation
<volume>11</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-11-3</pub-id><pub-id pub-id-type="pmid">24397957</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>C.</given-names></name><name><surname>Ling</surname><given-names>E. A.</given-names></name></person-group> (<year>1991</year>). <article-title>Study of the transformation of amoeboid microglial cells into microglia labelled with the isolectin Griffonia simplicifolia in postnatal rats</article-title>. <source/>Acta Anat.
<volume>142</volume>, <fpage>118</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1159/000147175</pub-id><pub-id pub-id-type="pmid">1781250</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>C.</given-names></name><name><surname>Sivakumar</surname><given-names>V.</given-names></name><name><surname>Zou</surname><given-names>Z.</given-names></name><name><surname>Ling</surname><given-names>E. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglia-derived proinflammatory cytokines tumor necrosis factor-α and interleukin-1β induce Purkinje neuronal apoptosis via their receptors in hypoxic neonatal rat brain</article-title>. <source/>Brain Struct. Funct.
<volume>219</volume>, <fpage>151</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-012-0491-5</pub-id><pub-id pub-id-type="pmid">23262920</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren-Shaul</surname><given-names>H.</given-names></name><name><surname>Spinrad</surname><given-names>A.</given-names></name><name><surname>Weiner</surname><given-names>A.</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O.</given-names></name><name><surname>Dvir-Szternfeld</surname><given-names>R.</given-names></name><name><surname>Ulland</surname><given-names>T. K.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A unique microglia type associated with restricting development of Alzheimer’s disease</article-title>. <source/>Cell
<volume>169</volume>, <fpage>1276.e17</fpage>–<lpage>1290.e17</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.05.018</pub-id><pub-id pub-id-type="pmid">28602351</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>R. C.</given-names></name></person-group> (<year>1997</year>). <article-title>The effects of stressful life events on depression</article-title>. <source/>Annu. Rev. Psychol.
<volume>48</volume>, <fpage>191</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.psych.48.1.191</pub-id><pub-id pub-id-type="pmid">9046559</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>R. C.</given-names></name><name><surname>McLaughlin</surname><given-names>K. A.</given-names></name><name><surname>Green</surname><given-names>J. G.</given-names></name><name><surname>Gruber</surname><given-names>M. J.</given-names></name><name><surname>Sampson</surname><given-names>N. A.</given-names></name><name><surname>Zaslavsky</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys</article-title>. <source/>Br. J. Psychiatry
<volume>197</volume>, <fpage>378</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.110.080499</pub-id><pub-id pub-id-type="pmid">21037215</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knuesel</surname><given-names>I.</given-names></name><name><surname>Chicha</surname><given-names>L.</given-names></name><name><surname>Britschgi</surname><given-names>M.</given-names></name><name><surname>Schobel</surname><given-names>S. A.</given-names></name><name><surname>Bodmer</surname><given-names>M.</given-names></name><name><surname>Hellings</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Maternal immune activation and abnormal brain development across CNS disorders</article-title>. <source/>Nat. Rev. Neurol.
<volume>10</volume>, <fpage>643</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.187</pub-id><pub-id pub-id-type="pmid">25311587</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konno</surname><given-names>T.</given-names></name><name><surname>Tada</surname><given-names>M.</given-names></name><name><surname>Tada</surname><given-names>M.</given-names></name><name><surname>Koyama</surname><given-names>A.</given-names></name><name><surname>Nozaki</surname><given-names>H.</given-names></name><name><surname>Harigaya</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS</article-title>. <source/>Neurology
<volume>82</volume>, <fpage>139</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000000046</pub-id><pub-id pub-id-type="pmid">24336230</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koso</surname><given-names>H.</given-names></name><name><surname>Tsuhako</surname><given-names>A.</given-names></name><name><surname>Lai</surname><given-names>C. Y.</given-names></name><name><surname>Baba</surname><given-names>Y.</given-names></name><name><surname>Otsu</surname><given-names>M.</given-names></name><name><surname>Ueno</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Conditional rod photoreceptor ablation reveals Sall1 as a microglial marker and regulator of microglial morphology in the retina</article-title>. <source/>Glia
<volume>64</volume>, <fpage>2005</fpage>–<lpage>2024</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23038</pub-id><pub-id pub-id-type="pmid">27459098</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koyama</surname><given-names>R.</given-names></name><name><surname>Ikegaya</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Microglia in the pathogenesis of autism spectrum disorders</article-title>. <source/>Neurosci. Res.
<volume>100</volume>, <fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2015.06.005</pub-id><pub-id pub-id-type="pmid">26116891</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krabbe</surname><given-names>G.</given-names></name><name><surname>Halle</surname><given-names>A.</given-names></name><name><surname>Matyash</surname><given-names>V.</given-names></name><name><surname>Rinnenthal</surname><given-names>J. L.</given-names></name><name><surname>Eom</surname><given-names>G. D.</given-names></name><name><surname>Bernhardt</surname><given-names>U.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Functional impairment of microglia coincides with β-amyloid deposition in mice with Alzheimer-like pathology</article-title>. <source/>PLoS One
<volume>8</volume>:<fpage>e60921</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0060921</pub-id><pub-id pub-id-type="pmid">23577177</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krabbe</surname><given-names>G.</given-names></name><name><surname>Minami</surname><given-names>S. S.</given-names></name><name><surname>Etchegaray</surname><given-names>J. I.</given-names></name><name><surname>Taneja</surname><given-names>P.</given-names></name><name><surname>Djukic</surname><given-names>B.</given-names></name><name><surname>Davalos</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Microglial NFκB-TNFα hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>114</volume>, <fpage>5029</fpage>–<lpage>5034</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1700477114</pub-id><pub-id pub-id-type="pmid">28438992</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krasemann</surname><given-names>S.</given-names></name><name><surname>Madore</surname><given-names>C.</given-names></name><name><surname>Cialic</surname><given-names>R.</given-names></name><name><surname>Baufeld</surname><given-names>C.</given-names></name><name><surname>Calcagno</surname><given-names>N.</given-names></name><name><surname>El Fatimy</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases</article-title>. <source/>Immunity
<volume>47</volume>, <fpage>566</fpage>–<lpage>581.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.08.008</pub-id><pub-id pub-id-type="pmid">28930663</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreisel</surname><given-names>T.</given-names></name><name><surname>Frank</surname><given-names>M. G.</given-names></name><name><surname>Licht</surname><given-names>T.</given-names></name><name><surname>Reshef</surname><given-names>R.</given-names></name><name><surname>Ben-Menachem-Zidon</surname><given-names>O.</given-names></name><name><surname>Baratta</surname><given-names>M. V.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis</article-title>. <source/>Mol. Psychiatry
<volume>19</volume>, <fpage>699</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.155</pub-id><pub-id pub-id-type="pmid">24342992</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>V.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The molecular neurobiology of depression</article-title>. <source/>Nature
<volume>455</volume>, <fpage>894</fpage>–<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1038/nature07455</pub-id><pub-id pub-id-type="pmid">18923511</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labonté</surname><given-names>B.</given-names></name><name><surname>Engmann</surname><given-names>O.</given-names></name><name><surname>Purushothaman</surname><given-names>I.</given-names></name><name><surname>Menard</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Sex-specific transcriptional signatures in human depression</article-title>. <source/>Nat. Med.
<volume>23</volume>, <fpage>1102</fpage>–<lpage>1111</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4386</pub-id><pub-id pub-id-type="pmid">28825715</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanier</surname><given-names>L. L.</given-names></name><name><surname>Bakker</surname><given-names>A. B.</given-names></name></person-group> (<year>2000</year>). <article-title>The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function</article-title>. <source/>Immunol. Today
<volume>21</volume>, <fpage>611</fpage>–<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-5699(00)01745-x</pub-id><pub-id pub-id-type="pmid">11114420</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauretti</surname><given-names>E.</given-names></name><name><surname>Di Meco</surname><given-names>A.</given-names></name><name><surname>Merali</surname><given-names>S.</given-names></name><name><surname>Praticò</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson’s disease</article-title>. <source/>Transl. Psychiatry
<volume>6</volume>:<fpage>e733</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2016.1</pub-id><pub-id pub-id-type="pmid">26859816</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavin</surname><given-names>Y.</given-names></name><name><surname>Winter</surname><given-names>D.</given-names></name><name><surname>Blecher-Gonen</surname><given-names>R.</given-names></name><name><surname>David</surname><given-names>E.</given-names></name><name><surname>Keren-Shaul</surname><given-names>H.</given-names></name><name><surname>Merad</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment</article-title>. <source/>Cell
<volume>159</volume>, <fpage>1312</fpage>–<lpage>1326</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.11.018</pub-id><pub-id pub-id-type="pmid">25480296</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>L. J.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Dri</surname><given-names>P.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>1990</year>). <article-title>Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain</article-title>. <source/>Neuroscience
<volume>39</volume>, <fpage>151</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(90)90229-w</pub-id><pub-id pub-id-type="pmid">2089275</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>L. J.</given-names></name><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>1992</year>). <article-title>Turnover of resident microglia in the normal adult mouse brain</article-title>. <source/>Neuroscience
<volume>48</volume>, <fpage>405</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(92)90500-2</pub-id><pub-id pub-id-type="pmid">1603325</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leday</surname><given-names>G. G. R.</given-names></name><name><surname>Vértes</surname><given-names>P. E.</given-names></name><name><surname>Richardson</surname><given-names>S.</given-names></name><name><surname>Greene</surname><given-names>J. R.</given-names></name><name><surname>Regan</surname><given-names>T.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Replicable and coupled changes in innate and adaptive immune gene expression in two case-control studies of blood microarrays in major depressive disorder</article-title>. <source/>Biol. Psychiatry
<volume>83</volume>, <fpage>70</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.01.021</pub-id><pub-id pub-id-type="pmid">28688579</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>A. S.</given-names></name><name><surname>Azmitia</surname><given-names>E. C.</given-names></name><name><surname>Whitaker-Azmitia</surname><given-names>P. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Developmental microglial priming in postmortem autism spectrum disorder temporal cortex</article-title>. <source/>Brain Behav. Immun.
<volume>62</volume>, <fpage>193</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2017.01.019</pub-id><pub-id pub-id-type="pmid">28159644</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname><given-names>K. M.</given-names></name><name><surname>Nugent</surname><given-names>B. M.</given-names></name><name><surname>Haliyur</surname><given-names>R.</given-names></name><name><surname>McCarthy</surname><given-names>M. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia are essential to masculinization of brain and behavior</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>2761</fpage>–<lpage>2772</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1268-12.2013</pub-id><pub-id pub-id-type="pmid">23407936</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leong</surname><given-names>S. K.</given-names></name><name><surname>Ling</surname><given-names>E. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Amoeboid and ramified microglia: their interrelationship and response to brain injury</article-title>. <source/>Glia
<volume>6</volume>, <fpage>39</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440060106</pub-id><pub-id pub-id-type="pmid">1380949</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levkovitz</surname><given-names>Y.</given-names></name><name><surname>Mendlovich</surname><given-names>S.</given-names></name><name><surname>Riwkes</surname><given-names>S.</given-names></name><name><surname>Braw</surname><given-names>Y.</given-names></name><name><surname>Levkovitch-Verbin</surname><given-names>H.</given-names></name><name><surname>Gal</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia</article-title>. <source/>J. Clin. Psychiatry
<volume>71</volume>, <fpage>138</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.4088/JCP.08m04666yel</pub-id><pub-id pub-id-type="pmid">19895780</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewitus</surname><given-names>G. M.</given-names></name><name><surname>Konefal</surname><given-names>S. C.</given-names></name><name><surname>Greenhalgh</surname><given-names>A. D.</given-names></name><name><surname>Pribiag</surname><given-names>H.</given-names></name><name><surname>Augereau</surname><given-names>K.</given-names></name><name><surname>Stellwagen</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Microglial TNF-α suppresses cocaine-induced plasticity and behavioral sensitization</article-title>. <source/>Neuron
<volume>90</volume>, <fpage>483</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.030</pub-id><pub-id pub-id-type="pmid">27112496</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leyns</surname><given-names>C. E. G.</given-names></name><name><surname>Ulricha</surname><given-names>J. D.</given-names></name><name><surname>Finna</surname><given-names>M. B.</given-names></name><name><surname>Stewart</surname><given-names>F. R.</given-names></name><name><surname>Koscala</surname><given-names>L. J.</given-names></name><name><surname>Serranoa</surname><given-names>J. R.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>114</volume>, <fpage>11524</fpage>–<lpage>11529</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1710311114</pub-id><pub-id pub-id-type="pmid">29073081</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Du</surname><given-names>X. F.</given-names></name><name><surname>Liu</surname><given-names>C. S.</given-names></name><name><surname>Wen</surname><given-names>Z. L.</given-names></name><name><surname>Du</surname><given-names>J. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Reciprocal regulation between resting microglial dynamics and neuronal activity <italic>in vivo</italic></article-title>. <source/>Dev. Cell
<volume>23</volume>, <fpage>1189</fpage>–<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.10.027</pub-id><pub-id pub-id-type="pmid">23201120</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liddelow</surname><given-names>S. A.</given-names></name><name><surname>Guttenplan</surname><given-names>K. A.</given-names></name><name><surname>Clarke</surname><given-names>L. E.</given-names></name><name><surname>Bennett</surname><given-names>F. C.</given-names></name><name><surname>Bohlen</surname><given-names>C. J.</given-names></name><name><surname>Schirmer</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Neurotoxic reactive astrocytes are induced by activated microglia</article-title>. <source/>Nature
<volume>541</volume>, <fpage>481</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1038/nature21029</pub-id><pub-id pub-id-type="pmid">28099414</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>P. Y.</given-names></name></person-group> (<year>2009</year>). <article-title>State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study</article-title>. <source/>Neurosci. Lett.
<volume>466</volume>, <fpage>139</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2009.09.044</pub-id><pub-id pub-id-type="pmid">19786073</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd</surname><given-names>S. A.</given-names></name><name><surname>Corkill</surname><given-names>B.</given-names></name><name><surname>Bruster</surname><given-names>M. C.</given-names></name><name><surname>Roberts</surname><given-names>R. L.</given-names></name><name><surname>Shanks</surname><given-names>R. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Chronic methamphetamine exposure significantly decreases microglia activation in the arcuate nucleus</article-title>. <source/>J. Chem. Neuroanat.
<volume>82</volume>, <fpage>5</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchemneu.2017.03.001</pub-id><pub-id pub-id-type="pmid">28323108</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luchtman</surname><given-names>D. W.</given-names></name><name><surname>Meng</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Shao</surname><given-names>D.</given-names></name><name><surname>Song</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Omega-3 fatty acid eicosapentaenoic acid attenuates MPP<sup>+</sup>-induced neurodegeneration in fully differentiated human SH-SY5Y and primary mesencephalic cells</article-title>. <source/>J. Neurochem.
<volume>124</volume>, <fpage>855</fpage>–<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12068</pub-id><pub-id pub-id-type="pmid">23106698</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lui</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Makinson</surname><given-names>S. R.</given-names></name><name><surname>Cahill</surname><given-names>M. K.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name><name><surname>Huang</surname><given-names>H. Y.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation</article-title>. <source/>Cell
<volume>165</volume>, <fpage>921</fpage>–<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.04.001</pub-id><pub-id pub-id-type="pmid">27114033</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>H.</given-names></name><name><surname>Pieber</surname><given-names>M.</given-names></name><name><surname>Harris</surname><given-names>R. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Lessons learned about neurodegeneration from microglia and monocyte depletion studies</article-title>. <source/>Front. Aging Neurosci.
<volume>9</volume>:<fpage>234</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2017.00234</pub-id><pub-id pub-id-type="pmid">28804456</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madore</surname><given-names>C.</given-names></name><name><surname>Leyrolle</surname><given-names>Q.</given-names></name><name><surname>Lacabanne</surname><given-names>C.</given-names></name><name><surname>Benmamar-Badel</surname><given-names>A.</given-names></name><name><surname>Joffre</surname><given-names>C.</given-names></name><name><surname>Nadjar</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Neuroinflammation in autism: plausible role of maternal inflammation, dietary omega 3, and microbiota</article-title>. <source/>Neural Plast.
<volume>2016</volume>:<fpage>3597209</fpage>. <pub-id pub-id-type="doi">10.1155/2016/3597209</pub-id><pub-id pub-id-type="pmid">27840741</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madore</surname><given-names>C.</given-names></name><name><surname>Nadjar</surname><given-names>A.</given-names></name><name><surname>Delpech</surname><given-names>J. C.</given-names></name><name><surname>Sere</surname><given-names>A.</given-names></name><name><surname>Aubert</surname><given-names>A.</given-names></name><name><surname>Portal</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes</article-title>. <source/>Brain Behav. Immun.
<volume>41</volume>, <fpage>22</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.03.021</pub-id><pub-id pub-id-type="pmid">24735929</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maezawa</surname><given-names>I.</given-names></name><name><surname>Jin</surname><given-names>L. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>5346</fpage>–<lpage>5356</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5966-09.2010</pub-id><pub-id pub-id-type="pmid">20392956</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Scianni</surname><given-names>M.</given-names></name><name><surname>Branchi</surname><given-names>I.</given-names></name><name><surname>D’Andrea</surname><given-names>I.</given-names></name><name><surname>Lauro</surname><given-names>C.</given-names></name><name><surname>Limatola</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>CX<sub>3</sub>CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment</article-title>. <source/>Front. Cell. Neurosci.
<volume>5</volume>:<fpage>22</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2011.00022</pub-id><pub-id pub-id-type="pmid">22025910</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>M.</given-names></name><name><surname>Simpson</surname><given-names>J. F.</given-names></name><name><surname>Parikh</surname><given-names>I.</given-names></name><name><surname>Wilfred</surname><given-names>B. R.</given-names></name><name><surname>Fardo</surname><given-names>D. W.</given-names></name><name><surname>Nelson</surname><given-names>P. T.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>13320</fpage>–<lpage>13325</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1224-13.2013</pub-id><pub-id pub-id-type="pmid">23946390</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marín-Teva</surname><given-names>J. L.</given-names></name><name><surname>Dusart</surname><given-names>I.</given-names></name><name><surname>Colin</surname><given-names>C.</given-names></name><name><surname>Gervais</surname><given-names>A.</given-names></name><name><surname>van Rooijen</surname><given-names>N.</given-names></name><name><surname>Mallat</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Microglia promote the death of developing Purkinje cells</article-title>. <source/>Neuron
<volume>41</volume>, <fpage>535</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(04)00069-8</pub-id><pub-id pub-id-type="pmid">14980203</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>S. A.</given-names></name><name><surname>Geil</surname><given-names>C. R.</given-names></name><name><surname>Nixon</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Prior binge ethanol exposure potentiates the microglial response in a model of alcohol-induced neurodegeneration</article-title>. <source/>Brain Sci.
<volume>6</volume>:<fpage>E16</fpage>. <pub-id pub-id-type="doi">10.3390/brainsci6020016</pub-id><pub-id pub-id-type="pmid">27240410</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mass</surname><given-names>E.</given-names></name><name><surname>Jacome-Galarza</surname><given-names>C. E.</given-names></name><name><surname>Blank</surname><given-names>T.</given-names></name><name><surname>Lazarov</surname><given-names>T.</given-names></name><name><surname>Durham</surname><given-names>B. H.</given-names></name><name><surname>Ozkaya</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease</article-title>. <source/>Nature
<volume>549</volume>, <fpage>389</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1038/nature23672</pub-id><pub-id pub-id-type="pmid">28854169</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matcovitch-Natan</surname><given-names>O.</given-names></name><name><surname>Winter</surname><given-names>D. R.</given-names></name><name><surname>Giladi</surname><given-names>A.</given-names></name><name><surname>Vargas Aguilar</surname><given-names>S.</given-names></name><name><surname>Spinrad</surname><given-names>A.</given-names></name><name><surname>Sarrazin</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Microglia development follows a stepwise program to regulate brain homeostasis</article-title>. <source/>Science
<volume>353</volume>:<fpage>aad8670</fpage>. <pub-id pub-id-type="doi">10.1126/science.aad8670</pub-id><pub-id pub-id-type="pmid">27338705</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>D.</given-names></name><name><surname>Djodari-Irani</surname><given-names>A.</given-names></name><name><surname>Hadar</surname><given-names>R.</given-names></name><name><surname>Pelz</surname><given-names>A.</given-names></name><name><surname>de Cossio</surname><given-names>L. F.</given-names></name><name><surname>Goetz</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia</article-title>. <source/>Brain Behav. Immun.
<volume>38</volume>, <fpage>175</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.01.019</pub-id><pub-id pub-id-type="pmid">24509090</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>D.</given-names></name><name><surname>Ivanov</surname><given-names>A.</given-names></name><name><surname>Ferrai</surname><given-names>C.</given-names></name><name><surname>Jordan</surname><given-names>P.</given-names></name><name><surname>Guneykaya</surname><given-names>D.</given-names></name><name><surname>Buonfiglioli</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment</article-title>. <source/>Transl. Psychiatry
<volume>7</volume>:<fpage>e1120</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2017.80</pub-id><pub-id pub-id-type="pmid">28485733</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattiace</surname><given-names>L. A.</given-names></name><name><surname>Davies</surname><given-names>P.</given-names></name><name><surname>Dickson</surname><given-names>D. W.</given-names></name></person-group> (<year>1990</year>). <article-title>Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors</article-title>. <source/>Am. J. Pathol.
<volume>136</volume>, <fpage>1101</fpage>–<lpage>1114</lpage>. <pub-id pub-id-type="pmid">1693471</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGeer</surname><given-names>P. L.</given-names></name><name><surname>Itagaki</surname><given-names>S.</given-names></name><name><surname>Tago</surname><given-names>H.</given-names></name><name><surname>McGeer</surname><given-names>E. G.</given-names></name></person-group> (<year>1987</year>). <article-title>Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR</article-title>. <source/>Neurosci. Lett.
<volume>79</volume>, <fpage>195</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(87)90696-3</pub-id><pub-id pub-id-type="pmid">3670729</pub-id></mixed-citation>
</ref>
<ref id="B504">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mease</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Foss</surname><given-names>C.</given-names></name><name><surname>Pomper</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Radiosynthesis and initial <italic>in vivo</italic> evaluation of 2-[<sup>18</sup>F]FBTTP, a radiotracer targeting CX<sub>3</sub>CR1</article-title>. <source/>J. Nucl. Med.
<volume>56</volume>:<fpage>356</fpage>.</mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melchior</surname><given-names>B.</given-names></name><name><surname>Garcia</surname><given-names>A. E.</given-names></name><name><surname>Hsiung</surname><given-names>B. K.</given-names></name><name><surname>Lo</surname><given-names>K. M.</given-names></name><name><surname>Doose</surname><given-names>J. M.</given-names></name><name><surname>Thrash</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer’s disease</article-title>. <source/>ASN Neuro
<volume>2</volume>:<fpage>e00037</fpage>. <pub-id pub-id-type="doi">10.1042/AN20100010</pub-id><pub-id pub-id-type="pmid">20640189</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U.</given-names></name></person-group> (<year>2014</year>). <article-title>Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems</article-title>. <source/>Biol. Psychiatry
<volume>75</volume>, <fpage>307</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.07.011</pub-id><pub-id pub-id-type="pmid">23938317</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U.</given-names></name><name><surname>Feldon</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Neural basis of psychosis-related behaviour in the infection model of schizophrenia</article-title>. <source/>Behav. Brain Res.
<volume>204</volume>, <fpage>322</fpage>–<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2008.12.022</pub-id><pub-id pub-id-type="pmid">19154759</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milior</surname><given-names>G.</given-names></name><name><surname>Lecours</surname><given-names>C.</given-names></name><name><surname>Samson</surname><given-names>L.</given-names></name><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Poggini</surname><given-names>S.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress</article-title>. <source/>Brain Behav. Immun.
<volume>55</volume>, <fpage>114</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.07.024</pub-id><pub-id pub-id-type="pmid">26231972</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M. W.</given-names></name><name><surname>Sadeh</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis</article-title>. <source/>Mol. Psychiatry
<volume>19</volume>, <fpage>1156</fpage>–<lpage>1162</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.111</pub-id><pub-id pub-id-type="pmid">25245500</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>A.</given-names></name><name><surname>Wake</surname><given-names>H.</given-names></name><name><surname>Ishikawa</surname><given-names>A. W.</given-names></name><name><surname>Eto</surname><given-names>K.</given-names></name><name><surname>Shibata</surname><given-names>K.</given-names></name><name><surname>Murakoshi</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Microglia contact induces synapse formation in developing somatosensory cortex</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>12540</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms12540</pub-id><pub-id pub-id-type="pmid">27558646</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaoka</surname><given-names>T.</given-names></name><name><surname>Wake</surname><given-names>R.</given-names></name><name><surname>Furuya</surname><given-names>M.</given-names></name><name><surname>Liaury</surname><given-names>K.</given-names></name><name><surname>Ieda</surname><given-names>M.</given-names></name><name><surname>Kawakami</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study</article-title>. <source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
<volume>37</volume>, <fpage>222</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2012.02.002</pub-id><pub-id pub-id-type="pmid">22349578</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaoka</surname><given-names>T.</given-names></name><name><surname>Yasukawa</surname><given-names>R.</given-names></name><name><surname>Yasuda</surname><given-names>H.</given-names></name><name><surname>Hayashida</surname><given-names>M.</given-names></name><name><surname>Inagaki</surname><given-names>T.</given-names></name><name><surname>Horiguchi</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Minocycline as adjunctive therapy for schizophrenia: an open-label study</article-title>. <source/>Clin. Neuropharmacol.
<volume>31</volume>, <fpage>287</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1097/WNF.0b013e3181593d45</pub-id><pub-id pub-id-type="pmid">18836347</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondelli</surname><given-names>V.</given-names></name><name><surname>Vernon</surname><given-names>A. C.</given-names></name><name><surname>Turkheimer</surname><given-names>F.</given-names></name><name><surname>Dazzan</surname><given-names>P.</given-names></name><name><surname>Pariante</surname><given-names>C. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Brain microglia in psychiatric disorders</article-title>. <source/>Lancet Psychiatry
<volume>4</volume>, <fpage>563</fpage>–<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/S2215-0366(17)30101-3</pub-id><pub-id pub-id-type="pmid">28454915</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>J. T.</given-names></name><name><surname>Chana</surname><given-names>G.</given-names></name><name><surname>Pardo</surname><given-names>C. A.</given-names></name><name><surname>Achim</surname><given-names>C.</given-names></name><name><surname>Semendeferi</surname><given-names>K.</given-names></name><name><surname>Buckwalter</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism</article-title>. <source/>Biol. Psychiatry
<volume>68</volume>, <fpage>368</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.024</pub-id><pub-id pub-id-type="pmid">20674603</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostany</surname><given-names>R.</given-names></name><name><surname>Anstey</surname><given-names>J. E.</given-names></name><name><surname>Crump</surname><given-names>K. L.</given-names></name><name><surname>Maco</surname><given-names>B.</given-names></name><name><surname>Knott</surname><given-names>G.</given-names></name><name><surname>Portera-Cailliau</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Altered synaptic dynamics during normal brain aging</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>4094</fpage>–<lpage>4104</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4825-12.2013</pub-id><pub-id pub-id-type="pmid">23447617</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mount</surname><given-names>M. P.</given-names></name><name><surname>Lira</surname><given-names>A.</given-names></name><name><surname>Grimes</surname><given-names>D.</given-names></name><name><surname>Smith</surname><given-names>P. D.</given-names></name><name><surname>Faucher</surname><given-names>S.</given-names></name><name><surname>Slack</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Involvement of interferon-γ in microglial-mediated loss of dopaminergic neurons</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>3328</fpage>–<lpage>3337</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5321-06.2007</pub-id><pub-id pub-id-type="pmid">17376993</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouton</surname><given-names>P. R.</given-names></name><name><surname>Long</surname><given-names>J. M.</given-names></name><name><surname>Lei</surname><given-names>D. L.</given-names></name><name><surname>Howard</surname><given-names>V.</given-names></name><name><surname>Jucker</surname><given-names>M.</given-names></name><name><surname>Calhoun</surname><given-names>M. E.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Age and gender effects on microglia and astrocyte numbers in brains of mice</article-title>. <source/>Brain Res.
<volume>956</volume>, <fpage>30</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-8993(02)03475-3</pub-id><pub-id pub-id-type="pmid">12426043</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulders</surname><given-names>P. C.</given-names></name><name><surname>van Eijndhoven</surname><given-names>P. F.</given-names></name><name><surname>Schene</surname><given-names>A. H.</given-names></name><name><surname>Beckmann</surname><given-names>C. F.</given-names></name><name><surname>Tendolkar</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>Resting-state functional connectivity in major depressive disorder: a review</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>56</volume>, <fpage>330</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.07.014</pub-id><pub-id pub-id-type="pmid">26234819</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muneer</surname><given-names>A.</given-names></name></person-group> (<year>2016a</year>). <article-title>The neurobiology of bipolar disorder: an integrated approach</article-title>. <source/>Chonnam Med. J.
<volume>52</volume>, <fpage>18</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.4068/cmj.2016.52.1.18</pub-id><pub-id pub-id-type="pmid">26865997</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muneer</surname><given-names>A.</given-names></name></person-group> (<year>2016b</year>). <article-title>The treatment of adult bipolar disorder with aripiprazole: a systematic review</article-title>. <source/>Cureus
<volume>8</volume>:<fpage>e562</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.562</pub-id><pub-id pub-id-type="pmid">27190727</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musiek</surname><given-names>E. S.</given-names></name><name><surname>Holtzman</surname><given-names>D. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Mechanisms linking circadian clocks, sleep, and neurodegeneration</article-title>. <source/>Science
<volume>354</volume>, <fpage>1004</fpage>–<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.1126/science.aah4968</pub-id><pub-id pub-id-type="pmid">27885006</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadjar</surname><given-names>A.</given-names></name><name><surname>Wigren</surname><given-names>H. M.</given-names></name><name><surname>Tremblay</surname><given-names>M. E.</given-names></name></person-group> (<year>2017</year>). <article-title>Roles of microglial phagocytosis and inflammatory mediators in the pathophysiology of sleep disorders</article-title>. <source/>Front. Cell. Neurosci.
<volume>11</volume>:<fpage>250</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00250</pub-id><pub-id pub-id-type="pmid">28912686</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasu</surname><given-names>T.</given-names></name><name><surname>Tsukahara</surname><given-names>Y.</given-names></name><name><surname>Terayama</surname><given-names>K.</given-names></name></person-group> (<year>1973</year>). <article-title>A lipid metabolic disease-“membranous lipodystrophy”-an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues</article-title>. <source/>Acta Pathol. Jpn.
<volume>23</volume>, <fpage>539</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1827.1973.tb01223.x</pub-id><pub-id pub-id-type="pmid">4800725</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neniskyte</surname><given-names>U.</given-names></name><name><surname>Vilalta</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>G. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Tumour necrosis factor α-induced neuronal loss is mediated by microglial phagocytosis</article-title>. <source/>FEBS Lett.
<volume>588</volume>, <fpage>2952</fpage>–<lpage>2956</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2014.05.046</pub-id><pub-id pub-id-type="pmid">24911209</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmerjahn</surname><given-names>A.</given-names></name><name><surname>Kirchhoff</surname><given-names>F.</given-names></name><name><surname>Helmchen</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Resting microglial cells are highly dynamic surveillants of brain parenchyma <italic>in vivo</italic></article-title>. <source/>Science
<volume>308</volume>, <fpage>1314</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1126/science.1110647</pub-id><pub-id pub-id-type="pmid">15831717</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njie</surname><given-names>E. G.</given-names></name><name><surname>Boelen</surname><given-names>E.</given-names></name><name><surname>Stassen</surname><given-names>F. R.</given-names></name><name><surname>Steinbusch</surname><given-names>H. W.</given-names></name><name><surname>Borchelt</surname><given-names>D. R.</given-names></name><name><surname>Streit</surname><given-names>W. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function</article-title>. <source/>Neurobiol. Aging
<volume>33</volume>, <fpage>195.e1</fpage>–<lpage>195.e12</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2010.05.008</pub-id><pub-id pub-id-type="pmid">20580465</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norden</surname><given-names>D. M.</given-names></name><name><surname>Muccigrosso</surname><given-names>M. M.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Microglial priming and enhanced reactivity to secondary insult in aging and traumatic CNS injury, and neurodegenerative disease</article-title>. <source/>Neuropharmacology
<volume>96</volume>, <fpage>29</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.10.028</pub-id><pub-id pub-id-type="pmid">25445485</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Northcutt</surname><given-names>A. L.</given-names></name><name><surname>Hutchinson</surname><given-names>M. R.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Baratta</surname><given-names>M. V.</given-names></name><name><surname>Hiranita</surname><given-names>T.</given-names></name><name><surname>Cochran</surname><given-names>T. A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling</article-title>. <source/>Mol. Psychiatry
<volume>20</volume>, <fpage>1525</fpage>–<lpage>1537</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.177</pub-id><pub-id pub-id-type="pmid">25644383</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notter</surname><given-names>T.</given-names></name><name><surname>Coughlin</surname><given-names>J. M.</given-names></name><name><surname>Gschwind</surname><given-names>T.</given-names></name><name><surname>Weber-Stadlbauer</surname><given-names>U.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Kassiou</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia</article-title>. <source/>Mol. Psychiatry [Epub ahead of print]. <pub-id pub-id-type="doi">10.1038/mp.2016.248</pub-id><pub-id pub-id-type="pmid">28093569</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olmos-Alonso</surname><given-names>A.</given-names></name><name><surname>Schetters</surname><given-names>S. T.</given-names></name><name><surname>Sri</surname><given-names>S.</given-names></name><name><surname>Askew</surname><given-names>K.</given-names></name><name><surname>Mancuso</surname><given-names>R.</given-names></name><name><surname>Vargas-Caballero</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology</article-title>. <source/>Brain
<volume>139</volume>, <fpage>891</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv379</pub-id><pub-id pub-id-type="pmid">26747862</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>L. K.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Kluge</surname><given-names>M.</given-names></name><name><surname>Tebay</surname><given-names>C.</given-names></name><name><surname>Zalewska</surname><given-names>K.</given-names></name><name><surname>Dickson</surname><given-names>P. W.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Reconsidering the role of glial cells in chronic stress-induced dopaminergic neurons loss within the substantia nigra? Friend or foe?</article-title>
<source/>Brain Behav. Immun.
<volume>60</volume>, <fpage>117</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.10.001</pub-id><pub-id pub-id-type="pmid">27717686</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orre</surname><given-names>M.</given-names></name><name><surname>Kamphuis</surname><given-names>W.</given-names></name><name><surname>Osborn</surname><given-names>L. M.</given-names></name><name><surname>Melief</surname><given-names>J.</given-names></name><name><surname>Kooijman</surname><given-names>L.</given-names></name><name><surname>Huitinga</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice</article-title>. <source/>Neurobiol. Aging
<volume>35</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.07.008</pub-id><pub-id pub-id-type="pmid">23954174</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otero</surname><given-names>K.</given-names></name><name><surname>Turnbull</surname><given-names>I. R.</given-names></name><name><surname>Poliani</surname><given-names>P. L.</given-names></name><name><surname>Vermi</surname><given-names>W.</given-names></name><name><surname>Cerutti</surname><given-names>E.</given-names></name><name><surname>Aoshi</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin</article-title>. <source/>Nat. Immunol.
<volume>10</volume>, <fpage>734</fpage>–<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1744</pub-id><pub-id pub-id-type="pmid">19503107</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Packer</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Neocortical neurogenesis and the etiology of autism spectrum disorder</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>64</volume>, <fpage>185</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.03.002</pub-id><pub-id pub-id-type="pmid">26949225</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Murana</surname><given-names>E.</given-names></name><name><surname>Cortese</surname><given-names>B.</given-names></name><name><surname>Di Angelantonio</surname><given-names>S.</given-names></name><name><surname>Zurolo</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Defective microglial development in the hippocampus of Cx3cr1 deficient mice</article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>:<fpage>111</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00111</pub-id><pub-id pub-id-type="pmid">25873863</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paloneva</surname><given-names>J.</given-names></name><name><surname>Autti</surname><given-names>T.</given-names></name><name><surname>Raininko</surname><given-names>R.</given-names></name><name><surname>Partanen</surname><given-names>J.</given-names></name><name><surname>Salonen</surname><given-names>O.</given-names></name><name><surname>Puranen</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts</article-title>. <source/>Neurology
<volume>56</volume>, <fpage>1552</fpage>–<lpage>1558</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.56.11.1552</pub-id><pub-id pub-id-type="pmid">11402114</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paloneva</surname><given-names>J.</given-names></name><name><surname>Kestilä</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Salminen</surname><given-names>A.</given-names></name><name><surname>Böhling</surname><given-names>T.</given-names></name><name><surname>Ruotsalainen</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts</article-title>. <source/>Nat. Genet.
<volume>25</volume>, <fpage>357</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1038/77153</pub-id><pub-id pub-id-type="pmid">10888890</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paloneva</surname><given-names>J.</given-names></name><name><surname>Manninen</surname><given-names>T.</given-names></name><name><surname>Christman</surname><given-names>G.</given-names></name><name><surname>Hovanes</surname><given-names>K.</given-names></name><name><surname>Mandelin</surname><given-names>J.</given-names></name><name><surname>Adolfsson</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype</article-title>. <source/>Am. J. Hum. Genet.
<volume>71</volume>, <fpage>656</fpage>–<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1086/342259</pub-id><pub-id pub-id-type="pmid">12080485</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Tremblay</surname><given-names>M. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Fractalkine regulation of microglial physiology and consequences on the brain and behaviour</article-title>. <source/>Front. Cell. Neurosci.
<volume>8</volume>:<fpage>129</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00129</pub-id><pub-id pub-id-type="pmid">24860431</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Scianni</surname><given-names>M.</given-names></name><name><surname>Panzanelli</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Synaptic pruning by microglia is necessary for normal brain development</article-title>. <source/>Science
<volume>333</volume>, <fpage>1456</fpage>–<lpage>1458</lpage>. <pub-id pub-id-type="doi">10.1126/science.1202529</pub-id><pub-id pub-id-type="pmid">21778362</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Jawaid</surname><given-names>A.</given-names></name><name><surname>Henstridge</surname><given-names>C. M.</given-names></name><name><surname>Valeri</surname><given-names>A.</given-names></name><name><surname>Merlini</surname><given-names>M.</given-names></name><name><surname>Robinson</surname><given-names>J. L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss</article-title>. <source/>Neuron
<volume>95</volume>, <fpage>297.e6</fpage>–<lpage>308.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.05.037</pub-id><pub-id pub-id-type="pmid">28669544</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkhurst</surname><given-names>C. N.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Ninan</surname><given-names>I.</given-names></name><name><surname>Savas</surname><given-names>J. N.</given-names></name><name><surname>Yates</surname><given-names>J. R.</given-names><suffix>III</suffix></name><name><surname>Lafaille</surname><given-names>J. J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor</article-title>. <source/>Cell
<volume>155</volume>, <fpage>1596</fpage>–<lpage>1609</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.11.030</pub-id><pub-id pub-id-type="pmid">24360280</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>O.</given-names></name><name><surname>Ben Achour</surname><given-names>S.</given-names></name><name><surname>Rostaing</surname><given-names>P.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Bessis</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>109</volume>, <fpage>E197</fpage>–<lpage>E205</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1111098109</pub-id><pub-id pub-id-type="pmid">22167804</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Immune involvement in schizophrenia and autism: etiology, pathology and animal models</article-title>. <source/>Behav. Brain Res.
<volume>204</volume>, <fpage>313</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2008.12.016</pub-id><pub-id pub-id-type="pmid">19136031</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peca</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Cellular and synaptic network defects in autism</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>22</volume>, <fpage>866</fpage>–<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2012.02.015</pub-id><pub-id pub-id-type="pmid">22440525</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penzes</surname><given-names>P.</given-names></name><name><surname>Cahill</surname><given-names>M. E.</given-names></name><name><surname>Jones</surname><given-names>K. A.</given-names></name><name><surname>VanLeeuwen</surname><given-names>J. E.</given-names></name><name><surname>Woolfrey</surname><given-names>K. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Dendritic spine pathology in neuropsychiatric disorders</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>, <fpage>285</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2741</pub-id><pub-id pub-id-type="pmid">21346746</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peri</surname><given-names>F.</given-names></name><name><surname>Nüsslein-Volhard</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion <italic>in vivo</italic></article-title>. <source/>Cell
<volume>133</volume>, <fpage>916</fpage>–<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.04.037</pub-id><pub-id pub-id-type="pmid">18510934</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perl</surname><given-names>D. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Neuropathology of Alzheimer’s disease</article-title>. <source/>Mt. Sinai J. Med.
<volume>77</volume>, <fpage>32</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1002/msj.20157</pub-id><pub-id pub-id-type="pmid">20101720</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>V. H.</given-names></name><name><surname>Matyszak</surname><given-names>M. K.</given-names></name><name><surname>Fearn</surname><given-names>S.</given-names></name></person-group> (<year>1993</year>). <article-title>Altered antigen expression of microglia in the aged rodent CNS</article-title>. <source/>Glia
<volume>7</volume>, <fpage>60</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440070111</pub-id><pub-id pub-id-type="pmid">8423063</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A.</given-names></name><name><surname>Sethares</surname><given-names>C.</given-names></name><name><surname>Luebke</surname><given-names>J. I.</given-names></name></person-group> (<year>2008</year>). <article-title>Synapses are lost during aging in the primate prefrontal cortex</article-title>. <source/>Neuroscience
<volume>152</volume>, <fpage>970</fpage>–<lpage>981</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.07.014</pub-id><pub-id pub-id-type="pmid">18329176</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petralia</surname><given-names>R. S.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name><name><surname>Yao</surname><given-names>P. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Communication breakdown: the impact of ageing on synapse structure</article-title>. <source/>Ageing Res. Rev.
<volume>14</volume>, <fpage>31</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2014.01.003</pub-id><pub-id pub-id-type="pmid">24495392</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Delaby</surname><given-names>E.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Barbosa</surname><given-names>M.</given-names></name><name><surname>Merikangas</surname><given-names>A.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Convergence of genes and cellular pathways dysregulated in autism spectrum disorders</article-title>. <source/>Am. J. Hum. Genet.
<volume>94</volume>, <fpage>677</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.018</pub-id><pub-id pub-id-type="pmid">24768552</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>G. N.</given-names></name><name><surname>Bezerra</surname><given-names>A. G.</given-names></name><name><surname>Tufik</surname><given-names>S.</given-names></name><name><surname>Andersen</surname><given-names>M. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Effects of acute sleep deprivation on state anxiety levels: a systematic review and meta-analysis</article-title>. <source/>Sleep Med.
<volume>24</volume>, <fpage>109</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.sleep.2016.07.019</pub-id><pub-id pub-id-type="pmid">27810176</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plane</surname><given-names>J. M.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Pleasure</surname><given-names>D. E.</given-names></name><name><surname>Deng</surname><given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>Prospects for minocycline neuroprotection</article-title>. <source/>Arch. Neurol.
<volume>67</volume>, <fpage>1442</fpage>–<lpage>1448</lpage>. <pub-id pub-id-type="doi">10.1001/archneurol.2010.191</pub-id><pub-id pub-id-type="pmid">20697034</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poewe</surname><given-names>W.</given-names></name><name><surname>Seppi</surname><given-names>K.</given-names></name><name><surname>Tanner</surname><given-names>C. M.</given-names></name><name><surname>Halliday</surname><given-names>G. M.</given-names></name><name><surname>Brundin</surname><given-names>P.</given-names></name><name><surname>Volkmann</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Parkinson disease</article-title>. <source/>Nat. Rev. Dis. Primers
<volume>3</volume>:<fpage>17013</fpage>. <pub-id pub-id-type="doi">10.1038/nrdp.2017.13</pub-id><pub-id pub-id-type="pmid">28332488</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pontieri</surname><given-names>F. E.</given-names></name><name><surname>Tanda</surname><given-names>G.</given-names></name><name><surname>Di Chiara</surname><given-names>G.</given-names></name></person-group> (<year>1995</year>). <article-title>Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the “shell” as compared with the “core” of the rat nucleus accumbens</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>92</volume>, <fpage>12304</fpage>–<lpage>12308</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.92.26.12304</pub-id><pub-id pub-id-type="pmid">8618890</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pont-Lezica</surname><given-names>L.</given-names></name><name><surname>Beumer</surname><given-names>W.</given-names></name><name><surname>Colasse</surname><given-names>S.</given-names></name><name><surname>Drexhage</surname><given-names>H.</given-names></name><name><surname>Versnel</surname><given-names>M.</given-names></name><name><surname>Bessis</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglia shape corpus callosum axon tract fasciculation: functional impact of prenatal inflammation</article-title>. <source/>Eur. J. Neurosci.
<volume>39</volume>, <fpage>1551</fpage>–<lpage>1557</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12508</pub-id><pub-id pub-id-type="pmid">24593277</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinz</surname><given-names>M.</given-names></name><name><surname>Priller</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease</article-title>. <source/>Nat. Rev. Neurosci.
<volume>15</volume>, <fpage>300</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3722</pub-id><pub-id pub-id-type="pmid">24713688</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>L.</given-names></name><name><surname>Crews</surname><given-names>F. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration</article-title>. <source/>J. Neuroinflammation
<volume>9</volume>:<fpage>130</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-130</pub-id><pub-id pub-id-type="pmid">22709825</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Hanes</surname><given-names>R. N.</given-names></name><name><surname>Pluzarev</surname><given-names>O.</given-names></name><name><surname>Hong</surname><given-names>J. S.</given-names></name><name><surname>Crews</surname><given-names>F. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment</article-title>. <source/>J. Neuroinflammation
<volume>5</volume>:<fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-5-10</pub-id><pub-id pub-id-type="pmid">18348728</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rademakers</surname><given-names>R.</given-names></name><name><surname>Baker</surname><given-names>M.</given-names></name><name><surname>Nicholson</surname><given-names>A. M.</given-names></name><name><surname>Rutherford</surname><given-names>N. J.</given-names></name><name><surname>Finch</surname><given-names>N.</given-names></name><name><surname>Soto-Ortolaza</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids</article-title>. <source/>Nat. Genet.
<volume>44</volume>, <fpage>200</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1038/ng.1027</pub-id><pub-id pub-id-type="pmid">22197934</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radewicz</surname><given-names>K.</given-names></name><name><surname>Garey</surname><given-names>L. J.</given-names></name><name><surname>Gentleman</surname><given-names>S. M.</given-names></name><name><surname>Reynolds</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>59</volume>, <fpage>137</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/59.2.137</pub-id><pub-id pub-id-type="pmid">10749103</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajkowska</surname><given-names>G.</given-names></name><name><surname>Miguel-Hidalgo</surname><given-names>J. J.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Dilley</surname><given-names>G.</given-names></name><name><surname>Pittman</surname><given-names>S. D.</given-names></name><name><surname>Meltzer</surname><given-names>H. Y.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression</article-title>. <source/>Biol. Psychiatry
<volume>45</volume>, <fpage>1085</fpage>–<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-3223(99)00041-4</pub-id><pub-id pub-id-type="pmid">10331101</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>J. S.</given-names></name><name><surname>Harry</surname><given-names>G. J.</given-names></name><name><surname>Rapoport</surname><given-names>S. I.</given-names></name><name><surname>Kim</surname><given-names>H. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>384</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.47</pub-id><pub-id pub-id-type="pmid">19488045</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Réu</surname><given-names>P.</given-names></name><name><surname>Khosravi</surname><given-names>A.</given-names></name><name><surname>Bernard</surname><given-names>S.</given-names></name><name><surname>Mold</surname><given-names>J. E.</given-names></name><name><surname>Salehpour</surname><given-names>M.</given-names></name><name><surname>Alkass</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>The Lifespan and turnover of microglia in the human brain</article-title>. <source/>Cell Rep.
<volume>20</volume>, <fpage>779</fpage>–<lpage>784</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.07.004</pub-id><pub-id pub-id-type="pmid">28746864</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>M. B.</given-names></name><name><surname>Taylor</surname><given-names>S. R.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Age-induced disruption of selective olfactory bulb synaptic circuits</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>107</volume>, <fpage>15613</fpage>–<lpage>15618</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1007931107</pub-id><pub-id pub-id-type="pmid">20679234</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigato</surname><given-names>C.</given-names></name><name><surname>Swinnen</surname><given-names>N.</given-names></name><name><surname>Buckinx</surname><given-names>R.</given-names></name><name><surname>Couillin</surname><given-names>I.</given-names></name><name><surname>Mangin</surname><given-names>J. M.</given-names></name><name><surname>Rigo</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Microglia proliferation is controlled by P2X7 receptors in a Pannexin-1-independent manner during early embryonic spinal cord invasion</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>11559</fpage>–<lpage>11573</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1042-12.2012</pub-id><pub-id pub-id-type="pmid">22915101</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimmerman</surname><given-names>N.</given-names></name><name><surname>Schottlender</surname><given-names>N.</given-names></name><name><surname>Reshef</surname><given-names>R.</given-names></name><name><surname>Dan-Goor</surname><given-names>N.</given-names></name><name><surname>Yirmiya</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>The hippocampal transcriptomic signature of stress resilience in mice with microglial fractalkine receptor (CX3CR1) deficiency</article-title>. <source/>Brain Behav. Immun.
<volume>61</volume>, <fpage>184</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.11.023</pub-id><pub-id pub-id-type="pmid">27890560</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritzel</surname><given-names>R. M.</given-names></name><name><surname>Patel</surname><given-names>A. R.</given-names></name><name><surname>Pan</surname><given-names>S.</given-names></name><name><surname>Crapser</surname><given-names>J.</given-names></name><name><surname>Hammond</surname><given-names>M.</given-names></name><name><surname>Jellison</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Age- and location-related changes in microglial function</article-title>. <source/>Neurobiol. Aging
<volume>36</volume>, <fpage>2153</fpage>–<lpage>2163</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.02.016</pub-id><pub-id pub-id-type="pmid">25816747</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>J. T.</given-names></name><name><surname>Morganti</surname><given-names>J. M.</given-names></name><name><surname>Bachstetter</surname><given-names>A. D.</given-names></name><name><surname>Hudson</surname><given-names>C. E.</given-names></name><name><surname>Peters</surname><given-names>M. M.</given-names></name><name><surname>Grimmig</surname><given-names>B. A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>16241</fpage>–<lpage>16250</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3667-11.2011</pub-id><pub-id pub-id-type="pmid">22072675</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roumier</surname><given-names>A.</given-names></name><name><surname>Béchade</surname><given-names>C.</given-names></name><name><surname>Poncer</surname><given-names>J. C.</given-names></name><name><surname>Smalla</surname><given-names>K. H.</given-names></name><name><surname>Tomasello</surname><given-names>E.</given-names></name><name><surname>Vivier</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>11421</fpage>–<lpage>11428</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2251-04.2004</pub-id><pub-id pub-id-type="pmid">15601948</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roumier</surname><given-names>A.</given-names></name><name><surname>Pascual</surname><given-names>O.</given-names></name><name><surname>Béchade</surname><given-names>C.</given-names></name><name><surname>Wakselman</surname><given-names>S.</given-names></name><name><surname>Poncer</surname><given-names>J. C.</given-names></name><name><surname>Réal</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function</article-title>. <source/>PLoS One
<volume>3</volume>:<fpage>e2595</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0002595</pub-id><pub-id pub-id-type="pmid">18612411</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozovsky</surname><given-names>I.</given-names></name><name><surname>Finch</surname><given-names>C. E.</given-names></name><name><surname>Morgan</surname><given-names>T. E.</given-names></name></person-group> (<year>1998</year>). <article-title>Age-related activation of microglia and astrocytes: <italic>in vitro</italic> studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation</article-title>. <source/>Neurobiol. Aging
<volume>19</volume>, <fpage>97</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(97)00169-3</pub-id><pub-id pub-id-type="pmid">9562510</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>J. L.</given-names></name><name><surname>Merzenich</surname><given-names>M. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems</article-title>. <source/>Genes Brain Behav.
<volume>2</volume>, <fpage>255</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1034/j.1601-183x.2003.00037.x</pub-id><pub-id pub-id-type="pmid">14606691</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rupprecht</surname><given-names>R.</given-names></name><name><surname>Papadopoulos</surname><given-names>V.</given-names></name><name><surname>Rammes</surname><given-names>G.</given-names></name><name><surname>Baghai</surname><given-names>T. C.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Akula</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders</article-title>. <source/>Nat. Rev. Drug Discov.
<volume>9</volume>, <fpage>971</fpage>–<lpage>988</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3295</pub-id><pub-id pub-id-type="pmid">21119734</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>I.</given-names></name><name><surname>Bubacco</surname><given-names>L.</given-names></name><name><surname>Greggio</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?</article-title>
<source/>J. Neuroinflammation
<volume>11</volume>:<fpage>52</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-11-52</pub-id><pub-id pub-id-type="pmid">24655756</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandiego</surname><given-names>C. M.</given-names></name><name><surname>Gallezot</surname><given-names>J. D.</given-names></name><name><surname>Pittman</surname><given-names>B.</given-names></name><name><surname>Nabulsi</surname><given-names>N.</given-names></name><name><surname>Lim</surname><given-names>K.</given-names></name><name><surname>Lin</surname><given-names>S. F.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Imaging robust microglial activation after lipopolysaccharide administration in humans with PET</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>112</volume>, <fpage>12468</fpage>–<lpage>12473</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1511003112</pub-id><pub-id pub-id-type="pmid">26385967</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>D. P.</given-names></name><name><surname>Heller</surname><given-names>C. T.</given-names></name><name><surname>Gunner</surname><given-names>G.</given-names></name><name><surname>Heller</surname><given-names>M.</given-names></name><name><surname>Gordon</surname><given-names>C.</given-names></name><name><surname>Hammond</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression</article-title>. <source/>Elife
<volume>5</volume>:<fpage>e15224</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.15224</pub-id><pub-id pub-id-type="pmid">27458802</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>D. P.</given-names></name><name><surname>Lehrman</surname><given-names>E. K.</given-names></name><name><surname>Kautzman</surname><given-names>A. G.</given-names></name><name><surname>Koyama</surname><given-names>R.</given-names></name><name><surname>Mardinly</surname><given-names>A. R.</given-names></name><name><surname>Yamasaki</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner</article-title>. <source/>Neuron
<volume>74</volume>, <fpage>691</fpage>–<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.026</pub-id><pub-id pub-id-type="pmid">22632727</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheff</surname><given-names>S. W.</given-names></name><name><surname>DeKosky</surname><given-names>S. T.</given-names></name><name><surname>Price</surname><given-names>D. A.</given-names></name></person-group> (<year>1990</year>). <article-title>Quantitative assessment of cortical synaptic density in Alzheimer’s disease</article-title>. <source/>Neurobiol. Aging
<volume>11</volume>, <fpage>29</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/0197-4580(90)90059-9</pub-id><pub-id pub-id-type="pmid">2325814</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheff</surname><given-names>S. W.</given-names></name><name><surname>Price</surname><given-names>D. A.</given-names></name><name><surname>Schmitt</surname><given-names>F. A.</given-names></name><name><surname>Mufson</surname><given-names>E. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment</article-title>. <source/>Neurobiol. Aging
<volume>27</volume>, <fpage>1372</fpage>–<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.09.012</pub-id><pub-id pub-id-type="pmid">16289476</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheff</surname><given-names>S. W.</given-names></name><name><surname>Price</surname><given-names>D. A.</given-names></name></person-group> (<year>1993</year>). <article-title>Synapse loss in the temporal lobe in Alzheimer’s disease</article-title>. <source/>Ann. Neurol.
<volume>33</volume>, <fpage>190</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410330209</pub-id><pub-id pub-id-type="pmid">8434881</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>S. A.</given-names></name><name><surname>Obeso</surname><given-names>J. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Clinical and pathological features of Parkinson’s disease</article-title>. <source/>Curr. Top. Behav. Neurosci.
<volume>22</volume>, <fpage>205</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1007/7854_2014_317</pub-id><pub-id pub-id-type="pmid">24850081</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrag</surname><given-names>A.</given-names></name><name><surname>Schott</surname><given-names>J. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism</article-title>. <source/>Lancet Neurol.
<volume>5</volume>, <fpage>355</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(06)70411-2</pub-id><pub-id pub-id-type="pmid">16545752</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>J. M.</given-names></name><name><surname>Sholar</surname><given-names>P. W.</given-names></name><name><surname>Bilbo</surname><given-names>S. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Sex differences in microglial colonization of the developing rat brain</article-title>. <source/>J. Neurochem.
<volume>120</volume>, <fpage>948</fpage>–<lpage>963</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07630.x</pub-id><pub-id pub-id-type="pmid">22182318</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>K. M.</given-names></name><name><surname>McLaughlin</surname><given-names>K. A.</given-names></name><name><surname>Smith</surname><given-names>D. A.</given-names></name><name><surname>Ellis</surname><given-names>P. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Childhood maltreatment and DSM-IV adult mental disorders: comparison of prospective and retrospective findings</article-title>. <source/>Br. J. Psychiatry
<volume>200</volume>, <fpage>469</fpage>–<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.111.103267</pub-id><pub-id pub-id-type="pmid">22661679</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekar</surname><given-names>A.</given-names></name><name><surname>Bialas</surname><given-names>A. R.</given-names></name><name><surname>de Rivera</surname><given-names>H.</given-names></name><name><surname>Davis</surname><given-names>A.</given-names></name><name><surname>Hammond</surname><given-names>T. R.</given-names></name><name><surname>Kamitaki</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Schizophrenia risk from complex variation of complement component 4</article-title>. <source/>Nature
<volume>530</volume>, <fpage>177</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1038/nature16549</pub-id><pub-id pub-id-type="pmid">26814963</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname><given-names>Y.</given-names></name><name><surname>Ouchi</surname><given-names>Y.</given-names></name><name><surname>Sugihara</surname><given-names>G.</given-names></name><name><surname>Takei</surname><given-names>N.</given-names></name><name><surname>Yoshikawa</surname><given-names>E.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Methamphetamine causes microglial activation in the brains of human abusers</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>5756</fpage>–<lpage>5761</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1179-08.2008</pub-id><pub-id pub-id-type="pmid">18509037</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellgren</surname><given-names>C. M.</given-names></name><name><surname>Sheridan</surname><given-names>S. D.</given-names></name><name><surname>Gracias</surname><given-names>J.</given-names></name><name><surname>Xuan</surname><given-names>D.</given-names></name><name><surname>Fu</surname><given-names>T.</given-names></name><name><surname>Perlis</surname><given-names>R. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors</article-title>. <source/>Mol. Psychiatry
<volume>22</volume>, <fpage>170</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.220</pub-id><pub-id pub-id-type="pmid">27956744</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seltzer</surname><given-names>B.</given-names></name><name><surname>Sherwin</surname><given-names>I.</given-names></name></person-group> (<year>1983</year>). <article-title>A comparison of clinical features in early- and late-onset primary degenerative dementia: one entity or two?</article-title>
<source/>Arch. Neurol.
<volume>40</volume>, <fpage>143</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.1983.04050030037006</pub-id><pub-id pub-id-type="pmid">6830452</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setiawan</surname><given-names>E.</given-names></name><name><surname>Wilson</surname><given-names>A. A.</given-names></name><name><surname>Mizrahi</surname><given-names>R.</given-names></name><name><surname>Rusjan</surname><given-names>P. M.</given-names></name><name><surname>Miler</surname><given-names>L.</given-names></name><name><surname>Rajkowska</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes</article-title>. <source/>JAMA Psychiatry
<volume>72</volume>, <fpage>268</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.2427</pub-id><pub-id pub-id-type="pmid">25629589</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankar</surname><given-names>G. M.</given-names></name><name><surname>Bloodgood</surname><given-names>B. L.</given-names></name><name><surname>Townsend</surname><given-names>M.</given-names></name><name><surname>Walsh</surname><given-names>D. M.</given-names></name><name><surname>Selkoe</surname><given-names>D. J.</given-names></name><name><surname>Sabatini</surname><given-names>B. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>2866</fpage>–<lpage>2875</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4970-06.2007</pub-id><pub-id pub-id-type="pmid">17360908</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankar</surname><given-names>G. M.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Mehta</surname><given-names>T. H.</given-names></name><name><surname>Garcia-Munoz</surname><given-names>A.</given-names></name><name><surname>Shepardson</surname><given-names>N. E.</given-names></name><name><surname>Smith</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Amyloid β-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory</article-title>. <source/>Nat. Med.
<volume>14</volume>, <fpage>837</fpage>–<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1038/nm1782</pub-id><pub-id pub-id-type="pmid">18568035</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherer</surname><given-names>T. B.</given-names></name><name><surname>Betarbet</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Greenamyre</surname><given-names>J. T.</given-names></name></person-group> (<year>2003</year>). <article-title>Selective microglial activation in the rat rotenone model of Parkinson’s disease</article-title>. <source/>Neurosci. Lett.
<volume>341</volume>, <fpage>87</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/s0304-3940(03)00172-1</pub-id><pub-id pub-id-type="pmid">12686372</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>G. K.</given-names></name><name><surname>Wdowicz</surname><given-names>A.</given-names></name><name><surname>Pickering</surname><given-names>M.</given-names></name><name><surname>Watters</surname><given-names>O.</given-names></name><name><surname>Halley</surname><given-names>P.</given-names></name><name><surname>O’Sullivan</surname><given-names>N. C.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity</article-title>. <source/>Front. Cell. Neurosci.
<volume>8</volume>:<fpage>233</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00233</pub-id><pub-id pub-id-type="pmid">25161610</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Chowdhury</surname><given-names>S.</given-names></name><name><surname>Ma</surname><given-names>R.</given-names></name><name><surname>Le</surname><given-names>K. X.</given-names></name><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Caldarone</surname><given-names>B. J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice</article-title>. <source/>Sci. Transl. Med.
<volume>9</volume>:<fpage>eaaf6295</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aaf6295</pub-id><pub-id pub-id-type="pmid">28566429</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Colodner</surname><given-names>K. J.</given-names></name><name><surname>Matousek</surname><given-names>S. B.</given-names></name><name><surname>Merry</surname><given-names>K.</given-names></name><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Kenison</surname><given-names>J. E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Complement C3-deficient mice fail to display age-related hippocampal decline</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>13029</fpage>–<lpage>13042</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1698-15.2015</pub-id><pub-id pub-id-type="pmid">26400934</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>A.</given-names></name><name><surname>Encinas</surname><given-names>J. M.</given-names></name><name><surname>Deudero</surname><given-names>J. J.</given-names></name><name><surname>Chancey</surname><given-names>J. H.</given-names></name><name><surname>Enikolopov</surname><given-names>G.</given-names></name><name><surname>Overstreet-Wadiche</surname><given-names>L. S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis</article-title>. <source/>Cell Stem Cell
<volume>7</volume>, <fpage>483</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2010.08.014</pub-id><pub-id pub-id-type="pmid">20887954</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>A.</given-names></name><name><surname>Gottfried-Blackmore</surname><given-names>A. C.</given-names></name><name><surname>McEwen</surname><given-names>B. S.</given-names></name><name><surname>Bulloch</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Microglia derived from aging mice exhibit an altered inflammatory profile</article-title>. <source/>Glia
<volume>55</volume>, <fpage>412</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20468</pub-id><pub-id pub-id-type="pmid">17203473</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>R.</given-names></name><name><surname>van der Lee</surname><given-names>S. J.</given-names></name><name><surname>Naj</surname><given-names>A. C.</given-names></name><name><surname>Bellenguez</surname><given-names>C.</given-names></name><name><surname>Badarinarayan</surname><given-names>N.</given-names></name><name><surname>Jakobsdottir</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>1373</fpage>–<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3916</pub-id><pub-id pub-id-type="pmid">28714976</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Šišková</surname><given-names>Z.</given-names></name><name><surname>Tremblay</surname><given-names>M.-È.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia and synapse: interactions in health and neurodegeneration</article-title>. <source/>Neural Plast.
<volume>2013</volume>:<fpage>42845</fpage>. <pub-id pub-id-type="doi">10.1155/2013/425845</pub-id><pub-id pub-id-type="pmid">24392228</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofuoglu</surname><given-names>M.</given-names></name><name><surname>Mooney</surname><given-names>M.</given-names></name><name><surname>Kosten</surname><given-names>T.</given-names></name><name><surname>Waters</surname><given-names>A.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans</article-title>. <source/>Psychopharmacology
<volume>213</volume>, <fpage>61</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-010-2014-5</pub-id><pub-id pub-id-type="pmid">20838775</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorge</surname><given-names>R. E.</given-names></name><name><surname>Mapplebeck</surname><given-names>J. C.</given-names></name><name><surname>Rosen</surname><given-names>S.</given-names></name><name><surname>Beggs</surname><given-names>S.</given-names></name><name><surname>Taves</surname><given-names>S.</given-names></name><name><surname>Alexander</surname><given-names>J. K.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Different immune cells mediate mechanical pain hypersensitivity in male and female mice</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>1081</fpage>–<lpage>1083</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4053</pub-id><pub-id pub-id-type="pmid">26120961</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spangenberg</surname><given-names>E. E.</given-names></name><name><surname>Lee</surname><given-names>R. J.</given-names></name><name><surname>Najafi</surname><given-names>A. R.</given-names></name><name><surname>Rice</surname><given-names>R. A.</given-names></name><name><surname>Elmore</surname><given-names>M. R.</given-names></name><name><surname>Blurton-Jones</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology</article-title>. <source/>Brain
<volume>139</volume>, <fpage>1265</fpage>–<lpage>1281</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww016</pub-id><pub-id pub-id-type="pmid">26921617</pub-id></mixed-citation>
</ref>
<ref id="B284">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spires-Jones</surname><given-names>T. L.</given-names></name><name><surname>Hyman</surname><given-names>B. T.</given-names></name></person-group> (<year>2014</year>). <article-title>The intersection of amyloid β and tau at synapses in Alzheimer’s disease</article-title>. <source/>Neuron
<volume>82</volume>, <fpage>756</fpage>–<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.05.004</pub-id><pub-id pub-id-type="pmid">24853936</pub-id></mixed-citation>
</ref>
<ref id="B285">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Squarzoni</surname><given-names>P.</given-names></name><name><surname>Oller</surname><given-names>G.</given-names></name><name><surname>Hoeffel</surname><given-names>G.</given-names></name><name><surname>Pont-Lezica</surname><given-names>L.</given-names></name><name><surname>Rostaing</surname><given-names>P.</given-names></name><name><surname>Low</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Microglia modulate wiring of the embryonic forebrain</article-title>. <source/>Cell Rep.
<volume>8</volume>, <fpage>1271</fpage>–<lpage>1279</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.07.042</pub-id><pub-id pub-id-type="pmid">25159150</pub-id></mixed-citation>
</ref>
<ref id="B286">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>J.</given-names></name><name><surname>Bielau</surname><given-names>H.</given-names></name><name><surname>Brisch</surname><given-names>R.</given-names></name><name><surname>Danos</surname><given-names>P.</given-names></name><name><surname>Ullrich</surname><given-names>O.</given-names></name><name><surname>Mawrin</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide</article-title>. <source/>J. Psychiatr. Res.
<volume>42</volume>, <fpage>151</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2006.10.013</pub-id><pub-id pub-id-type="pmid">17174336</pub-id></mixed-citation>
</ref>
<ref id="B287">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephan</surname><given-names>A. H.</given-names></name><name><surname>Madison</surname><given-names>D. V.</given-names></name><name><surname>Mateos</surname><given-names>J. M.</given-names></name><name><surname>Fraser</surname><given-names>D. A.</given-names></name><name><surname>Lovelett</surname><given-names>E. A.</given-names></name><name><surname>Coutellier</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>A dramatic increase of C1q protein in the CNS during normal aging</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>13460</fpage>–<lpage>13474</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1333-13.2013</pub-id><pub-id pub-id-type="pmid">23946404</pub-id></mixed-citation>
</ref>
<ref id="B288">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stichel</surname><given-names>C. C.</given-names></name><name><surname>Luebbert</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Inflammatory processes in the aging mouse brain: participation of dendritic cells and T-cells</article-title>. <source/>Neurobiol. Aging
<volume>28</volume>, <fpage>1507</fpage>–<lpage>1521</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2006.07.022</pub-id><pub-id pub-id-type="pmid">16959379</pub-id></mixed-citation>
</ref>
<ref id="B289">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stokholm</surname><given-names>M. G.</given-names></name><name><surname>Iranzo</surname><given-names>A.</given-names></name><name><surname>Ostergaard</surname><given-names>K.</given-names></name><name><surname>Serradell</surname><given-names>M.</given-names></name><name><surname>Otto</surname><given-names>M.</given-names></name><name><surname>Svendsen</surname><given-names>K. B.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study</article-title>. <source/>Lancet Neurol.
<volume>16</volume>, <fpage>789</fpage>–<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(17)30173-4</pub-id><pub-id pub-id-type="pmid">28684245</pub-id></mixed-citation>
</ref>
<ref id="B290">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streit</surname><given-names>W. J.</given-names></name><name><surname>Braak</surname><given-names>H.</given-names></name><name><surname>Xue</surname><given-names>Q. S.</given-names></name><name><surname>Bechmann</surname><given-names>I.</given-names></name></person-group> (<year>2009</year>). <article-title>Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease</article-title>. <source/>Acta Neuropathol.
<volume>118</volume>, <fpage>475</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-009-0556-6</pub-id><pub-id pub-id-type="pmid">19513731</pub-id></mixed-citation>
</ref>
<ref id="B291">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streit</surname><given-names>W. J.</given-names></name><name><surname>Sammons</surname><given-names>N. W.</given-names></name><name><surname>Kuhns</surname><given-names>A. J.</given-names></name><name><surname>Sparks</surname><given-names>D. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Dystrophic microglia in the aging human brain</article-title>. <source/>Glia
<volume>45</volume>, <fpage>208</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1002/glia.10319</pub-id><pub-id pub-id-type="pmid">14730714</pub-id></mixed-citation>
</ref>
<ref id="B292">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stridh</surname><given-names>L.</given-names></name><name><surname>Ek</surname><given-names>C. J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Nilsson</surname><given-names>H.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Regulation of Toll-like receptors in the choroid plexus in the immature brain after systemic inflammatory stimuli</article-title>. <source/>Transl. Stroke Res.
<volume>4</volume>, <fpage>220</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1007/s12975-012-0248-8</pub-id><pub-id pub-id-type="pmid">23741282</pub-id></mixed-citation>
</ref>
<ref id="B293">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suárez-Calvet</surname><given-names>M.</given-names></name><name><surname>Araque Caballero</surname><given-names>M. Á.</given-names></name><name><surname>Kleinberger</surname><given-names>G.</given-names></name><name><surname>Bateman</surname><given-names>R. J.</given-names></name><name><surname>Fagan</surname><given-names>A. M.</given-names></name><name><surname>Morris</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury</article-title>. <source/>Sci. Transl. Med.
<volume>8</volume>:<fpage>369ra178</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aag1767</pub-id><pub-id pub-id-type="pmid">27974666</pub-id></mixed-citation>
</ref>
<ref id="B294">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundal</surname><given-names>C.</given-names></name><name><surname>Lash</surname><given-names>J.</given-names></name><name><surname>Aasly</surname><given-names>J.</given-names></name><name><surname>Øygarden</surname><given-names>S.</given-names></name><name><surname>Roeber</surname><given-names>S.</given-names></name><name><surname>Kretzschman</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity</article-title>. <source/>J. Neurol. Sci.
<volume>314</volume>, <fpage>130</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2011.10.006</pub-id><pub-id pub-id-type="pmid">22050953</pub-id></mixed-citation>
</ref>
<ref id="B295">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Sugihara</surname><given-names>G.</given-names></name><name><surname>Ouchi</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Futatsubashi</surname><given-names>M.</given-names></name><name><surname>Takebayashi</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Microglial activation in young adults with autism spectrum disorder</article-title>. <source/>JAMA Psychiatry
<volume>70</volume>, <fpage>49</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.272</pub-id><pub-id pub-id-type="pmid">23404112</pub-id></mixed-citation>
</ref>
<ref id="B296">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swinnen</surname><given-names>N.</given-names></name><name><surname>Smolders</surname><given-names>S.</given-names></name><name><surname>Avila</surname><given-names>A.</given-names></name><name><surname>Notelaers</surname><given-names>K.</given-names></name><name><surname>Paesen</surname><given-names>R.</given-names></name><name><surname>Ameloot</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Complex invasion pattern of the cerebral cortex bymicroglial cells during development of the mouse embryo</article-title>. <source/>Glia
<volume>61</volume>, <fpage>150</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22421</pub-id><pub-id pub-id-type="pmid">23001583</pub-id></mixed-citation>
</ref>
<ref id="B297">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Rochford</surname><given-names>C. D.</given-names></name><name><surname>Neumann</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2</article-title>. <source/>J. Exp. Med.
<volume>201</volume>, <fpage>647</fpage>–<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20041611</pub-id><pub-id pub-id-type="pmid">15728241</pub-id></mixed-citation>
</ref>
<ref id="B298">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname><given-names>T. L.</given-names></name><name><surname>Hagemeyer</surname><given-names>N.</given-names></name><name><surname>Prinz</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>The force awakens: insights into the origin and formation of microglia</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>39</volume>, <fpage>30</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2016.04.003</pub-id><pub-id pub-id-type="pmid">27107946</pub-id></mixed-citation>
</ref>
<ref id="B299">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname><given-names>T. L.</given-names></name><name><surname>Mai</surname><given-names>D.</given-names></name><name><surname>Dautzenberg</surname><given-names>J.</given-names></name><name><surname>Fernández-Klett</surname><given-names>F.</given-names></name><name><surname>Lin</surname><given-names>G.</given-names></name><collab>Sagar</collab><etal></etal></person-group>. (<year>2017a</year>). <article-title>A new fate mapping system reveals context-dependent random or clonal expansion of microglia</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>793</fpage>–<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4547</pub-id><pub-id pub-id-type="pmid">28414331</pub-id></mixed-citation>
</ref>
<ref id="B300">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname><given-names>T. L.</given-names></name><name><surname>Savage</surname><given-names>J. C.</given-names></name><name><surname>Hui</surname><given-names>C. W.</given-names></name><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Tremblay</surname><given-names>M. E.</given-names></name></person-group> (<year>2017b</year>). <article-title>Microglia across the lifespan: from origin to function in brain development, plasticity and cognition</article-title>. <source/>J. Physiol.
<volume>595</volume>, <fpage>1929</fpage>–<lpage>1945</lpage>. <pub-id pub-id-type="doi">10.1113/jp272134</pub-id><pub-id pub-id-type="pmid">27104646</pub-id></mixed-citation>
</ref>
<ref id="B301">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terry</surname><given-names>R. D.</given-names></name><name><surname>Masliah</surname><given-names>E.</given-names></name><name><surname>Salmon</surname><given-names>D. P.</given-names></name><name><surname>Butters</surname><given-names>N.</given-names></name><name><surname>DeTeresa</surname><given-names>R.</given-names></name><name><surname>Hill</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment</article-title>. <source/>Ann. Neurol.
<volume>30</volume>, <fpage>572</fpage>–<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410300410</pub-id><pub-id pub-id-type="pmid">1789684</pub-id></mixed-citation>
</ref>
<ref id="B302">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium</collab></person-group> (<year>2015</year>). <article-title>Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>199</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3922</pub-id><pub-id pub-id-type="pmid">25599223</pub-id></mixed-citation>
</ref>
<ref id="B303">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>D. M.</given-names></name><name><surname>Walker</surname><given-names>P. D.</given-names></name><name><surname>Benjamins</surname><given-names>J. A.</given-names></name><name><surname>Geddes</surname><given-names>T. J.</given-names></name><name><surname>Kuhn</surname><given-names>D. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>311</volume>, <fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.104.070961</pub-id><pub-id pub-id-type="pmid">15163680</pub-id></mixed-citation>
</ref>
<ref id="B304">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>L.</given-names></name><name><surname>Hui</surname><given-names>C. W.</given-names></name><name><surname>Bisht</surname><given-names>K.</given-names></name><name><surname>Tan</surname><given-names>Y.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Microglia under psychosocial stressors along the aging trajectory: consequences on neuronal circuits, behavior, and brain diseases</article-title>. <source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
<volume>79</volume>, <fpage>27</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.01.007</pub-id><pub-id pub-id-type="pmid">28095309</pub-id></mixed-citation>
</ref>
<ref id="B305">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tononi</surname><given-names>G.</given-names></name><name><surname>Cirelli</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration</article-title>. <source/>Neuron
<volume>81</volume>, <fpage>12</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.12.025</pub-id><pub-id pub-id-type="pmid">24411729</pub-id></mixed-citation>
</ref>
<ref id="B306">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>L.</given-names></name><name><surname>Danver</surname><given-names>J.</given-names></name><name><surname>Ji</surname><given-names>K.</given-names></name><name><surname>Miyauchi</surname><given-names>J. T.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Anderson</surname><given-names>M. E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Dynamic microglial modulation of spatial learning and social behavior</article-title>. <source/>Brain Behav. Immun.
<volume>55</volume>, <fpage>6</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.09.001</pub-id><pub-id pub-id-type="pmid">26348580</pub-id></mixed-citation>
</ref>
<ref id="B307">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Platas</surname><given-names>S. G.</given-names></name><name><surname>Cruceanu</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>G. G.</given-names></name><name><surname>Turecki</surname><given-names>G.</given-names></name><name><surname>Mechawar</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides</article-title>. <source/>Brain Behav. Immun.
<volume>42</volume>, <fpage>50</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.05.007</pub-id><pub-id pub-id-type="pmid">24858659</pub-id></mixed-citation>
</ref>
<ref id="B308">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>M. É.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of microglia at synapses in the healthy CNS: novel insights from recent imaging studies</article-title>. <source/>Neuron Glia Biol.
<volume>7</volume>, <fpage>67</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1017/S1740925X12000038</pub-id><pub-id pub-id-type="pmid">22418067</pub-id></mixed-citation>
</ref>
<ref id="B309">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>M. É.</given-names></name><name><surname>Lowery</surname><given-names>R. L.</given-names></name><name><surname>Majewska</surname><given-names>A. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Microglial interactions with synapses are modulated by visual experience</article-title>. <source/>PLoS Biol.
<volume>8</volume>:<fpage>e1000527</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1000527</pub-id><pub-id pub-id-type="pmid">21072242</pub-id></mixed-citation>
</ref>
<ref id="B310">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>M. É.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name><name><surname>Sierra</surname><given-names>A.</given-names></name><name><surname>Wake</surname><given-names>H.</given-names></name><name><surname>Bessis</surname><given-names>A.</given-names></name><name><surname>Nimmerjahn</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of microglia in the healthy brain</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>16064</fpage>–<lpage>16069</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4158-11.2011</pub-id><pub-id pub-id-type="pmid">22072657</pub-id></mixed-citation>
</ref>
<ref id="B311">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>M. É.</given-names></name><name><surname>Zettel</surname><given-names>M. L.</given-names></name><name><surname>Ison</surname><given-names>J. R.</given-names></name><name><surname>Allen</surname><given-names>P. D.</given-names></name><name><surname>Majewska</surname><given-names>A. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices</article-title>. <source/>Glia
<volume>60</volume>, <fpage>541</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22287</pub-id><pub-id pub-id-type="pmid">22223464</pub-id></mixed-citation>
</ref>
<ref id="B312">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>M.</given-names></name><name><surname>Fujita</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Kikuta</surname><given-names>J.</given-names></name><name><surname>Ishii</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Layer V cortical neurons require microglial support for survival during postnatal development</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>543</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3358</pub-id><pub-id pub-id-type="pmid">23525041</pub-id></mixed-citation>
</ref>
<ref id="B503">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulland</surname><given-names>T. K.</given-names></name><name><surname>Song</surname><given-names>W. M.</given-names></name><name><surname>Huang</surname><given-names>S. C.-C.</given-names></name><name><surname>Ulrich</surname><given-names>J. D.</given-names></name><name><surname>Sergushichev</surname><given-names>A.</given-names></name><name><surname>Beatty</surname><given-names>W. L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>TREM2 maintains microglial metabolic fitness in Alzheimer’s disease</article-title>. <source/>Cell
<volume>170</volume>, <fpage>649</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.07.023</pub-id><pub-id pub-id-type="pmid">28802038</pub-id></mixed-citation>
</ref>
<ref id="B313">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdearcos</surname><given-names>M.</given-names></name><name><surname>Douglass</surname><given-names>J. D.</given-names></name><name><surname>Robblee</surname><given-names>M. M.</given-names></name><name><surname>Dorfman</surname><given-names>M. D.</given-names></name><name><surname>Stifler</surname><given-names>D. R.</given-names></name><name><surname>Bennett</surname><given-names>M. L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Microglial inflammatory signaling orchestrates the hypothalamic immune response to dietary excess and mediates obesity susceptibility</article-title>. <source/>Cell Metab.
<volume>26</volume>, <fpage>185.e3</fpage>–<lpage>197.e3</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.05.015</pub-id><pub-id pub-id-type="pmid">28683286</pub-id></mixed-citation>
</ref>
<ref id="B314">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdearcos</surname><given-names>M.</given-names></name><name><surname>Robblee</surname><given-names>M. M.</given-names></name><name><surname>Benjamin</surname><given-names>D. I.</given-names></name><name><surname>Nomura</surname><given-names>D. K.</given-names></name><name><surname>Xu</surname><given-names>A. W.</given-names></name><name><surname>Koliwad</surname><given-names>S. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function</article-title>. <source/>Cell Rep.
<volume>9</volume>, <fpage>2124</fpage>–<lpage>2138</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.11.018</pub-id><pub-id pub-id-type="pmid">25497089</pub-id></mixed-citation>
</ref>
<ref id="B315">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Berckel</surname><given-names>B. N.</given-names></name><name><surname>Bossong</surname><given-names>M. G.</given-names></name><name><surname>Boellaard</surname><given-names>R.</given-names></name><name><surname>Kloet</surname><given-names>R.</given-names></name><name><surname>Schuitemaker</surname><given-names>A.</given-names></name><name><surname>Caspers</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Microglia activation in recent-onset schizophrenia: a quantitative (<italic>R</italic>)-[<sup>11</sup>C]PK11195 positron emission tomography study</article-title>. <source/>Biol. Psychiatry
<volume>64</volume>, <fpage>820</fpage>–<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.04.025</pub-id><pub-id pub-id-type="pmid">18534557</pub-id></mixed-citation>
</ref>
<ref id="B316">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Os</surname><given-names>J.</given-names></name><name><surname>Kapur</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Schizophrenia</article-title>. <source/>Lancet
<volume>374</volume>, <fpage>635</fpage>–<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60995-8</pub-id><pub-id pub-id-type="pmid">19700006</pub-id></mixed-citation>
</ref>
<ref id="B317">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanRyzin</surname><given-names>J. W.</given-names></name><name><surname>Yu</surname><given-names>S. J.</given-names></name><name><surname>Perez-Pouchoulen</surname><given-names>M.</given-names></name><name><surname>McCarthy</surname><given-names>M. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Temporary depletion of microglia during the early postnatal period induces lasting sex-dependent and sex-independent effects on behavior in rats</article-title>. <source/>eNeuro
<volume>3</volume>:<fpage>ENEURO.0297-16.2016</fpage>. <pub-id pub-id-type="doi">10.1523/ENEURO.0297-16.2016</pub-id><pub-id pub-id-type="pmid">27957532</pub-id></mixed-citation>
</ref>
<ref id="B318">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>D. L.</given-names></name><name><surname>Nascimbene</surname><given-names>C.</given-names></name><name><surname>Krishnan</surname><given-names>C.</given-names></name><name><surname>Zimmerman</surname><given-names>A. W.</given-names></name><name><surname>Pardo</surname><given-names>C. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Neuroglial activation and neuroinflammation in the brain of patients with autism</article-title>. <source/>Ann. Neurol.
<volume>57</volume>, <fpage>67</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20315</pub-id><pub-id pub-id-type="pmid">15546155</pub-id></mixed-citation>
</ref>
<ref id="B319">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voineagu</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Johnston</surname><given-names>P.</given-names></name><name><surname>Lowe</surname><given-names>J. K.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>. <source/>Nature
<volume>474</volume>, <fpage>380</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/nature10110</pub-id><pub-id pub-id-type="pmid">21614001</pub-id></mixed-citation>
</ref>
<ref id="B320">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volta</surname><given-names>M.</given-names></name><name><surname>Milnerwood</surname><given-names>A. J.</given-names></name><name><surname>Farrer</surname><given-names>M. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson’s disease</article-title>. <source/>Lancet Neurol.
<volume>14</volume>, <fpage>1054</fpage>–<lpage>1064</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(15)00186-6</pub-id><pub-id pub-id-type="pmid">26376970</pub-id></mixed-citation>
</ref>
<ref id="B321">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuong</surname><given-names>B.</given-names></name><name><surname>Odero</surname><given-names>G.</given-names></name><name><surname>Rozbacher</surname><given-names>S.</given-names></name><name><surname>Stevenson</surname><given-names>M.</given-names></name><name><surname>Kereliuk</surname><given-names>S. M.</given-names></name><name><surname>Pereira</surname><given-names>T. J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Exposure to gestational diabetes mellitus induces neuroinflammation, derangement of hippocampal neurons and cognitive changes in rat offspring</article-title>. <source/>J. Neuroinflammation
<volume>14</volume>:<fpage>80</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-017-0859-9</pub-id><pub-id pub-id-type="pmid">28388927</pub-id></mixed-citation>
</ref>
<ref id="B322">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vyas</surname><given-names>S.</given-names></name><name><surname>Rodrigues</surname><given-names>A. J.</given-names></name><name><surname>Silva</surname><given-names>J. M.</given-names></name><name><surname>Tronche</surname><given-names>F.</given-names></name><name><surname>Almeida</surname><given-names>O. F.</given-names></name><name><surname>Sousa</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Chronic stress and glucocorticoids: from neuronal plasticity to neurodegeneration</article-title>. <source/>Neural Plast.
<volume>2016</volume>:<fpage>6391686</fpage>. <pub-id pub-id-type="doi">10.1155/2016/6391686</pub-id><pub-id pub-id-type="pmid">27034847</pub-id></mixed-citation>
</ref>
<ref id="B323">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahner</surname><given-names>A. D.</given-names></name><name><surname>Sinsheimer</surname><given-names>J. S.</given-names></name><name><surname>Bronstein</surname><given-names>J. M.</given-names></name><name><surname>Ritz</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease</article-title>. <source/>Arch. Neurol.
<volume>64</volume>, <fpage>836</fpage>–<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.64.6.836</pub-id><pub-id pub-id-type="pmid">17562931</pub-id></mixed-citation>
</ref>
<ref id="B324">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wake</surname><given-names>H.</given-names></name><name><surname>Moorhouse</surname><given-names>A. J.</given-names></name><name><surname>Jinno</surname><given-names>S.</given-names></name><name><surname>Kohsaka</surname><given-names>S.</given-names></name><name><surname>Nabekura</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Resting microglia directly monitor the functional state of synapses <italic>in vivo</italic> and determine the fate of ischemic terminals</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>3974</fpage>–<lpage>3980</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4363-08.2009</pub-id><pub-id pub-id-type="pmid">19339593</pub-id></mixed-citation>
</ref>
<ref id="B325">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakselman</surname><given-names>S.</given-names></name><name><surname>Béchade</surname><given-names>C.</given-names></name><name><surname>Roumier</surname><given-names>A.</given-names></name><name><surname>Bernard</surname><given-names>D.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Bessis</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>8138</fpage>–<lpage>8143</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1006-08.2008</pub-id><pub-id pub-id-type="pmid">18685038</pub-id></mixed-citation>
</ref>
<ref id="B326">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>T. J.</given-names></name><name><surname>Crews</surname><given-names>F. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Microglial depletion alters the brain neuroimmune response to acute binge ethanol withdrawal</article-title>. <source/>J. Neuroinflammation
<volume>14</volume>:<fpage>86</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-017-0856-z</pub-id><pub-id pub-id-type="pmid">28427424</pub-id></mixed-citation>
</ref>
<ref id="B328">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Cella</surname><given-names>M.</given-names></name><name><surname>Mallinson</surname><given-names>K.</given-names></name><name><surname>Ulrich</surname><given-names>J. D.</given-names></name><name><surname>Young</surname><given-names>K. L.</given-names></name><name><surname>Robinette</surname><given-names>M. L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model</article-title>. <source/>Cell
<volume>160</volume>, <fpage>1061</fpage>–<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.01.049</pub-id><pub-id pub-id-type="pmid">25728668</pub-id></mixed-citation>
</ref>
<ref id="B327">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuroinflammation in Parkinson’s disease and its potential as therapeutic target</article-title>. <source/>Transl. Neurodegener.
<volume>4</volume>:<fpage>19</fpage>. <pub-id pub-id-type="doi">10.1186/s40035-015-0042-0</pub-id><pub-id pub-id-type="pmid">26464797</pub-id></mixed-citation>
</ref>
<ref id="B329">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Szretter</surname><given-names>K. J.</given-names></name><name><surname>Vermi</surname><given-names>W.</given-names></name><name><surname>Gilfillan</surname><given-names>S.</given-names></name><name><surname>Rossini</surname><given-names>C.</given-names></name><name><surname>Cella</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia</article-title>. <source/>Nat. Immunol.
<volume>13</volume>, <fpage>753</fpage>–<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2360</pub-id><pub-id pub-id-type="pmid">22729249</pub-id></mixed-citation>
</ref>
<ref id="B330">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>R. J.</given-names></name><name><surname>Schuldiner</surname><given-names>O.</given-names></name><name><surname>Perrino</surname><given-names>J.</given-names></name><name><surname>Larsen</surname><given-names>C.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name></person-group> (<year>2004</year>). <article-title>Glia engulf degenerating axons during developmental axon pruning</article-title>. <source/>Curr. Biol.
<volume>14</volume>, <fpage>678</fpage>–<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2004.03.035</pub-id><pub-id pub-id-type="pmid">15084282</pub-id></mixed-citation>
</ref>
<ref id="B331">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstock</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Effects of maternal stress on development and behaviour in rat offspring</article-title>. <source/>Stress
<volume>4</volume>, <fpage>157</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.3109/10253890109035015</pub-id><pub-id pub-id-type="pmid">22432137</pub-id></mixed-citation>
</ref>
<ref id="B332">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wierzba-Bobrowicz</surname><given-names>T.</given-names></name><name><surname>Lewandowska</surname><given-names>E.</given-names></name><name><surname>Kosno-Kruszewska</surname><given-names>E.</given-names></name><name><surname>Lechowicz</surname><given-names>W.</given-names></name><name><surname>Pasennik</surname><given-names>E.</given-names></name><name><surname>Schmidt-Sidor</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics</article-title>. <source/>Folia Neuropathol.
<volume>42</volume>, <fpage>157</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="pmid">15535034</pub-id></mixed-citation>
</ref>
<ref id="B333">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wierzba-Bobrowicz</surname><given-names>T.</given-names></name><name><surname>Lewandowska</surname><given-names>E.</given-names></name><name><surname>Lechowicz</surname><given-names>W.</given-names></name><name><surname>Stepien</surname><given-names>T.</given-names></name><name><surname>Pasennik</surname><given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics</article-title>. <source/>Folia Neuropathol.
<volume>43</volume>, <fpage>81</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="pmid">16012909</pub-id></mixed-citation>
</ref>
<ref id="B334">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>Z.</given-names></name><name><surname>Kuti</surname><given-names>D.</given-names></name><name><surname>Ferenczi</surname><given-names>S.</given-names></name><name><surname>Gulyás</surname><given-names>K.</given-names></name><name><surname>Polyák</surname><given-names>A.</given-names></name><name><surname>Kovács</surname><given-names>K. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Impaired microglia fractalkine signaling affects stress reaction and coping style in mice</article-title>. <source/>Behav. Brain Res.
<volume>334</volume>, <fpage>119</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2017.07.023</pub-id><pub-id pub-id-type="pmid">28736330</pub-id></mixed-citation>
</ref>
<ref id="B335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisor</surname><given-names>J. P.</given-names></name><name><surname>Schmidt</surname><given-names>M. A.</given-names></name><name><surname>Clegern</surname><given-names>W. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Evidence for neuroinflammatory and microglial changes in the cerebral response to sleep loss</article-title>. <source/>Sleep
<volume>34</volume>, <fpage>261</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1093/sleep/34.3.261</pub-id><pub-id pub-id-type="pmid">21358843</pub-id></mixed-citation>
</ref>
<ref id="B400">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wlodarczyk</surname><given-names>A.</given-names></name><name><surname>Holtman</surname><given-names>I. R.</given-names></name><name><surname>Krueger</surname><given-names>M.</given-names></name><name><surname>Yogev</surname><given-names>N.</given-names></name><name><surname>Bruttger</surname><given-names>J.</given-names></name><name><surname>Khorooshi</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A novel microglial subset plays a key role in myelinogenesis in developing brain</article-title>. <source/>EMBO J.
<volume>36</volume>, <fpage>3292</fpage>–<lpage>3308</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201696056</pub-id><pub-id pub-id-type="pmid">28963396</pub-id></mixed-citation>
</ref>
<ref id="B336">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohleb</surname><given-names>E. S.</given-names></name><name><surname>McKim</surname><given-names>D. B.</given-names></name><name><surname>Sheridan</surname><given-names>J. F.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior</article-title>. <source/>Front. Neurosci.
<volume>8</volume>:<fpage>447</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2014.00447</pub-id><pub-id pub-id-type="pmid">25653581</pub-id></mixed-citation>
</ref>
<ref id="B337">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohleb</surname><given-names>E. S.</given-names></name><name><surname>Terwilliger</surname><given-names>R.</given-names></name><name><surname>Duman</surname><given-names>C. H.</given-names></name><name><surname>Duman</surname><given-names>R. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Stress-induced neuronal colony stimulating factor 1 provokes microglia-mediated neuronal remodeling and depressive-like behavior</article-title>. <source/>Biol. Psychiatry
<volume>83</volume>, <fpage>38</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.05.026</pub-id><pub-id pub-id-type="pmid">28697890</pub-id></mixed-citation>
</ref>
<ref id="B338">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>Y.</given-names></name><name><surname>Yona</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>K. W.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Microglia, seen from the CX3CR1 angle</article-title>. <source/>Front. Cell. Neurosci.
<volume>7</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2013.00026</pub-id><pub-id pub-id-type="pmid">23507975</pub-id></mixed-citation>
</ref>
<ref id="B339">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worley</surname><given-names>M. J.</given-names></name><name><surname>Heinzerling</surname><given-names>K. G.</given-names></name><name><surname>Roche</surname><given-names>D. J.</given-names></name><name><surname>Shoptaw</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study</article-title>. <source/>Drug Alcohol Depend.
<volume>162</volume>, <fpage>245</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2016.02.036</pub-id><pub-id pub-id-type="pmid">26993372</pub-id></mixed-citation>
</ref>
<ref id="B340">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>M. J.</given-names></name><name><surname>Liao</surname><given-names>Y.</given-names></name><name><surname>Thiyagarajan</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Sleep drives metabolite clearance from the adult brain</article-title>. <source/>Science
<volume>342</volume>, <fpage>373</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1126/science.1241224</pub-id><pub-id pub-id-type="pmid">24136970</pub-id></mixed-citation>
</ref>
<ref id="B341">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>E.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Xiong</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of microglia in methamphetamine-induced neurotoxicity</article-title>. <source/>Int. J. Physiol. Pathophysiol. Pharmacol.
<volume>9</volume>, <fpage>84</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="pmid">28694920</pub-id></mixed-citation>
</ref>
<ref id="B342">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Miller</surname><given-names>E. C.</given-names></name><name><surname>Pozzo-Miller</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Dendritic spine dysgenesis in Rett syndrome</article-title>. <source/>Front. Neuroanat.
<volume>8</volume>:<fpage>97</fpage>. <pub-id pub-id-type="doi">10.3389/fnana.2014.00097</pub-id><pub-id pub-id-type="pmid">25309341</pub-id></mixed-citation>
</ref>
<ref id="B343">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L.</given-names></name><name><surname>Kan</surname><given-names>E. M.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Hao</surname><given-names>A.</given-names></name><name><surname>Dheen</surname><given-names>S. T.</given-names></name><name><surname>Kaur</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia</article-title>. <source/>J. Neuroinflammation
<volume>10</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-10-23</pub-id><pub-id pub-id-type="pmid">23388509</pub-id></mixed-citation>
</ref>
<ref id="B344">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>S. M.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name></person-group> (<year>1999</year>). <article-title>Increased interleukin-6 expression by microglia from brain of aged mice</article-title>. <source/>J. Neuroimmunol.
<volume>93</volume>, <fpage>139</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-5728(98)00217-3</pub-id><pub-id pub-id-type="pmid">10378877</pub-id></mixed-citation>
</ref>
<ref id="B345">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yirmiya</surname><given-names>R.</given-names></name><name><surname>Rimmerman</surname><given-names>N.</given-names></name><name><surname>Reshef</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Depression as a microglial disease</article-title>. <source/>Trends Neurosci.
<volume>38</volume>, <fpage>637</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2015.08.001</pub-id><pub-id pub-id-type="pmid">26442697</pub-id></mixed-citation>
</ref>
<ref id="B346">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yona</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>K. W.</given-names></name><name><surname>Wolf</surname><given-names>Y.</given-names></name><name><surname>Mildner</surname><given-names>A.</given-names></name><name><surname>Varol</surname><given-names>D.</given-names></name><name><surname>Breker</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis</article-title>. <source/>Immunity
<volume>38</volume>, <fpage>79</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.12.001</pub-id><pub-id pub-id-type="pmid">23273845</pub-id></mixed-citation>
</ref>
<ref id="B502">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>P.</given-names></name><name><surname>Condello</surname><given-names>C.</given-names></name><name><surname>Keene</surname><given-names>C. D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Bird</surname><given-names>T. D.</given-names></name><name><surname>Paul</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy</article-title>. <source/>Neuron
<volume>90</volume>, <fpage>724</fpage>–<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.05.003</pub-id><pub-id pub-id-type="pmid">27196974</pub-id></mixed-citation>
</ref>
<ref id="B347">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>R. K. C.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Bookman</surname><given-names>M.</given-names></name><name><surname>Howe</surname><given-names>L. J.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>Patel</surname><given-names>R. V.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>602</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4524</pub-id><pub-id pub-id-type="pmid">28263302</pub-id></mixed-citation>
</ref>
<ref id="B348">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>Y.</given-names></name><name><surname>Paolicelli</surname><given-names>R. C.</given-names></name><name><surname>Sforazzini</surname><given-names>F.</given-names></name><name><surname>Weinhard</surname><given-names>L.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Pagani</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>400</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3641</pub-id><pub-id pub-id-type="pmid">24487234</pub-id></mixed-citation>
</ref>
<ref id="B349">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Shirayama</surname><given-names>Y.</given-names></name><name><surname>Shimizu</surname><given-names>E.</given-names></name><name><surname>Iyo</surname><given-names>M.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain</article-title>. <source/>Eur. J. Pharmacol.
<volume>544</volume>, <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2006.05.047</pub-id><pub-id pub-id-type="pmid">16859675</pub-id></mixed-citation>
</ref>
<ref id="B350">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Pei</surname><given-names>Z.</given-names></name><name><surname>Miller</surname><given-names>D. S.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Block</surname><given-names>M. L.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Aggregated α-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease</article-title>. <source/>FASEB J.
<volume>19</volume>, <fpage>533</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1096/fj.04-2751com</pub-id><pub-id pub-id-type="pmid">15791003</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>